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ABSTRACT 
 
The present research sought to understand patient experiences during Hyperbaric Oxygen 
Therapy (HBOT) by using 24 HBOT patients (17 men, 7 women) to examine the 
relationship between individual variables and anxiety, and providing One Session 
Exposure Therapy (OSET; Öst, 1989) if necessary. Pre-HBOT participants completed the 
following measures: State-Trait Anxiety Inventory (STAI; Spielberger, 1983), 
Claustrophobia Questionnaire (CLQ; Radomsky, Rachman, Thordarson, McIsaac, & 
Teachman, 2001), Anxiety Sensitivity Index (ASI; Reiss, Peterson, Gursky, & McNally, 
1986), and Treatment Credibility/Expectancy Questionnaire (CEQ; Devilly & Borkovec, 
2000). State Anxiety was assessed pre-HBOT and at the tenth and last sessions. Findings 
suggest Dispositional Anxiety (STAI-Trait + ASI), Expectancy of symptom improvement 
(CEQ), and gender were significantly predictive of State Anxiety before and during 
HBOT. Limitations and directions for future research are discussed.  
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CHAPTER ONE  
1. INTRODUCTION 
 
 
Experiencing an intrusive medical intervention is an inevitable event for the majority of 
the population. Should medical conditions give rise to sometime in life unpleasant 
medical procedures or hospitalisation, psychological distress and anxiety may be 
encountered (Sarafino, 1998). Psychological distress in medical settings encompasses the 
emotional reactions a patient has in response to their interactions and involvement with, 
for example, medical professionals, locales, procedures and/or surgeries. Recent research 
suggests ‘typical’ manifestations of psychological distress in medical studies include 
symptoms of anxiety and fear (Lowenstein, Deutcsh, Gruberg, Solt, Yagil, Nevo, et al., 
2006; Vögele, 2004). For example, reactions to Magnetic Resonance Imaging (MRI) 
scans range from nervousness to intense fear or terror (Lukins, Davan, & Drummond, 
1997). Similarly, even relatively common outpatient procedures, such as cervical smears 
and dental check-ups, can be anxiety-provoking (Vögele, 2004). This is illustrated by 
Anderson and Masur’s (1983) review which found that patients facing surgical or dental 
procedures often report high levels of anxiety.  
 
Generally, anxiety and fear as emotions can appear very similar; therefore distinguishing 
them can be difficult (Lader & Marks, 1971). Both anxiety and fear are characterised by 
increased arousal and subjective and/or physiological arousal (Rachman, 1998). Anxiety, 
in this instance, is defined in the Diagnostic and Statistical Manual of Mental Disorders 
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(DSM-IV) as “apprehensive anticipation of future danger or misfortune accompanied by 
a feeling of dysphoria or somatic symptoms of tension.” (American Psychiatric 
Association (APA); 2000, p. 820). People may experience apprehension along with 
physiological symptoms such as increased heart rate, when contemplating upcoming 
medical procedures. ‘Fear responses’ however, are said to involve the interaction of two 
elements: physiological arousal and cognitions that interpret the situation as dangerous 
and therefore attribute this arousal to fear (Meichenbaum, 1977). This implies that the 
stressful situation (namely, medical procedures) is largely unrelated to the emotional 
response of the individual, but rather that it is the individual’s evaluation of the ‘danger’, 
and how they interpret their body’s responses, which determines the individual’s 
emotional response to the situation (Davis, Robbins Eshelman, & McKay, 2000). Thus, 
perception of a situation will control or determine fear, whether the perception is correct 
or incorrect, whereas anxiety is not so clearly directed or determined (Rachman, 1998). In 
practice, it is harder to differentiate between anxiety and fear than in theory and the terms 
are often used interchangeably (Rachman, 1998).  
 
It is important to distinguish between normal anxiety and clinical anxiety. Normal 
anxiety is widespread, affects most individuals, and depending on individuals, often is 
related to specific situations (Lader & Marks, 1971). However, clinical anxiety can be 
defined in the sense that it is “more marked, more frequent or more persistent than the 
intensity, occurrence or duration which the patient regards as his norm or as the norm for 
his or her peers” (Lader & Marks, 1971, p. 22). As mentioned, anxiety surrounding 
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medical procedures is a common reaction (Vögele, 2004), thus this anxiety, while 
unpleasant, is not an atypical response. 
 
The experience of anxiety and fear when individuals undergo routine medical treatments 
varies in prevalence between studies and procedures. The literature, depending on study, 
has described a range of incidence for adult preoperative anxiety from 11% to 80% 
(Maranets & Kain, 1999). For instance, MRI research has reported that as many as two 
out of three people who complete an MRI scan experienced anxiety or claustrophobic 
fear before or during their scan (Quirk, Letendre, Ciottone, & Lingley, 1989a). In 
addition, an MRI review (Phillips & Deary, 1995) described these common reactions by 
reporting that 35% of patients experience apprehension and between 5–10% experience 
extreme panic and/or claustrophobia. For the procedure Hyperbaric Oxygen Therapy 
(HBOT), research reported 43% of 87 patients who had undergone this experienced 
anxiety to some degree, with five discontinuing because of their anxiety (Ellis & Mandal, 
1983). Therefore, the current rates of prevalence of anxiety in patients before and during 
medical procedures are varied according to procedure and study, and thus justify further 
research into investigating this phenomenon.  
 
Unfortunately, the effect of fearful or anxious reactions within a medical setting may be 
adverse (Luck, Pearson, Maddern, & Hewett, 1999). Psychological distress (e.g. extreme 
anxiety), lack of ability to comprehend information, fear of the unknown, unfamiliar 
surroundings and procedures, and cultural and social backgrounds, can all affect a 
patient’s ability to adjust and cope with prescribed medical procedures (Horne, 
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Vatmanidis, & Careri, 1994). While there are many medical procedures, settings, and 
types of surgeries that can evoke anxiety and fear in the individual, the purpose of this 
study is to contribute to the body of knowledge regarding patient psychological distress – 
particularly anxiety and fear – in the context of contemplating or undergoing the medical 
procedure of HBOT.  
 
1.1. HYPERBARIC OXYGEN THERAPY 
 
HBOT is a medical procedure involving the administration of 100% oxygen in 
conjunction with a higher than atmospheric pressure (Feldmeier, 2003). This procedure is 
used to treat a variety of acute and chronic medical conditions (see next section). Pressure 
vessels and oxygen therapy has been used for more than 100 years (Sosiak & Evans, 
2005) for divers and caisson workers who developed decompression sickness, or “the 
Bends”. Scientific use of HBOT in clinical medicine, however, was introduced in 1955, 
and became formalised in 1976 by the Undersea Medical Society who formed an ad hoc 
committee on hyperbaric oxygenation (Kindwall & Whelan, 1999). Hyperbaric centres 
have since extended across the developed world.  
 
HBOT takes place in a hyperbaric chamber. A hyperbaric chamber is a pressure vessel 
utilised within medical settings. Hyperbaric chamber types can be monoplace (refer to 
Image 11) or a multiplace (refer to Images 2 and 3). Monoplace chambers are hollow 
spheres, approximately 1.4m in diameter, and accommodate one patient, generally placed 
                                                 
1
 Permission for use of photos was granted by Christchurch Hospital’s Hyperbaric Medicine Unit, and 
photos are available for public use via their website http://www.cdhb.govt.nz/hbu/.  
12  
in a prone position (Kot, Houman, & Müller, 2006). The multiplace chamber 
accommodates two or more patients, and medical personnel (Feldmeier, 2003). This type 
of chamber is large enough to accommodate trolleys, or beds, if necessary. The 
development of the multiplace chamber provided several benefits over monoplace 
chambers. The most important justification of multiplace preference is that it provides 
increased quality of patient care during HBOT sessions (Kindwall & Whelan, 1999). 
With the larger area clinicians are able to provide necessary direct care to patients who 
for example, may have multiple intravenous drips and ventilators that need manipulating 
or monitoring. Additionally, the multiplace chambers are more economically viable, 
allowing more patients to be treated simultaneously.  
 
Image 1: Monoplace chamber  
Image 2: Multiplace chamber – outside  
Image 3: Multiplace chamber – inside 
1   2   3    
 
The process of a patient undergoing a treatment session in the chamber is called a “dive”. 
A dive generally takes approximately two and a half hours, and involves the 
incorporation of compression, oxygen intake ‘at depth’, and decompression, in that order. 
In a multiplace chamber, compression takes between five and ten minutes. Patients then 
breathe 100% oxygen from a Built-In-Breathing system (BIBs) via a face mask or a head 
hood for approximately 60–120 minutes. Current practice is to have the patient breathe 
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100% oxygen at a pressure of 203-284kPa (2–2.8Ata) (normal atmospheric pressure is 
101.3kPa) (Hyperbaric Chamber Safety Committee, 1994). Approximately half way 
through a treatment session patients take an ‘air break’ of approximately 10 minutes, as 
this is reported to minimise pulmonary oxygen toxicity (Kindwall & Whelan, 1999). This 
involves patients removing headgear. Prior to exiting the chamber, patients are subject to 
a 30 minute period of decompression, essential to prevent the development of “the 
Bends” (decompression sickness).   
   
HBOT patients typically undergo a series of sessions (usually 20 to 40 sessions, five days 
a week) in the hyperbaric chamber (with the variation depending on the condition of the 
patient). Different maximum pressures and durations of treatment are used in varying 
clinical situations – for example, the emergency treatment of a diver with decompression 
sickness may start at 405kPa on a helium/oxygen breathing mix and last over seven 
hours, while a patient with problem wounds will undergo a series of two and a half hour 
sessions as described.  
 
Who Uses Hyperbaric Oxygen Therapy and Why? 
 
The medical use of HBOT is to treat patients with a variety of medical conditions. 
Currently, the Undersea and Hyperbaric Medical Society recognises as many as 13 
clinical indications for HBOT (Feldmeier, 2003), and classifies the benefits of HBOT 
into four categories: mechanical effects, bacteriostatic effects, treatment of poisoning, 
and treatment of hypoxia (Broussard, 2004). Additionally, because of the diversity of 
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HBOT’s uses, and the benefits and side effects, HBOT has attracted attention from 
various fields of research, including military medicine (Clark, Rock, & Tackett, 1994), 
aviation and space medicine (Plafki, Peters, Almeling, Welslau, & Busch, 2000), and 
nursing (Broussard, 2004).  
 
There is much research on the proposed benefits of HBOT on medical conditions, for 
example, wound healing (Broussard, 2004), musculoskeletal disorders (Wang, Calhoun, 
& Mader, 2002), tinnitus (Stiegler, Matzi, Lipp, Kontaxis, Klemen, Walch, et al., 2006), 
and necrotizing fasciitis (Wilkinson & Doolette, 2004), demonstrating the potential 
importance HBOT can have in many patients’ health plans. HBOT is used to treat ‘acute’ 
and ‘chronic’ cases and its rationale is complex and varies according to the pathology of 
the patient. ‘Acute’ patients may present with decompression sickness and therefore 
require immediate and potentially extensive life-saving treatment. Treatment, in this 
instance, works via the regulation and reduction of nitrogen in the body’s tissues, thereby 
correcting hypoxia (a shortage of oxygen in the body). Some serious infections (gas 
gangrene) and poisoning (carbon monoxide) are also considered acute and require 
immediate care. More common today however, is the use of HBOT for chronic 
conditions that include but are not limited to non-healing wounds, radiation tissue 
damage, sports injuries, and some infective cases. The therapeutic effect for non-acute 
cases lies in both the increased achieved oxygen partial pressure at higher than normal 
atmospheric pressure, as well as the increased oxygen transport capacity of the blood. For 
example, for non-healing hypoxic wounds, the aim of the procedure is to supply extra 
oxygen, thus enhancing healing (Broussard, 2004). 
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Distressing features of Hyperbaric Oxygen Therapy 
 
It is important to delineate how and why the distressing features of HBOT can affect 
patients requiring this treatment. Invasive medical procedures often are not pleasant 
procedures, and research suggests that the degree of anxiety during medical procedures is 
associated with the level of invasiveness associated with that procedure (Weller & Hener, 
1993). While HBOT is technically a ‘non-invasive’ form of treatment – where ‘invasive’ 
is defined as “any operative or diagnostic technique, usually involving the use of 
instruments, that necessitates the penetration of tissue or the invasion of a body orifice.” 
(Anderson & Masur, 1983, p. 2) – it still has the potential to cause varying degrees of 
discomfort and pain in some patients, despite the fact it does not actually ‘invade’ the 
patient’s body. Issues reported significant to undergoing HBOT include discomfort of the 
face mask or head hood, boredom, noise and coldness of the chamber (Chalmers, 
Mitchell, Rosenthal, & Elliot, 2007), and aural or sinus barotraumas (Wang et al., 2002).  
 
Several situational and mechanical features of HBOT may cause patients to experience 
psychological distress. Firstly, the chamber is small and restrictive and it is not possible 
to escape rapidly unless there is an emergency. Secondly, the headgear worn during the 
procedure can be uncomfortable. Finally, patients are often uncertain about treatment and 
this can subsequently provoke feelings of anxiety. The restrictive nature of the chamber 
and its relationship to claustrophobic anxieties will be discussed later in this section, and 
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research regarding patient uncertainty and discomfort in the HBOT setting will presently 
be discussed.  
 
Research surrounding the psychological impact of medical procedures and surgery has 
been published for some time. Reports from medical and dental studies include, among 
others, at least five frequently occurring themes: fear of complications; fear of pain; fear 
of the unknown; fear of discomfort; and disruption of life plans (Anderson & Masur, 
1983). Firstly, undergoing HBOT, like all medical procedures, increases the risk of 
potential complications. HBOT complications include trauma to ear drums, sinuses or 
teeth, mild rise in blood pressure, mild cough and soreness behind the breast bone, mild 
reduction in quality of distance vision, oxygen convulsion, and an increased fire hazard 
(due to high oxygen concentrations). While some of these complications however, are 
mild and/or reversible, they remain factors which patients are made aware of both prior to 
and during their treatment. Secondly, patients may have the added fear of how HBOT 
may affect pain, if present. Thirdly, for those who have not experienced HBOT before, 
despite information given by staff, there is also the fear of the unknown, especially when 
undertaking the first “dive”. As mentioned, the DSM-IV includes anticipatory 
apprehension in its definition of anxiety (APA, 2000) and patients requiring HBOT may 
be anxious and/or apprehensive about undertaking a procedure they know little about. 
Consequently, patients experiencing distress may choose not to undergo their hyperbaric 
sessions. Where the clinical prognosis indicates that if patients’ health care is delayed, the 
potential for future adverse health complications can become more likely and this may 
increase future health care needs. A fear or anxiety-based decision to terminate HBOT, or 
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not to have it at all, may lead to adverse medical outcomes, e.g. loss of limbs, lack of 
wound healing, potential reduction of intensity and duration of pain, etc. Fourthly, 
patients may worry about the discomfort of wearing oxygen headgear for a prolonged 
period. Lastly, because it necessitates repetitive treatments HBOT is a significant 
disruption to patients’ lives, requiring a time commitment of approximately three hours a 
day, five days a week, for up to two months.  
 
It has been well documented that potential side effects of HBOT include confinement 
anxiety and/or claustrophobic fear (e.g. Broussard, 2004; Kindwall & Whelan, 1999; 
Plafki et al., 2000). Kindwall and Whelan (1999) report that approximately one in 50 
patients experience some level of confinement anxiety in a multiplace chamber. 
Furthermore, it has also been reported that some people fail to complete treatment 
altogether because their reported levels of anxiety are so high (Ellis & Mandal, 1983; 
Plafki et al., 2000; Weaver, 2006; Weaver, Hopkins, Chan, Churchill, Elliot, Clemmer, et 
al., 2002). However, while the medical literature surrounding hyperbaric therapy 
recognises confinement anxiety as an issue, existing research generally affords anxiety 
and claustrophobic fear no more than a passing reference (e.g. Broussard, 2004; Escobar, 
Slade, Hunt, & Cianci, 2005; Sosiak & Evans, 2005; Tibbles & Edelsberg, 1996; Wang et 
al., 2002; Weaver, 2006). Generally, medical literature on HBOT introduces confinement 
anxiety in the context of outlining potential side effects or adverse consequences (Tibbles 
& Edelsberg, 1996; Wang et al., 2002) or briefly as a description in their results (Escobar 
et al., 2005). As a consequence, this lack of examination leaves the full phenomenology, 
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natural course, and/or predictor of the relationship between HBOT and anxiety in need of 
further empirical investigation.  
 
Two studies that have attempted to investigate patients’ experiences while undergoing 
HBOT come from a military and a nursing background. These are discussed below.  
 
Clark et al. (1994) sought to determine the magnitude and specific foci of anxiety 
experienced by a sample of 24 adult patients referred for their initial hyperbaric treatment 
at an American military centre. Levels of anxiety were assessed at three intervals: before 
any health care teaching, one hour pre-treatment (and post-health care teaching), and 
immediately post-treatment. In addition to this, patients participated in a personal 
interview immediately after their initial HBO treatment regarding concerns and feelings 
about the session. The pre-teaching State and Trait anxiety levels were found to be low, 
in comparison to normative data. Further, there was no significant difference between 
pre-teaching and pre-treatment phases, but there were significant decreases from both 
pre-teaching to post-treatment, and pre-treatment to post-treatment. Regarding the 
specific foci of anxiety, 48% confirmed that the orientations helped prepare them for their 
HBOT while 52% had no concerns regarding their first HBOT. Collectively, 82% 
expressed positive views about the orientation sessions. The strengths of this study 
included a specific focus on anxiety levels and an effort to determine patient perspectives. 
However, the research setting (Veteran’s Hospital) could explain why the general levels 
of anxiety were low. Most of the sample would have experienced some or many intense 
stress-provoking situations during military service, and may not be typical of other 
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general hospital patients undergoing HBOT. Additionally, the sample was not randomly 
selected, was mostly male (only two females), and had a mean age of 55 years (range 27 
– 81 years). These factors necessitate caution when interpreting this study, and limit its 
generalisability to other populations.  
 
More recently, Chalmers et al., (2007) undertook an exploration of patients’ memories 
and experiences of HBOT in a multiplace chamber in Australia. They used a sample of 
seven patients at the conclusion of their HBOT sessions, using a semi-structured 
interview. The qualitative analysis used was Grounded Theory. Categories were not 
developed prior to data analysis, but became known from the analysis. Four different 
issues were derived: uncertainty of treatment; discomfort of the face mask or head hood; 
noise and cold of the chamber; and boredom. Chalmers et al. (2007) reported that even 
when patients are educated about the process of HBOT via an orientation, they often 
continue to feel fairly unprepared and uncertain for their actual sessions. Additionally, it 
was noted, patient apprehension may have some link with past adverse radiotherapy or 
surgical experiences. Chalmers et al. (2007) also found that the physical discomfort of the 
face mask or head hood is a real issue for some patients when it comes to continuing their 
HBO treatment. This is because, on one hand, the face mask (see Image 4) works by the 
activation of a demand regulator (Christchurch Hospital, 2008), which can make patients 
with respiratory conditions more vigilant than normal with their breathing. The head 
hood (see Image 5), on the other hand, has a continuous flow of 100% oxygen in and a 
mixture of oxygen and CO2 out (Christchurch Hospital, 2008), which results in intrusive 
noise directly around the face. While both types of headgear have their own pros and 
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cons, Chalmers et al. (2007) report that individual preference is the determining factor as 
to which is less distressing. Chalmers et al., (2007) applied the findings in their research 
to their future practices to attempt to make patient experiences less stress-invoking. They 
introduced increased communication with the patients during their orientation, achieved 
noise reduction during the session, and initiated air-breaks from the face mask or head 
hood to relieve boredom and discomfort. Anecdotally, subsequent patient reports were 
positive in regards to these clinical changes (Chalmers et al., 2007). For this study, it is 
important to be aware when drawing conclusions that this research was an exploratory 
design and thus only provides an insight into a small group of patients during HBOT. 
While strengths in this research included the foci on patient experiences and use of the 
more widespread multiplace chamber, caution needs to be exercised in making definitive 
conclusions, and further replication research and quantitative data would provide 
beneficial information.  
 
Image 4: Face Mask 
Image 5: Head Hood 
4   5  
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As described above, the limited research there is recognises confinement anxiety or 
claustrophobic fear as a potential anxiety-arousing factor in HBOT (e.g. Broussard, 
2004). Consequently, it is beneficial to describe claustrophobia, its characteristics, and 
how it relates to HBOT. 
 
Claustrophobia is classified as a situational subtype of Specific Phobias in the DSM-IV 
(APA, 2000), which states that the “essential feature of specific phobia is marked and 
persistent fear of clearly discernible, circumscribed objects or situations” (APA, 2000, p. 
443). Claustrophobic fear is cued by a specific situation such as lifts, small rooms, and 
enclosed places. The mean age of claustrophobic onset is approximately 20 years and 
prior to diagnosis has a mean duration of approximately 17 years (Öst, 1987). While 
severe claustrophobia is estimated to occur in as much as 2-5% of the population 
(Rachman, 1997), the number of people who seek help for symptoms of claustrophobia is 
much smaller. Accordingly, the prevalence for mild to moderate claustrophobia in 
individuals, it would be assumed, may be significantly higher than this, though for many 
living with claustrophobic fear it may not present itself as a problem in their life. 
However, for people with claustrophobic tendencies, requiring HBOT may be an issue 
because of its association with confinement anxiety (Broussard, 2004). This is because 
the hyperbaric chamber can evoke claustrophobic fear, even potentially in individuals 
without previous experiences of claustrophobic fear. Therefore, individuals with previous 
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experiences of fear of enclosed places are likely to experience some degree of anxiety in 
the HBOT setting, and more so than individuals low on such fear. 
 
Claustrophobia is reported to be made up of two elements – a fear of restriction and a fear 
of suffocation (Rachman, 1997). This two-factor structure has been well researched and 
widely supported; Rachman and Taylor (1993) propose that while either of the two 
elements can sufficiently produce claustrophobic reactions in the individual, when 
experienced in combination it is far more likely. Subsequent research further supports the 
restriction and suffocation components of claustrophobic fear. Febbraro and Clum (1995) 
extend upon these findings by arguing that key claustrophobic cognitions include 
suffocation, entrapment, and loss of control.  
 
HBOT has features that pertain to both restriction and suffocation elements. Firstly, as 
discussed, patients are required to wear headgear, which is directly related to one’s 
breathing and air supply and may cause anxiety for patients with fears of suffocation. 
Patients do receive 100% oxygen through their respective headgear, but it tends to be a 
physically uncomfortable process for most. While the pressured chamber contains air 
vents and a carbon dioxide remover, the sealed chamber may also cause anxiety for 
patients with cognitions about fear of suffocation through a lack of oxygen. Secondly, the 
chamber can evoke feelings of restriction, even for the most relaxed patient. To allow for 
the change in pressure, the chamber door is sealed shut, and to return to normal 
atmospheric pressure takes approximately half an hour, although in an emergency this is 
achieved in approximately two minutes. This creates a situation where individuals are 
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unable exit rapidly and may cause people who have existing claustrophobic fears or 
tendencies to feel frightened and feel an urgent need to escape (Rachman, 1997). 
Essentially, patients must remain inside the hyperbaric chamber as it is too dangerous, 
even fatal, to leave without the correct decompression sequence. In addition to both 
restriction and suffocation elements influencing anxiety, the size of the chamber may be 
another distressing factor. The multiplace chamber used in the present study measures 
2.25m wide by 2.97m long and 2.1m high (Fink Engineering, 2000). With several 
patients and a nurse inside, this small area may create a cramped and uncomfortable 
environment for the patient. In summary, HBOT contains characteristics of suffocation 
and restriction and/or entrapment, and the combination of a perception of physical 
restriction and a perception of threat to one’s air supply can be dangerous and provide a 
foundation for claustrophobic reactions (Rachman, 1993).  
 
While research surrounding HBOT and psychological distress is limited, fear and anxiety 
surrounding MRI procedures are much better investigated. MRI, like HBOT, is a medical 
procedure that appears to elicit some distress regarding confinement from patients. It is 
therefore interesting to briefly consider the relevant literature.  
 
Similar to HBOT, termination of the MRI procedure due to acute anxiety has been 
observed: McIsaac, Thordarson, Shafran, Rachman, and Poole (1998) found that for a 
subset of patients, claustrophobic fear can be so intense that it triggers panic during the 
MRI scan – which in a number of instances leads to termination of the scan. Research 
also suggests that between five and ten percent of patients report claustrophobic reactions 
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during an MRI scan (Kilborn & Labbé, 1990), and it is estimated 1% to 10% diagnostic 
studies have failed because patients refused to complete the procedure (Friday & Kubal, 
1990). Research into claustrophobia and MRI scanning proposes that the anxiety induced 
by MRI scans is primarily claustrophobic in nature (McIsaac et al., 1998). HBOT also 
appears to be associated with the claustrophobia components and while there are some 
potential differences with HBOT, it is beneficial to be informed by the larger body of 
knowledge that MRI research allows.  
 
In summary, while data reporting on the psychological experiences of patients’ during 
HBOT remains limited – especially with regard to multiplace chambers – it certainly is 
recognised that it can be a distressing procedure.  
 
1.2. REDUCING DISTRESS IN MEDICAL SETTINGS 
 
Why distress in medical settings needs to be reduced 
 
The experience of anxiety and/or fear before surgery or a medical procedure is something 
that is frequently described by patients (Kendall & Watson, 1981). In fact, as Stoddart, 
White, Covin, and Strauss (2005) point out, fear and anxiety is reported by more than 
80% of adult patients undergoing a medical procedure. While many of these may not 
require intervention, some do find it extremely anxiety-provoking, thus it is vital to 
investigate the effect that this type of distress can have on patients, both prior to and 
immediately following their scheduled medical procedure.  
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Distress needs to be reduced because much research links the experience of fear and 
anxiety before medical procedures or surgery with negative post-procedure outcomes 
(e.g. Horne et al. 1994; Kiecolt-Glaser, Marucha, MacCallum, & Glaser, 1998). Very 
recently Kagan and Bar-Tal (2008) showed that for patients undergoing elective 
arthroplasty, post-operative well-being and mental health were negatively affected by 
preoperative anxiety. Furthermore, reducing distress may benefit diagnostic results. 
Results may be affected by the level of distress experienced by the individual within the 
medical setting. The experience of strong fear and anxiety impinging upon a patient’s 
ability to keep still over an extended period of time (for example during the imaging 
process of an MRI) increases the likelihood that the results of the procedure will be 
compromised. As two case studies demonstrate (Klonoff, Janata, & Kaufman, 1986; 
Simon, 1999. Refer to Table 2) the inability to achieve accurate diagnostic results and 
complete an MRI scan, due to anxiety and a patient’s inability to remain still in the 
scanner, are motivating factors for the implementation of psychological intervention in 
MRI settings.  
 
Ideally, it is hoped that by reducing distress surrounding HBOT, adjustment and coping 
to the aforementioned distressing features of HBOT will be less stressful. In turn, this is 
hoped to increase the likelihood for the patient to commence, and complete, all of their 
required HBOT sessions, thereby achieving the positive health outcomes from treatment. 
Reducing distress in patients before and during medical procedures can be advantageous 
to medical staff and hospitals, be cost-effective, and of benefit to the patient themselves. 
26  
Thus, it is important to address psychological preparation before medical procedures, in 
order for patients to have the best possible outcome.   
 
 
Review of techniques used for reducing distress in medical settings 
 
Over the past four decades the importance of investigating how the reduction of distress 
in medical settings can be of benefit to patients has been made evident in a number of 
studies (Devine, 1992; Vögele, 2004). Psychological preparation before nonsurgical 
medical procedures has been shown to be of benefit by improving adjustment and 
recovery both prior and following a medical procedure (Sarafino, 1998). The designs of 
psychological preparation for medical procedures and surgery have tended to focus 
primarily on reducing pre-procedural anxiety and concerns. The general rationale for 
psychological preparation prior to an invasive medical procedure/surgery is that, as 
previously discussed, a high pre-procedure level of fear can create adverse adjustment 
problems or negative impacts on well-being subsequent to procedure. A major meta-
analysis (Devine, 1992) supports the provision of pre-procedural psychological 
preparation as having a small to moderate beneficial effect on patient psychological 
distress. 
 
The above rationale does not specifically pertain to HBOT for a number of reasons. 
Firstly, the rationale for psychological preparation prior to HBOT should focus on 
adjustment and exposure to the HBOT sessions themselves, rather than on any post-
procedural benefits of psychological preparation, as any post-procedure benefits will 
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derive from the HBOT treatment itself. Secondly, as described, HBOT is technically not 
an invasive procedure. Finally, while surgery and invasive procedures like cardiac 
catheterisation are normally one-off treatments, HBOT is a repetitive medical procedure, 
not unlike procedures such as burn debridement and renal dialysis. 
 
The next section will briefly review techniques that have been used to reduce distress in 
medical settings, with a specific focus on MRI and HBOT. Table 1 lists outcome studies 
that have investigated psychological preparation before general medical procedures or 
surgery. The type of medical procedure/surgery, type of psychological preparation, 
sample description and group assignment, design, outcome measures, and results are all 
specified.   
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Table 1 
Studies Investigating Psychological Preparation before Medical Procedures or Surgery 
Author/s Design Type of Procedure/Surgery 
Type of 
Assignment 
(N) 
Type of 
Control 
Group 
Type of Psychological 
Preparation 
Outcome 
Measures Results 
Strengths/Limitations 
+/- 
Claar, Walker, 
and Smith, 
(2002) 
Descriptive, 
correlational 
Esophagogastroduodenoscopy 
(EGD) 
Children (8 
– 17 years) 
(100) 
No control 
group 
Information appraisal Endoscopy 
Knowledge & 
Patient Preparation 
 
EGD Appraisals 
 
State Trait Anxiety 
Inventory (STAI) 
for Children 
 
Scale based on the 
Observation Scale 
of Behavioural 
Distress-Revised 
 
Faces Pain Scale 
 
Modified version of 
Post-Endoscopy 
Patient 
Questionnaire 
Children with less 
knowledge about the 
EGD appraised it as 
more threatening 
 
Children with higher 
threat appraisals 
reported higher 
anxiety 
 
Children with more 
knowledge reported 
lower threat and 
those with lower 
threat reported less 
anxiety 
 
Children reporting 
greater anxiety 
showed more 
distress 
- Two scales had no 
reliability or validity 
information 
 
- Sample size lacked 
power 
 
-Lack of ethnic 
generalisability 
 
- Just by being in the 
study may have 
produced some 
changes in anxiety for 
parents and children 
Hackett, Lane, 
and McCarthy 
(1998) 
Experimental Gastrointestinal Endoscopy 
Random 
Adults (18 – 
65 years) 
(48) 
 
Attention -
control 
Group 1: Cognitive 
Group 2: Behavioural 
Group 3: Combination 
Group 4: Attention 
control 
STAI 
 
The Positive and 
Negative Affect 
Schedule 
 
Endoscopy 
Confidence 
Questionnaire 
 
Credibility 
Assessment 
Groups 1 & 3 
experienced 
significant reduction 
in anxiety and 
increase in self-
confidence from 
pre- to post-
intervention 
- No statistics reported 
with measures 
 
- Unable to rule out 
age as a confounding 
variable – was 
identified and 
implications discussed 
 
- Self reported 
questionnaires 
 
 
 
 
Kendall, 
Williams, 
Pechacek, 
Graham, 
Experimental Cardiac Catheterisation Random 
 
Standard 
Care 
Group 1: Control group 
Group 2: Attentional 
focus 
Group 3: Cognitive 
STAI 
 
Physician and 
technician ratings 
Groups 2, 3 and 4 
showed significantly 
lower state anxiety 
post-procedure 
- Be cautious with 
physicians and 
technicians reporting 
psychological distress 
29  
Shisslak, & 
Herzoff 
(1979) 
Behavioural Therapy 
(CBT) 
Group 4: Information 
provision 
 
During procedure 
groups 3 and 4 had 
significantly lower 
anxiety than groups 
1 and 2 
 
CBT participants 
were rated as best 
adjusted 
 
- Some patients had 
undergone this 
procedure before 
Lang, 
Berbaum, 
Faintuch, 
Hatsiopoulou, 
Halsey, Li et 
al. (2006) 
Experimental Large core needle breast 
biopsy 
Random 
Women 
Adults (18 – 
86 years) 
(236) 
Standard 
Care 
Group 1: Standard Care 
Group 2: Structured 
empathic attention 
Group 3: Self-hypnotic 
relaxation 
STAI -Y 
 
Verbal pain and 
anxiety ratings 
from 0-10 
Structured empathy 
and hypnosis 
decrease procedural 
pain and anxiety 
 
Hypnosis provided 
more powerful 
anxiety relief 
without undue cost, 
thus they concluded 
this to be a better 
outpatient pain 
management option 
- Clinical team was not 
blind to group 
assignments 
 
- Unknown whether 
self-hypnosis provides 
better anxiety relief 
than medicated options 
 
- Hypnosis offers a 
drug-free alternative 
for patients 
Lenzen, 
Gamel, & 
Immink, 
(2002) 
Cross-
sectional, 
descriptive 
correlational 
with a 
quantitative 
and qualitative 
component 
Percutaneous Transluminal 
Coronary Angioplasty 
(PTCA) 
Adults 
(median 60 
years) 
(86) 
No control 
group 
Provision of information 
 
First PTCA (1-PTCA) 
patients versus repeat 
PTCA (re-PTCA) 
patients 
Hospital Anxiety & 
Depression Scale 
(HADS) 
 
Heart Patients 
Psychological 
Questionnaire 
(HPPQ) 
 
Visual Analogue 
Scale (VAS) 
Re-PTCA patients 
were more likely to 
have worse 
despondency scores 
on the HPPQ – this 
difference was more 
pronounced in males 
 
Anxiety and well-
being showed a 
trend – though not 
statistically different 
– towards a worse 
condition for re-
PTCA patients. 
 
 
 
 
- Self-report 
questionnaires 
 
- Does not explain 
rationale behind 
preparatory 
information 
 
- Discuss trends and 
non-significant results 
as important outcomes, 
citing clinical 
relevance 
 
+ They cannot 
conclude undergoing a 
repeat PTCA causes 
more anxiety 
 
+ Validates anxiety is 
present prior to 
medical procedures 
Luck et al. Experimental Colonoscopy Random Routine Information provision/ STAI Females and those + Manipulation checks 
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(1999) Adults (20 – 
88 years) 
(150) 
 
treatment Modelling – everyone 
received an information 
leaflet regarding 
colonoscopy then were 
randomly assigned to 
watch the video (video 
group) or not (non-
video group) 
 
Knowledge 
Questionnaire 
(developed for 
purpose of study) 
who had not had 
previous 
colonoscopy had 
higher baseline 
anxiety 
 
The video group had 
significantly higher 
knowledge 
regarding the 
procedure and a 
significant decrease 
in anxiety pre-
procedure 
performed 
 
+ Blind assessors used 
 
- Not enough 
information provided 
discerning the two 
groups 
Mahajan, 
Wyllie, 
Steffen, Kay, 
Kitaoka, 
Dettorre et al., 
(1998) 
Experimental Gastrointestinal Endoscopy 
Random 
Children (6 
– 19 years) 
(60) 
 
Routine 
treatment 
Group 1: Control group 
Group 2: Modelling and 
information with parent 
STAI 
 
Heart Rate & Blood 
Pressure 
 
Observational Scale 
of Behavioural 
Distress 
 
Group 2 experienced 
significantly less 
self-reported anxiety 
before and during 
the procedure than 
Group 1 
 
Group 2 had 
significantly less 
autonomic nervous 
system stimulation 
before procedure 
than Group 1 
+ Used both self-report 
and physiological 
measures 
 
- No clearly articulated 
hypotheses 
 
- No manipulation 
checks 
 
- No strong rationale 
provided for 
psychological 
preparation 
Stoddart et al., 
(2005) 
Experimental Day surgery – benign 
surgeries with favourable 
outcomes only 
Random 
Adults(22 – 
54 years) 
(98) 
Basic 
background 
information 
control 
group 
Group 1: Control Call – 
basic background 
information 
Group 2: Intervention 
Call – permitted to 
request as much or as 
little information as they 
desired 
 
Group 2 would be 
moderated by “monitors 
vs. blunters” coping 
styles 
STAI 
 
Miller Behavioral 
Style Scale (MBSS) 
 
The Amsterdam 
Preoperative 
Anxiety and 
Information Scale 
(APAIS) 
No significant 
findings were 
identified – 
*preoperative 
anxiety remained 
constant over time 
*monitors and 
blunters used equal 
amounts of time on 
phone call 
+ Explanations are 
discussed for lack of 
findings 
 
+ Findings are 
discussed well in 
conjunction with past 
research 
 
- Despite random 
assignment baseline 
anxiety was greater for  
Group 2 
 
- No manipulation or 
integrity  checks were 
performed 
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Reducing distress within medical settings is not a new initiative and varieties of 
techniques have been suggested. While medication has been employed as a short-term 
solution, this would not be a suitable treatment for anxiety in patients undergoing HBOT 
because it is a repetitive and daily procedure. Additionally, it has been suggested that 
psychological approaches – such as information provision, modelling, varying procedures 
of relaxation, cognitive, behavioural, or cognitive and behavioural combined – are more 
popular alternatives (Phillips & Deary, 1995). The reported success of these techniques, 
as they pertain to reducing distress in medical settings, is varied. Each has particular 
strengths that need to be explored. 
 
Information provision is an approach frequently used as a means of psychological 
preparation prior to a medical procedure (Anderson & Masur, 1983). This technique 
relates to what has been defined as ‘typical’ or ‘normal’ reactions to unknown 
experiences. Thus, where a normal reaction before undergoing an unknown or atypical 
experience within medical settings is to seek out information regarding what will arise 
and how this may impact on oneself, it is believed that patients with insufficient 
information may experience psychological distress (Horne et al., 1994). As such, the aim 
of information provision is to provide the patient with enough information to reduce 
anxiety and allow for accurate cognitions regarding procedures. However, research 
suggests that there are variations of what the ideal medium for information provision is 
(Luck et al., 1999), in addition to the varying amount of information desired by or 
suitable for individuals (Woloshynowych, Oakley, Saunders, & Williams,1996). 
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Research is inconsistent regarding the benefits and effectiveness of information provision 
approaches in reducing distress in medical settings. For example, a recent study that 
looked into the effect of information provision on patient distress, via the use of a phone 
call from the anaesthesiologist prior to surgery, reported no significant difference in 
anxiety between control and information groups (Stoddart et al., 2005). Additionally, 
information provision has not been shown to be particularly successful in studies related 
to reducing distress during endoscopic treatment (Woloshynowych et al., 1996). At the 
same time, however, Luck et al. (1999) reported a significant decrease in pre-procedure 
anxiety for patients undergoing a colonoscopy when they were provided with an 
informational video. Another study, which looked at the relationship between levels of 
distress and the technique of information provision, found that, when coupled with 
‘modelling’, patients who receive information provision reported significant decreases in 
self-reported anxiety and less autonomic nervous system stimulation before their 
gastrointestinal procedure (Mahajan et al., 1998). Lastly, a study on children undergoing 
an EGD found those with more knowledge tended to have lower threat appraisals, and 
those with lower threat appraisals generally exhibited less anxiety. These studies 
therefore, show that while information provision can reduce distress, this is not always 
the case. Such findings are therefore inconsistent and create difficulty when generalising 
between procedures, populations, and settings.  
 
Modelling, or observational learning, happens when an individual witnesses another 
individual perform a particular behaviour (Bandura, 1977), and is part of Bandura’s 
Social Cognitive Theory. When modelling, as a psychological preparation, has been 
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demonstrated as an effective tool for the reduction of distress in medical settings 
(Anderson & Masur, 1983), it is generally used as a component, or in association with 
another technique, such as information provision (Mahajan et al., 1998; Luck et al., 
1999), or cognitive restructuring and relaxation (O’Halloran, 1995). Although a variety of 
modelling approaches have been used successfully, more research is needed to delineate 
modelling methods and the populations that benefit most from use of such techniques 
(Anderson & Masur, 1983).  
 
Relaxation techniques range from hypnosis to relaxation tapes and have frequently been 
used within the medical settings to assist with patient distress. For example, in a study 
conducted by Lang et al. (2006), self-hypnotic relaxation, as compared to structured 
empathic attention, was demonstrated to be a good outpatient pain management option 
for a particularly anxiety provoking procedure. The authors suggested that self-hypnotic 
relaxation may provide a powerful, and relatively cheap, anxiety relief to patients 
undergoing invasive medical procedures such as needle biopsies. However, as with 
modelling, relaxation techniques tend to be utilised in conjunction with other 
psychological techniques, thus making it difficult to differentiate the benefits of 
relaxation as a sole treatment as no manipulation checks have been performed.  
 
Cognitive Behavioural Therapy (CBT) approaches, on the other hand, have shown 
promising results in the literature to date. For example, Hackett et al. (1998) found 
patients who receive either cognitive or CBT interventions before undergoing 
gastrointestinal endoscopy have a significant reduction in anxiety, in comparison to the 
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attention-control and behavioural-only groups. Additionally, a review on preparing 
patients for invasive medical procedures and surgical procedures suggests CBT 
approaches are successful for both adults and children in decreasing anxiety and pain, as 
well as being a cost-effective method (Horne et al., 1994).  
 
Because of the similarity to HBOT the next section will review techniques that have been 
used to reduce distress in MRI settings. In the last 20 years there has been an attempt to 
confront the issue of patient anxiety with regard to MRI scans (refer to Table 2). Using an 
experimental design, Quirk, Letendre, Ciottone, and Lingley (1989b) investigated how 
MRI patient anxiety levels varied across a set of groups, when a variety of psychological 
approaches were manipulated and implemented. The three groups in this study were: 
information alone, information and counselling, or information and relaxation. The study 
found that psychological preparation that incorporates relaxation is more effective than 
information alone. A randomised control trial explored the use of relaxation tapes for 
diminishing anxiety related to MRI scans (Lukins et al., 1997). This found that the 
patients who used relaxation tapes before and/or during MRI demonstrated lessened 
anxiety during their scan. Other instances where methods to reduce anxiety before MRI 
scans are illustrated through case reports (Klonoff et al., 1986; Simon, 1999). These case 
reports used systematic desensitisation and hypnosis to enable patients to successfully 
complete their MRI scans. While their results suggested that the introduction of 
psychological approaches into medical settings is beneficial, one problem that was 
identified is that having a technician skilled in a psychological preparation approach 
onsite may not always be feasible or affordable. Lastly, research has suggested that the 
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psychological approach was the most popular way to alleviate anxiety during MRI and to 
take into account cost-effectiveness, individuality, and practicality when choosing the 
appropriate psychological approach (Phillips & Deary, 1995). 
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Table 2 
Studies Investigating Psychological Preparation before MRI 
Author/s Design Type of 
Assignment 
(N) 
Type of 
Control 
Group 
Type of Psychological 
Preparation 
Outcome 
Measures 
Results Strengths/Limitations 
Klonoff et 
al., (1986) 
Case Report n/a n/a Systematic Desensitisation MRI completion 
with minimal 
movements 
MRI was completed successfully 
 
Results demonstrate that there are 
steps that can be taken to allow for 
completion  
+ The success suggests the further 
interaction between radiology and 
psychology 
 
- One patient only 
Lukins et 
al. (1997) 
Experimental Random Standard Care Group 1: Control  
Group 2: Anxiety reduction 
tape pre-MRI 
Group 3: Anxiety reduction 
tape pre-MRI and adapted 
version of tape during MRI 
STAI Y-2 
 
Fear Survey 
Schedule 
Patients who used relaxation before 
and during scan showed reduced 
anxiety during the scan 
- Bias sample of less fearful individuals 
because those who considered themselves 
claustrophobic chose general anaesthetic 
Phillips & 
Deary 
(1995) 
Review n/a n/a Interventions to alleviate 
anxiety during MRI 
Anxiety Cost-effectiveness, individuality, 
and practicality need to be 
accounted for 
 
Psychological approach the most 
popular  
+ Covers physical and psychological 
approaches 
 
- Not particularly thorough 
Quirk et al. 
(1989b) 
Experimental Random Information 
only 
Group 1: Information only 
Group 2: Information plus 
counselling  
Group 3: Information plus 
relaxation exercise 
STAI 
 
 
Patients in Group 3 showed 
significant less increase in anxiety 
compared with those in Groups 1 
and 2 
 
Results suggest that to reduce 
anxiety levels, patient preparation 
should include more than the 
provision of information alone 
+ Important implication suggesting that 
information alone is not sufficient 
 
- No “standard care” control group 
Simon 
(1999) 
Case Report n/a n/a Hypnosis MRI completion 
with minimal 
movements 
MRI was completed successfully 
 
Results suggested that hypnosis can 
be a viable option in treating MRI 
claustrophobia 
+ Worked for a patient who previously 
had failed completion of MRIs twice even 
with medication 
 
- One patient only 
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Of significance to the present study is the research, albeit limited, regarding the reduction 
of anxiety and distress in patients requiring HBOT (refer to Table 3). In 1989, one study 
compared standard care procedures to the supply of an informational video before 
HBOT, and the use of film distraction during the session (Allen, Danforth, & Drabman, 
1989). Although the patients who watched the video and film described themselves as 
less distressed than control patients, there were no manipulation checks performed and 
the sample size was particularly low (n = 11). Another case report investigating the 
benefits of psychological preparation before HBOT focused on a patient’s refusal of 
HBOT sessions due to their experience of claustrophobic fear (Hillard, 1990). The author 
sought to demonstrate how relaxation, visualisation, and medication enabled this patient 
to successfully undergo all of their required HBOT sessions. Clearly there is a lack of 
controlled HBOT research, making it difficult to know what approach/approaches is/are 
most appropriate for the treatment of distress in patients undergoing HBOT.  
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Table 3 
Studies Investigating Psychological Preparation before HBOT 
Author/s Design Type of 
Assignment 
(N) 
Type of 
Control 
Group 
Type of Psychological 
Preparation 
Outcome 
Measures 
Results Strengths/Limitations 
Allen et al. 
(1989) 
Experimental Random 
(11) 
Standard 
Care 
Group 1: Control group – 
standard preparation 
Group 2: Experimental 
group – watched an 
informational video, and 
had a film to watch during 
first session for distraction 
Subjective Units 
of Distress 
(SUDs) 
 
Ways-Of-Coping 
Questionnaire 
 
Miller 
Behavioural 
Style Scale 
Results support the use of 
modelling and distraction 
during HBOT to reduce 
distress and increase 
compliance 
+ Specific to HBOT 
 
- No reliability or validity 
scores reported for scales  
 
- No manipulation check 
between the informational 
video and distraction film 
 
- Very low sample size 
Hillard 
(1990) 
Case Report n/a n/a Relaxation, visualisation 
and medication 
HBOT 
completion 
Successfully completed 
HBOT sessions 
 
Author suggested you could 
conceptualise the first 
session as flooding then 
subsequent sessions as 
reinforcement of this 
flooding 
+ Patient was able to 
complete HBOT even after 
initially refusing it 
 
- One patient only 
Sax (1990) 
ABSTRACT 
ONLY 
Experimental Random  
(40) 
Control 
Condition 
Group 1: Intervention – 
Stress Inoculation tape 
Group 2: Control – Music 
tape 
Self-report 
anxiety measures 
 
Pulse rates 
 
Medical staff 
ratings of distress 
and anxiety 
Anxiety related to HBOT 
can be therapeutically 
impacted by psychological 
intervention 
 
Intervention patients 
reported lower anxiety pre-
HBOT 
- Abstract only was available 
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While the research described suggests that psychological preparation has its merits and 
prospects within a medical setting, it is essential to interpret the above studies with 
caution due to widespread methodological limitations and generalisability issues. No 
research is without unavoidable limitations; however some methodological problems can 
seriously compromise definitive conclusions. To name a few such issues, studies failed to 
include: manipulation checks to determine which part of the intervention facilitated 
change (e.g. Allen et al. 1989; Mahajan et al., 1998; & Stoddart et al., 2005); sufficient 
statistics regarding outcome measures (e.g. Allen et al. 1989; Claar et al., 2002; & 
Hackett et al., 1998); sufficient sample size (e.g. Allen et al. 1989; & Claar et al.,, 2002); 
and control groups (e.g. Claar et al., 2002; Lenzen et al., 2002; & Quirk et al., 1989b). 
These problems significantly limit the ability to make inferences, and indicate the need 
for more well-controlled studies. Limitations aside, one evident trend is that CBT 
approaches may show promise as a means of psychological preparation in a variety of 
medical settings. As such, the application of CBT to claustrophobia and to HBOT 
settings will be discussed. 
 
Claustrophobia, Cognitive-Behavioural Therapy, and One-session Exposure Therapy  
 
Current practices of treating claustrophobia have developed from the original theoretical 
foundation underpinning the treatment of anxiety disorders. The complex history of the 
current treatments for anxiety disorders includes two pathways from which treatment 
methods have been developed; behavioural theories and cognitive theories. Both 
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behavioural and cognitive theories are centrally concerned with the acquisition and 
maintenance of fear as it relates to phobic stimuli, and in turn the treatment applications.  
 
Behavioural treatments for anxiety disorders originate from a variety of behavioural 
theories which aim to identify an individual’s predisposing vulnerabilities, specific 
learning experiences, and response deficits in association with specific phobic stimuli 
(Craske & Rowe, 1997). It is subsequently the unlearning of these associations that is the 
foci of behavioural treatments. Developed from behaviour therapy is a set of procedures 
known as exposure therapy. Traditional in vivo exposure incorporates both systematic 
and repetitive exposure to a feared stimulus and the essential component being not to 
escape the stimuli, thus remaining ‘exposed’ until anxiety subsides. Treatments 
associated with exposure treatments that developed included covert conditioning (e.g. for 
alcohol abusers), flooding, implosive therapy, and gradual exposure methods (Sweet, 
Giles, & Young, 1987). The goal of exposure therapy is twofold: firstly, to extinguish the 
arousal of fear in the presence of the phobic stimulus; and secondly, to concurrently 
initiate approach to the stimulus as a counter to avoidance/escape (Koch, Spates & 
Himle, 2004). The differing forms of exposure can range from graduated to intense; 
imaginal or in vivo; massed versus spaced; and with or without a therapist. Relevant to 
this study, is the way exposure theory implies a systematic, gradual, and in vivo exposure 
to the phobic stimulus, the hyperbaric chamber. 
 
Cognitive treatments originate from cognitive theories and are well utilised as a stand-
alone treatment for anxiety disorders, or in combination with others (Choy, Fyer, & 
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Lipsitz, 2007). The underlying theory behind cognitive treatments is the notion that, due 
to incorrect thinking, an individual has an irrational and maladaptive fear of a phobic 
stimulus (McGlynn & Lawyer, 2000). Research supports the cognitive element to phobic 
beliefs, suggesting that the connotation of the phobic stimulus is influenced by a range of 
beliefs that make up phobic thoughts (Thorpe & Salkovskis, 1995). Maintenance of 
phobias are closely related to these beliefs, which are thought to be influenced by an 
individual’s perceptions of harm by the stimulus, harm felt by individual, and feelings of 
helplessness (Thorpe & Salkovskis, 1995). As such, patterns of thinking in anxious 
patients are seen to reflect perceptions of harm or danger, and their interpretations 
(conscious and unconscious) are assumed to generate anxiety (Craske & Rowe, 1997). 
Cognitive therapy posits that emotions based on cognitive processes are amenable to 
change through conscious reasoning (Craske & Rowe, 1997). It is therefore the 
reorganisation of incorrect or irrational cognitions regarding the phobic stimulus that is 
the main foci of cognitive therapy (Choy et al., 2007). Thus, once the phobic stimulus is 
addressed cognitively, anxiety is intended to decrease. Pertinent to the present study are 
patients’ irrational cognitions regarding the perceived distressing procedure of HBOT. 
Therefore, in this instance, the focus of the cognitive therapy would be identifying and 
modifying a person’s cognitions regarding HBOT, and thus influencing their levels of 
anxiety.  
 
The result of the amalgamation of the above two approaches (behavioural and cognitive) 
has led to the development of CBT. Historically, the objective of CBT has been to change 
an individual’s maladaptive thoughts. However, at the same time, this theory recognises 
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the importance of implementing behavioural techniques – in this case in vivo exposure – 
to assist with the achievement of the targeted change (Emery & Tracy, 1987). 
Accordingly, exposure treatments are combined with a cognitive approach, particularly in 
the treatment of anxiety disorders (Chambless & Gillis, 1993), and behavioural 
techniques remain ways for cognitions to be tested and modified (Craske & Rowe, 1997).   
 
Behavioural and CBT therapies are often suggested as the treatment of choice for anxiety 
disorders, including specific phobias, such as claustrophobia (Sweet et al., 1987). For 
example, a recent review conducted by Choy et al. (2007) suggests cognitive or cognitive 
with in vivo exposure are efficacious therapies for claustrophobia. Specifically, the CBT 
treatment of an individual’s claustrophobic fear is treated via both exposure (behavioural) 
exercises in combination with cognitive therapy (Choy et al., 2007; Rachman, 1997). 
Through the development of CBT in the field of specific phobias, in vivo exposure has 
further been refined into a one-session treatment. This refinement, which includes already 
proven successful forms of treatment for phobias, namely cognitive and behavioural (in 
vivo exposure) components, was done by Öst (1989), whose purpose was to present a 
rapid and effective method for the treatment of specific phobias. The differences of the 
One-Session Exposure Therapy (OSET) to traditional in vivo exposure was firstly that the 
patient is presented with all exposure steps at a single session – as opposed to the usual 
four to eight sessions for specific phobias (Öst, 1989) – and secondly, that modelling is 
used to help the patient when required (e.g. for spider phobics). Öst (1989; 1997) 
proposes that the cognitive restructuring inherent in the use of such behavioural tests 
yields a more rapid shift in avoidance and anxiety, suggesting that this type of treatment 
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can be completed over a shorter period of time while still remaining efficacious. As with 
general in vivo exposure, OSET principles are similar: the patient makes a commitment to 
remain in the exposure situation until their anxiety subsides; they are encouraged to 
approach the stimulus as much as possible; they are to remain in contact with the specific 
stimuli until their anxiety subsides; and the therapy session does not conclude until the 
anxiety level of the individual has been reduced by at least 50% or is completely gone. 
As mentioned, in addition to the cognitive and behavioural components in OSET is 
modelling; characteristically included as an adjunctive method for behaviour 
modification interventions (Kazdin, 2001). Modelling enables the therapist to 
demonstrate the behavioural tasks set for the client and to help make the step to achieving 
them less stressful.  
 
Subsequent to Öst’s (1989) development of OSET, it has demonstrated therapeutic 
success for individuals with specific phobias. The pioneering study by Öst in 1989 treated 
20 patients with specific phobia and found positive results; 90% were much improved or 
completely recovered after a mean of 2.1 hours of therapy. These results are on a par with 
regular behavioural treatment with multiple sessions. Hence, with results that are just as 
effective as a longer treatment method it is logical to conclude that using the one-session 
method for this particular population was not a disadvantage and had clinical efficacy. 
These outcomes resulted in subsequent attempts at replication, from which the one-
session method was suggested as the treatment of choice for a variety of specific phobias 
such as spider, blood-injury, injection, claustrophobia, and flying (Öst, 1997). From Öst's 
(1997) review, it is reported that although there were a small number of studies reviewed, 
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some suggestions could be made. Across the different specific phobias the one-session 
treatment method yielded 74-94% clinically improved patients after 2-3 hours of 
treatment and effects were maintained or somewhat better at the 1-year follow-up. Since 
Öst’s 1997 review, several studies have used OSET within an experimental design on 
specific phobias. A study on claustrophobia revealed all three experimental groups, five 
sessions of exposure, five sessions of cognitive therapy, or OSET, to be clinically 
improved as per Jacobson, Follette, and Revenstorf’s (1984) criteria, and there were no 
significant differences between outcome variables for the three groups (Öst, Alm, 
Brandberg, & Breitholtz, 2001). Additionally, Koch et al. (2004) found that OSET and 
behavioural therapy achieved the same cognitive change, but participants rated OSET as 
less intrusive. Choy et al. (2007) suggest, after reviewing the literature, that in vivo 
exposure is a strong method to use for specific phobias and cognitive therapy has strong 
evidence as a stand alone therapy, or as an adjunct method, for claustrophobia. In 
summary, cognitive, behavioural and CBT procedures are efficacious treatments for 
specific phobias, and OSET has shown to be as effective, and less intrusive, as the longer 
treatment methods it has been compared to. Additionally, as health care costs are a 
continuing issue, and feasible brief interventions (like OSET) are preferred by most 
clients (Lane, 2000),  brief and effective treatments like OSET can only be a help to 
reduce costs, lengthy waiting lists, and benefits the patients.  
 
On the background of this literature, the current study will evaluate the effectiveness of 
OSET to reduce atypical claustrophobic anxiety in patients undergoing HBOT. 
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1.3. POTENTIAL PREDICTORS OF STATE ANXIETY  
 
This study aims to examine psychological factors associated with adverse psychological 
distress in patients undergoing HBOT. This research was intended to enhance the 
understanding of Hyperbaric Medicine Unit (HMU) staff at Christchurch Hospital 
regarding patient experiences concerning the process of undergoing HBOT. In this 
section of the thesis I will provide an overview of these variables – state and trait anxiety, 
claustrophobic anxieties, anxiety sensitivity, and treatment credibility/expectancy – and 
how they relate to the research at hand. Additionally, other potential confounding 
variables of interest to the study will be discussed.  
 
State and Trait Anxiety  
 
Anxiety is a theoretical construct. Freud (1936) viewed anxiety as something people feel, 
and contemporary psychology generally refers to anxiety as a transitory and clear 
condition of feelings, for example, subjective feelings of apprehension and tension 
(Spielberger, 1972). It has been suggested that anxiety be viewed as at least two related, 
and yet dissimilar constructs (Spielberger, 1966). Anxiety can be expressed as a 
particular condition of feeling (Spielberger, 1972), or more specifically, as an unpleasant 
emotional state. In this instance, someone’s state is defined as one’s given condition at a 
particular moment in time, thus suggesting that a person’s state is subject to change as 
that moment in time passes. That is, an individual’s anxiety state, or their anxiety levels, 
can vary from moment to moment. This amenable component of anxiety is called ‘state 
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anxiety’ and is defined as a transitory group of emotions influenced by environmental 
factors (Spielberger, 1966).  
 
Another expression of anxiety is the way in which it manifests itself as a disposition, or 
personality trait. From this perspective, anxiety is regarded as a relatively stable 
individual difference variable in anxiety-proneness and is called ‘trait anxiety’ 
(Spielberger, 1983). In contrast to state anxiety, trait anxiety is classified as established 
and therefore less influenced by environmental factors. Trait anxiety can be viewed as an 
inclination to anxiety, as well as a tendency to, and a predictability to, perceive particular 
situations and to react in certain ways (Spielberger, 1983).  
 
Research argues that it is important to recognise the distinction between trait and state 
anxiety (Gaudry, Vagg, & Spielberger, 1975). However, while state and trait anxiety can 
be discriminated as two separate constructs, it is important to understand their 
relationship. Spielberger’s (1983) Trait-State Anxiety Theory summarises briefly how 
trait anxiety influences and impacts on state anxiety. The theory postulates that trait 
anxiety is the individual differences in the perceptions of stressful situations and the 
individual’s reactions to these situations. Consequently, these perceptions, influenced by 
one’s trait anxiety, dictate the intensity of one’s state anxiety. Furthermore, the Trait-
State Anxiety Theory describes the ways in which trait anxiety has the ability to reveal 
differences between individuals in frequency and intensity of past anxiety states, and 
predicts differences in the future. Accordingly, Spielberger’s (1983) Trait-State Theory 
claims that individuals with higher trait anxiety are more likely to experience higher 
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intensity anxiety states in anxiety-provoking situations, as well as to perceive a larger 
number of situations as more dangerous or threatening (Spielberger, 1972). Recent 
research by Lau, Eley, and Stevenson (2006) supports this theory by demonstrating that 
while trait anxiety has moderate genetic and large non-environmental effects, state 
anxiety is to a considerable extent influenced by environmental factors. When relating the 
Trait-State Theory to the study at hand, it suggests that persons with higher trait anxiety 
may perceive hyperbaric treatment as a more dangerous or threatening situation than 
someone with lower trait anxiety. In addition to experiencing higher intensity states of 
anxiety, people with higher trait anxiety have the potential for more frequent episodes of 
state anxiety throughout their treatment. Therefore, anxiety is delineated as two 
connected but differing constructs that attempt to partially explain and predict 
individuals’ behaviours.  
 
Both trait and state anxiety have been used extensively as outcome measures in research 
and clinical practice. They have been applied to a variety of populations, namely medical 
samples (e.g. Asmundson & Norton, 1995; Hackett et al., 1998; Luck et al., 1999; 
Mahajan et al., 1998), and including HBOT research. Clark et al. (1994) were able to 
measure change in patients’ state anxiety levels regarding HBOT before and after the first 
session, and to measure trait anxiety to observe its relationship with state anxiety. Thus, 
measuring state and trait anxiety can provide a snapshot of how a patient may feel at a 
particular moment in time, demonstrate when individual state anxiety may vary, and 
allow for an understanding of how state and trait anxiety are interrelated.  
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Accordingly, in the present study, it is hypothesised that as patients continue with their 
hyperbaric sessions, their perception of the situation as threatening will decrease, and 
therefore produce a change in state anxiety. Because state anxiety is a transitory set of 
emotions, it is expected that should one’s anxiety regarding HBOT change, the state 
anxiety score will reflect this. Additional to this, trait anxiety will be measured to 
examine its association with state anxiety during HBOT. 
 
Claustrophobic Anxieties 
 
As described earlier, claustrophobic fear is cued by specific situations, for example a 
hyperbaric chamber. Research has recognised the need to focus on how claustrophobia 
manifests itself, and can be of impact in medical settings. Specifically, MRI studies have 
investigated claustrophobia because of the potential adverse affects to the MRI procedure 
(Harris, Robinson, & Menzies, 1999; Harris, Robinson, & Menzies, 2001; McGlynn, 
Smitherman, Hammel, & Lazarte, 2007; McIsaac et al., 1998). McIsaac et al. (1998), in 
part, wanted to determine the best predictors of anxiety during MRI scans. They found 
that claustrophobia scores pre-MRI significantly predicted participants’ distress during 
the scan. They further found that claustrophobia scores were able to differentiate between 
those who reported panic during the scan, and those who did not.  
 
MRI research also has found support for the two components of claustrophobia, fear of 
suffocation and fear of restriction (McGlynn et al., 2007). McGlynn et al. (2007) 
concluded that fear of suffocation, fear of restriction, and sensitivity to symptoms of 
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suffocation had some influence on participant’s fear regarding their mock MRI scan. In 
1999, Harris et al. however, claimed that MRI-related fears were based more on fear of 
restriction, than on suffocation, as while MRIs are restrictive, dark, and the patient must 
remain still, it is not sealed. However, findings that fear of suffocation doesn’t play a role 
in subjective fear in the MRI context has yet to be definitively confirmed (McGlynn et 
al., 2007). Unlike MRI scans, HBOT characteristics may evoke both restriction and 
suffocation fears, and thus a scale measuring claustrophobic fears needs to include both 
these components. Claustrophobic tendencies have been of interest in medical settings, 
(e.g. Radomsky, Rachman, Thordarson, McIsaac, & Teachman, 2001) and proved to be a 
sensitive tool in identifying who may experience high levels of fear for patients 
undergoing MRI scans (McIsaac et al., 1998). The present study will assess 
claustrophobic fears for patients undergoing HBOT and observe the associations with 
state anxiety.  
 
Anxiety Sensitivity  
 
Anxiety sensitivity is the fear of one’s own anxiety symptoms, and on occasion may be of 
more importance to examine than the actual experience of anxiety. A critical finding in 
the first published article measuring anxiety sensitivity was that it may be more important 
to understand what an individual may think will happen because of their anxiety, rather 
than actually how often they experience the anxiety (Reiss, Peterson, Gursky, & 
McNally, 1986). Specifically, anxiety sensitivity pertains to fears of anxiety symptoms, 
and the beliefs of negative consequences attached to these symptoms. While trait anxiety 
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measures anxiety proneness (Spielberger, 1983), anxiety sensitivity measures individual 
levels of fear of anxiety-related symptoms (Reiss & McNally, 1985). Initially, there was 
much debate over whether anxiety sensitivity is distinct from trait anxiety; however it has 
become more accepted that anxiety sensitivity has qualities that go above and beyond 
trait anxiety, despite being moderately related to anxiety sensitivity (Taylor, 1999). More 
recently, further support that anxiety sensitivity and trait anxiety are distinct constructs 
has been demonstrated on a Spanish sample (Sandin, Chorot, & McNally, 2001). 
 
Although anxiety sensitivity has been linked strongly to agoraphobia and generally 
associated with other anxiety problems (Reiss et al., 1986), there is some evidence that 
anxiety sensitivity also is elevated in claustrophobia (Booth & Rachman, 1992). A 
justification for this is that fear based on a particular object is intensified by one’s anxiety 
sensitivity, because fear is being caused by both the object itself and the fear of the 
consequences of this fear (Reiss, 1991). Additionally, Rachman and Taylor (1993) 
suggested that anxiety sensitivity may actually intensify the components of 
claustrophobia – fears of suffocation and restriction– or possibly is a third contributing 
factor. For the small group of patients requiring HBOT that present with claustrophobic 
fears and/or high anxiety sensitivity, the anxiety-provoking features of HBOT may 
trigger higher levels of state anxiety. 
 
Anxiety sensitivity has previously been of interest in medical settings, for example, a 
study found that chronic back pain patients were more likely to be negatively affected by 
their pain experiences if they had high anxiety sensitivity (Asmundson & Norton, 1995). 
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The present study will investigate anxiety sensitivity and HBOT because it is thought that 
patients with higher anxiety sensitivity will find their experience more stressful and 
potentially experience higher state anxiety than those with lower anxiety sensitivity. 
 
Treatment Credibility and Expectancy 
 
Belief in the credibility of HBOT as a medical procedure, in addition to an expectancy of 
symptom improvement, may influence patient anxiety when undergoing HBOT. 
Credibility is defined as “the quality of meriting belief or confidence” (Colman, 2003, p. 
175) and can be viewed in context of patients’ interpretations of the quality of HBOT as a 
medical procedure. Expectancy can be expressed as “improvements that clients believe 
will be achieved” (Kazdin, 1979, p.82) and, for this study, is the level of improvement of 
symptoms patients expect to see from undergoing HBOT.  
 
Treatment credibility and expectancy of treatment were originally investigated when 
comparing therapy rationales (Borkovec & Nau, 1972), and then for evaluating the 
efficacy of several therapies for non-phobic anxiety disorders (Borkorvec & Mathews, 
1988). From further investigations, Devilly and Borkovec (2000) reported that the two 
constructs, credibility and expectancy, were separate yet related factors, and while 
research has linked both treatment credibility and expectancy with outcome measures, the 
results are indicative of different predicting abilities. Credibility of a treatment has shown 
on occasion to be related to outcome measures (Borkovec & Mathews, 1988; Kirsch & 
Henry, 1977, 1979) while expectancy of symptom improvement has been linked more 
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regularly to outcome measures (Devilly & Spence, 1999; Borkovec & Costello, 1993; 
Chambless, Tran, & Glass, 1997; Collins & Hyer, 1986).  
 
Treatment credibility and expectancy have been investigated as variables that may 
influence change or have potential impact on outcome measures(Kirsch & Henry, 1977, , 
1979). Early findings linked higher credibility of treatments to improvements 
surrounding subclinical speech anxiety (Kirsch & Henry, 1977, , 1979). Specifically, 
Kirsch and Henry (1979) considered how the credibility of treatment rationales for 
programs designed to lessen public speaking anxiety may impact on this fear. They 
reported that only those who rated the treatment rationale for the speech anxiety program 
as highly credible demonstrated changes in the physiological appearance of anxiety and 
reductions in self reported anxiety.  Further research explorations suggest that psychiatric 
inpatients with higher treatment expectancy of symptom improvement tended to have 
better outcomes for community adjustment and improvement for the original problem 
three months post-discharge (Collins & Hyer, 1986). Furthermore, research looking at 
predictors of social phobia treatment found that the participants who reported both a 
higher expectancy for benefit of treatment, and higher credibility of  treatment were more 
likely to improve (Chambless, Tran, & Glass, 1997). In addition to the above therapy 
environment, expectancy has been associated with positive outcomes in a medical setting. 
A study on patients undergoing HBOT due to tinnitus revealed that the success rate of 
HBOT appeared to be associated with pre-HBOT patient expectations regarding their 
symptoms (Stiegler et al., 2006). Specifically, positive effects were reported in 60% of 
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those who believed in the effectiveness of HBOT as compared to just 47% or 19% in 
those who respectively reported indifferent or negative expectations.   
 
Thus, perception of credibility of treatment and expectancy of symptom improvement 
appear to be important variables on impacting outcome measures in therapy and medical 
research. If this rationale is applied to medical procedures that have anxiety-provoking 
features, it may lead to the question, if one believes their treatment is credible and have a 
high expectancy of outcome, will they be less anxious about their procedure? Lastly, the 
current study will examine the relationship between expectancy of symptom 
improvement and credibility of HBOT with State Anxiety, of which few if any studies 
have previously investigated. 
 
1.4. POTENTIAL CONFOUNDING VARIABLES OF ANXIETY 
 
Past Exposure 
 
As mentioned previously, hyperbaric treatment is an integral part of patient health plans. 
For that reason, it is of medical value to observe how psychological distress regarding 
HBOT may fluctuate. Pertinent questions addressed in previous research regarding the 
reduction of psychological distress include how patients may become more 
“experienced” with hyperbaric treatment through exposure (Sandal, Vernes, Bergan, 
Warncke, & Ursin, 1996). Experience can be interpreted through adaptation and exposure 
to treatment. For example, Sandal et al. (1996) investigated psychological reactions and 
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adaptation to long-term isolation in a hyperbaric chamber. While it is unwise to 
generalise because their objective was focused on a space simulation study, and their 
sample (professional astronauts and space personnel) and methodology (isolation in the 
chamber for 4 to 9 weeks) were very different to the current research, the study did 
indicate a steady increase in coping with isolation, and to fundamental adaptation to the 
environment.  
 
Investigating whether patient psychological distress may reduce as exposure to HBOT 
increases may support the importance of preparation for HBOT for those with high 
anticipatory anxiety. The premise that anxiety about a feared stimulus will reduce derives 
from in vivo exposure rationale, whereby enhancing the reduction of fear occurs by 
repeated exposure to the stimulus that evokes the anxiety (Craske & Rowe, 1997). 
Accordingly, the repeat experiences of HBOT theoretically will help reduce some of the 
anxiety surrounding it. For example, Clark et al. (1994) did find a significant decrease in 
anxiety from pre- to post-hyperbaric treatment. If the experience of hyperbaric treatment 
in Clark et al.’s (1994) study did contribute to reductions in anxiety regarding that 
HBOT, then it would support the fundamentals of exposure theory. Therefore, this study 
will observe and measure changes in state anxiety over time as patients become more 
experienced with hyperbaric treatment.  
 
Demographic Variables  
 
 55 
Individual variables influence our behaviour and responses to different situations, for 
example our coping mechanisms with stressful medical situations. Research examining 
anxiety within the medical context typically entails the need to control for factors similar 
to age, gender, and medical variables like previous operations and post-operative 
complications (e.g. Boeke, Stronks, Verhage, & Zwaveling, 1991; de Groot, Boeke, 
Duivenvoorden, Bonke, & Passichier, 1996; de Groot, Boeke, vanden Berge, 
Duivnvoorden, Bonke, & Passchier, 1997). Boeke et al. (1991) suggest that although 
further research is needed, medical-status variables have the potential to be more 
significant for invasive medical procedures. The present study will include demographic 
and medical variables to investigate the possible significant correlations they may have 
with HBOT patients’ anxiety before and during their hyperbaric sessions. 
 
While research has demonstrated a relationship between age and state anxiety within the 
medical setting, outcomes have been inconsistent. de Jong, Erdman, van den Brand, 
Verhage, Trijsburg, & Passchier (1994) investigated anxiety, heart rate, and skin 
conductance level before cardiac procedures and if they could be predicted by anxiety-
related factors at one’s home before the procedure. They found that advanced age 
predicted low state anxiety in hospital. However, Clark et al. (1994) found a significant 
positive correlation between age and state anxiety after participants had completed 
HBOT. MRI research has also taken into account demographic influences, for example 
Lukins et al. (1997) reported a significant tendency for older patients to report less 
anxiety both before and during the scan, although this tendency was weak. Furthermore, 
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patients’ age has been found not to be related to precolonoscopy anxiety (Luck et al., 
1999). Consequently, the present study will consider age as a potential covariate. 
 
The literature reporting gender influences on anxiety in a variety of medical settings have 
been more consistent than findings related to age. de Jong et al. (1994) found that being 
female predicted high state anxiety in hospital prior to invasive cardiac procedures. 
Within the MRI setting, females have demonstrated higher anxiety before and during an 
MRI scan than males (Lukins et al., 1997). Furthermore, precolonoscopy anxiety has also 
been associated with gender; female patients exhibited higher baseline anxiety scores 
(Luck et al., 1999). One study (Stoddart et al., 2005) which did not find a significant 
difference between genders for preoperative anxiety had a low number of male 
participants; they postulated this factor as affecting their power to find any statistical 
differences should they exist. Accordingly, the present study will consider gender as a 
potential covariate. 
 
In addition to the aforementioned demographic variables, there is potential for other 
variables to confound patient anxiety before and during HBOT. This study will take into 
account several medical variables because it has been suggested that research results may 
be confounded by medical-status variables (Boeke et al., 1991). It has been previously 
mentioned in this review that patients undergoing HBOT are required to wear headgear. 
Thus, whether participants are wearing a face mask or a head hood will be noted. 
Additionally, the main condition that is prompting the need for HBOT for each 
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participant will be noted, as well as if participants have undergone a course of HBOT 
previously.  
 
A further variable that may have confounding impact on patient anxiety during HBOT is 
the number of other people in the chamber. Research has shown that patients who are 
waiting to undergo surgery and share a hospital room with other patients who have 
recently undergone the same surgery, demonstrate less preoperative anxiety and fare 
better on outcome variables like length of hospital stay (Kulik & Mahler, 1987, as cited 
in Sarafino, 1998). Thus, this research will report the number of other people, including 
the nurse attending, in the hyperbaric chamber for each session. Lastly, the total number 
of sessions participants’ complete will be recorded.   
 
There are many potential confounding factors with patient anxiety surrounding medical 
procedures, and inevitably not all can be accounted for. Influences from patients’ 
illnesses may be related to behaviour, for instance pain has been found to be associated 
with state anxiety in the older adult population (Feeny, 2004). Strength of familial and 
social support, and other uncertainties, like worry about future medical 
procedures/surgery, health concerns, and fear of prognosis, may all influence patient 
experiences within medical settings.  
 
1.5. THIS STUDY 
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Hyperbaric medicine began in Christchurch in 1973 using a special hyperbaric single 
patient bed. In the late 1970s a dual-lock monoplace chamber was donated to the 
Christchurch Hospital Board and remained in use until 1994. The hyperbaric unit was 
then moved to its present location at Christchurch Hospital late 1995, and in 2000 the unit 
was expanded, permanent staff appointed, and the current rectangular, walk-in, 
multiplace chamber (refer back to Images 2 & 3) was officially opened. Presently, the 
HMU has permanent staff, improved patient care facilities and offers a full range of 
hyperbaric medical services.  
 
Rationale 
 
This study has been prompted by the need within the medical field to better understand 
patient reactions to HBOT and evaluate effective strategies when dealing with them. The 
clinical need for help with patients undergoing HBOT was the motivating reason for this 
study. The medical director of the Christchurch Hospital’s HMU, Dr Mike Davis, 
approached the University of Canterbury Psychology Department for assistance with 
patients who experience such extreme anxiety they are unable to undergo HBOT. 
Associate Professor Neville M Blampied, Dr Lois Surgenor, and I developed this request 
into the current study via reviewing the current literature, and through consultation with 
Dr Mike Davis. It is believed that no similar study has been undertaken on a New 
Zealand (NZ) sample. 
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Research on psychological distress in relation to hyperbaric treatment, and how patients 
cope, is presently a limited body of knowledge. Clark et al. (1994) showed that patients 
experienced anxiety before undergoing HBOT, and demonstrated a reduction in anxiety 
after the first HBOT session. While Clark et al. (1994) explored how trait anxiety and 
state anxiety may be related when undergoing HBOT, this study does not tell us about the 
potential relationship of other individual factors with state anxiety. More recently, 
Chalmers et al. (2007) examined the experiences of patients undergoing HBOT and 
outlined issues of concern experienced by patients. While Chalmers et al. (2007) report 
that responses to HBOT are influenced by individual personalities, their sample size was 
small (n = 7) and this conclusion was not subject to statistical analyses. While this does 
provide us with issues of concern regarding patient experiences during HBOT, further 
quantitative analyses would be beneficial. The current study differs from the two 
previous studies in a number of ways. It differs from Clark et al. (1994) in that it 
measures a number of individual factors that research has associated with distress in 
medical settings, rather than only trait anxiety. It also differs in that the current study 
used an outpatient sample, as opposed to patients from a Veterans’ Hospital. 
Additionally, rather than only measuring state anxiety before and after one HBOT 
session, the current study incorporates a longer prospective design that assesses state 
anxiety from before an individual’s first HBOT session to their very last session in an 
attempt to better demonstrate change in state anxiety levels. The current study also varies 
from Chalmers et al. (2007) in that it will use quantitative methods to investigate if 
patient individual factors influence HBOT experiences, rather than exploratory 
techniques.  
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Therefore, because of an expressed clinical need and a limited knowledge base, this study 
aims to examine individual factors and adverse psychological reactions during HBOT. 
The hypotheses of this research are as follows:  
 
(1) The study hypothesises that we will find individual predictors of and/or associations 
with adverse psychological reactions to hyperbaric treatment; namely; 
a. Participants with higher trait anxiety disposition will experience higher state 
anxiety during their hyperbaric treatment. 
b. Participants with higher claustrophobia scores will experience higher state anxiety 
during their hyperbaric treatment.  
c. Participants with higher Anxiety Sensitivity will experience higher state anxiety 
during their hyperbaric treatment.  
d. Participants with higher treatment expectation and credibility regarding 
hyperbaric therapy will experience less state anxiety during their hyperbaric 
treatment. 
e. Past exposure to treatment will be a significant covariate to state anxiety. 
f. Wearing a head hood versus a face mask will be a significant covariate to state 
anxiety. 
 
(2) Psychological reactions to hyperbaric treatment will decrease over time as individuals 
become experienced with hyperbaric treatment  
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Clinically and academically, more research on reducing distress in medical settings is 
needed. Two studies have focused on methods of reducing anxiety before HBOT. Allen 
et al. (1989) supported the use of modelling and distraction as ways to reduce anxiety 
pre-HBOT, and Hillard’s (1990) case study successfully completed HBOT after 
relaxation, visualisation, and medication. However, what these studies lack is the ability 
to prepare patients in vivo and sufficient sample size. Therefore, the present study aimed 
to evaluate the effectiveness Öst’s (1989) OSET because of its quick nature and its ability 
to be done in the chamber in vivo. Additionally, the present study aimed to evaluate 
OSET in a novel context – hyperbaric treatment. It was hypothesised that OSET would 
facilitate a decrease in anxiety regarding HBOT and consequently result in successful 
completion of hyperbaric treatment. However, while this part of the present study was 
prepared for, OSET was not able to be implemented due to no participants presenting 
suitable as for treatment.  
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CHAPTER TWO 
2. METHOD 
 
 
PART A – DESCRIPTIVE STUDY 
 
2.1. SETTING 
 
The Hyperbaric Centre used for this study is Christchurch Hospital’s HMU and is located 
at Christchurch Hospital on the lower-ground floor, Parkside West, near the western lifts. 
When entering the unit patients are greeted with a relatively small open plan room that 
accommodates the multiplace chamber, an open waiting and reception area, a private 
doctor’s office, and a patient care room. To the right of the rectangular multiplace 
chamber is an open technician area with an equipment panel (refer back to Image 2), a 
kitchen room, and two glass-surrounded offices for various staff members.   
 
Current practice at the HMU includes patient referrals to the HMU for HBOT from a 
variety of sources, for example, General Practitioners, specialists, and other departments 
within the Christchurch Hospital. Patients are seen by an HMU doctor and subsequently 
accepted or declined for HBOT. Patients will also have an assessment with an HMU 
nurse to undergo further medical checks. Current practice is for patients to express a 
personal preference for wearing a face mask or a head hood during sessions, unless their 
condition dictates otherwise. Information regarding HBOT and the chamber are provided 
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by both the doctor and the nurse, and a leaflet (see Appendix 1) outlining information 
regarding HBOT is given. This leaflet provides information about what to expect, 
possible side effects, and how the treatment is effective. Additional information for 
patients is available via self-information provision on the HMU website 
(http://www.cdhb.govt.nz/hbu/). Currently, there are no official protocols or guidelines to 
manage patients who experience intrusive or high anxiety while contemplating or 
undergoing hyperbaric treatment. There is an attending nurse in the chamber during each 
session and those who feel distressed during the session are helped via the distraction of 
conversation with the nurse. The HMU commonly use this distraction method to help 
“take the patients’ minds” off the anxieties involved in the treatment, especially during 
the last half hour where it physically can be the most uncomfortable. There is no official 
protocol in place to help those patients who refuse treatment altogether. 
 
2.2. PARTICIPANTS 
 
Participants recruited for this project were patients accepted to undergo HBOT at the 
HMU between July 2007 and May 2008. During initial HMU medical assessment, 
patients were informed by HMU staff about the current research. If the patient agreed, 
they were approached by the researcher either during or immediately after their medical 
assessment. Participation was entirely voluntary. Prior to this study a power analysis was 
done to identify an appropriate sample size. This analysis was based on the intention to 
perform correlational analysis and hierarchical regression between the aforementioned 
variables and state anxiety. The analysis suggested that a sample size of approximately 70 
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would provide an 80% probability of detecting differences. However, due to the nature of 
the participants in this sample the numbers were clinically determined.  
 
Inclusion and exclusion criteria were as follows. Acute HBOT patients (e.g. 
decompression sickness; carbon monoxide poisoning) were excluded from participation 
because of their inability to participate fully, and because of the inappropriateness of 
approaching them under emergency circumstances. People with chronic conditions (e.g. 
diabetes) were included so long as they (a) were competent in spoken and written 
English, (b) were cognitively competent to complete questionnaires, and (c) gave written 
consent. A summary of participant exclusion and attrition can be seen in Figure 1. 
 
 
Figure 1. Summary of participant exclusion and attrition from July 2007 to May 2008 
 
Patients accepted for Hyperbaric Oxygen Therapy 
N = 43 
Patient consents to participation  
N = 25 
 
Exclusion: acute cases  
N = 15 
 
Exclusion: participant withdrew consent  
N = 1 
 
Exclusion: intellectual and language ability 
compromised  
N = 1 
Exclusion: patient became ill or died 
N = 2 
 
Exclusion: did not give consent 
N = 2 
 65 
Twenty-eight patients were approached regarding this study between July 2007 and May 
2008. Two patients did not consent to participation and one patient was excluded due to 
comprehension difficulties, leaving 25 patients agreeing to participate in this research. 
Participants consented both to complete the questionnaires and for the primary 
investigator and supervisors to have access to their medical records for information 
directly related to the study.2 One participant withdrew consent after completing their 
first set of data. Consequently, all data from this participant was destroyed. Of the 24 
remaining consenting patients, two became ill or died and four had incomplete data (see 
Table 4).  
 
Table 4 
Number of Participants with Complete Data at Times* One, Two, and Three 
 
   Time One  Time Two  Time Three 
 
Participants  24   20   21  
*Time one was before participants’ first session, Time two was before the tenth session, and Time   
three was before the last session. 
 
The initial sample (see Table 5) consisted of 24 participants, 17 males and 7 females, 
ranging in age from 19 to 81 years. The majority (91.7%) identified as NZ European, and 
37.5% had undergone previous HBOT. The most common medical reasons for requiring 
HBOT were Problem Wounds (45.8%) and Radiation Tissue Damage (41.7%) (See 
Appendix 20). 
                                                 
2
 Initial ethical approval subject to minor changes was granted on the 17th of July, 2007. Once the changes 
were made, full ethical approval was obtained by the Upper South B Regional Ethics Committee on the 14th 
of August, 2007. This study was also submitted to Te Komiti Whakarite for consultation and was 
supported. Please refer to Appendices 12, 13, and 14 for these approval letters. 
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Table 5 
Sample Characteristics at Time One (N = 24) 
 
Characteristics 
Gender n (%) 
   Male       17 (70.1%) 
   Female      7 (29.2%) 
 
Age 
   Range      19 – 81 years 
   Mean      62.9 years (S.D. = 13.4) 
   Median      65 years 
 
Ethnicity n (%) 
   NZ European     22 (91.7%) 
   Maori      1 (4.2%) 
   Samoan      1 (4.2%) 
 
Previous HBOT n (%) 
   Yes       9 (37.5%) 
   No       15 (62.5%) 
 
Condition n (%) 
   Problem Wounds     11 (45.8%) 
   Radiation Tissue Damage    10 (41.7%) 
   Other      3 (12.5%) 
 
Headgear n (%) 
   Mask      18 (75%) 
   Hood      6 (25%) 
 
HBOT sessions per patients 
Average      28 (S.D. = 12.3) 
Range       4 – 47 
 
Average number of other patients 
in chamber per session    2.9 (S.D. = 0.22)  
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2.3. MATERIALS 
  
The central variable of interest in this study was state anxiety. Specifically, the dependent 
variable was state anxiety, and independent variables were trait anxiety, claustrophobic 
fears, treatment expectancy and credibility, and anxiety sensitivity. Potential covariates 
investigated were age, gender, previous HBOT, and number of other people in chamber 
during each session (see Appendix 2 and 21). From here on, variables will be identified 
by capitalising the first letter of the variable names. For example, “…State Anxiety” 
specifies the variable State Anxiety in this thesis, as measured by the scale State-Trait 
Anxiety Inventory-State (STAI: Form Y-1). This also applies for Trait Anxiety 
(measured via STAI-Trait, Form Y-2) and Anxiety Sensitivity (measured via the Anxiety 
Sensitivity Index (ASI)). Subscales for the Treatment Credibility/Expectancy 
Questionnaire (CEQ) is referred to as Credibility and Expectancy, and the total score as 
CEQ-T. The Claustrophobia Questionnaire (CLQ) total scores and subscales – Fear of 
Suffocation and Fear of Restriction – may become cumbersome therefore are shortened 
to Suffocation and Restriction, respectively, and the total scores are referred to as CLQ-T.  
 
A descriptive, correlational, prospective design was used for non-intervention 
participants. The dependent variable, State Anxiety, was measured repeatedly during 
each participants’ HBOT course, that is, before session one, before session ten, and 
before the last session. It will be referred to as State Anxiety time one, State Anxiety time 
two, and State Anxiety time three. Independent variables were measured before 
participants’ first HBOT session. The prospective design was used to allow for the 
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measurement of change in participants’ State Anxiety over time. The descriptive, 
correlational design used self-report, observational questionnaires both to describe the 
sample, and in a relational approach to determine how variables were associated with one 
another.  
 
Participants were required to complete three sets of Participant Booklets (refer to Table 
6). In addition to participants completing Participant Booklet for Time one, clinicians 
were required to complete the Clinician’s Questionnaire (see Appendix 2) which 
enquired: 1) had the patient had HBOT previously, 2) what was the main condition that 
the patient was receiving HBOT for, 3) what category of illness best describes this 
condition, and 4) was the patient using a face mask or a head hood? Lastly, the researcher 
collected information regarding participants’ total number of sessions and average 
number of people in the chamber with participant after all their sessions were completed. 
 
Table 6 
Data Collected from Participants using Participant Booklets Time One, Two, and Three.  
 
*Time one was before participants’ first session, Time two was before the tenth session, and Time   
three was before the last session. 
Time One* Time Two* Time Three* 
 
Consent Form 
 
State Anxiety 
 
State Anxiety 
Age 
Gender 
Ethnicity 
State Anxiety 
Trait Anxiety 
Treatment Credibility 
Treatment Expectancy 
Anxiety Sensitivity 
Claustrophobic Fears 
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2.1.1. Variables 
 
Demographic Information (age, gender, and ethnicity) was collected and coded for each 
participant from a personal information form (see Appendix 21) and patient hospital 
labels. Participants were coded into ethnicity groups via self-identification with group/s 
according to Statistics New Zealand Census 2001. Information regarding clinical 
condition and condition category was collected from the Clinician Questionnaire.  
 
Several variables were collated to aid the description of the experience of undergoing 
HBOT. These measures were as follows: 
 Headgear: Participant’s were coded as to whether they wore an oxygen head hood or 
an oxygen mask. (Refer to Appendix 2) 
 Previous HBOT: Participants were coded as those who had previously undergone 
HBOT before and those who had not. (Refer to Appendix 2) 
 HBOT Sessions: Since patients have varying sessions of HBOT, the number of 
HBOT sessions each participant underwent was recorded. (Refer to Appendix 4) 
 People in Chamber: Since the number of people in the chamber for each dive varies, 
the number of other people present in the chamber (including the staff attending) for 
each session with the participant was recorded. (Refer to Appendix 4) 
 
As described in the introduction, State and Trait Anxiety, Claustrophobia, Anxiety 
Sensitivity, and Treatment Credibility/Expectancy are core issues of interest in this study. 
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Therefore, the following measures participants were required to complete are described in 
detail.  
 
2.1.2. The State-Trait Anxiety Inventory  
 
 The State-Trait Anxiety Inventory (STAI; Spielberger, 1983. See Appendix 5) is a 40-
item questionnaire – two subscales of 20 questions – designed to measure both the State 
and Trait conceptual elements of anxiety. Of the two versions of the STAI, the more 
recent Form Y – used in this study – was developed in 1983, and is said to have improved 
psychometric properties than the previous version (Barnes, Harp, & Jung, 2002). 
Participants are asked to complete the two subscales, utilising two sets of instructions. 
The first set (State) asks for the participant to indicate how they are feeling right now, at 
this moment when answering the description statements. The second set (Trait) asks the 
participant to indicate how they generally feel in regards to the description statements. 
Answers are from 1 to 4 on an intensity scale (State – not at all, somewhat, moderately 
so, very much so; Trait – almost never, sometimes, often, almost always) with various 
answers inversed. It takes approximately 10 minutes to complete both subscales and is 
scored as two separate scores. Both State and Trait subscales can range from 20 to 80.  
 
Spielberger (1983) reports adequate test-retest reliabilities for Trait scores with a 
correlation range of .65 to .86, but correlations were much lower for State scores, with a 
median of .33. This is understandable as mean levels of State Anxiety are amenable to 
change due the situational cues that influence it, as supported by findings in a review on 
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STAI reliability (Barnes et al., 2002). Internal consistency was high, Cronbach’s alpha = 
.93 (State) and .90 (Trait) (Spielberger, 1983). Additionally, Spielberger (1983) reports 
good construct, concurrent, convergent and divergent validity of the STAI. Internal 
consistency reliability estimates for State and Trait scores obtained over various studies 
and populations investigated are generally satisfactory (Barnes et al., 2002).  
 
Permission to use this questionnaire was acquired through the University of Canterbury. 
The Psychology Department Test Library has purchased the manual and thus provides 
copies of the instruments to students for academic use.  
 
2.1.3. The Claustrophobia Questionnaire  
 
The Claustrophobia Questionnaire (CLQ; Radomsky et al., 2001. See Appendix 6) is a 
26-item, self-report questionnaire that measures the two reported components 
encompassing claustrophobia; fear of Restriction and fear of Suffocation. The 
questionnaire enables the calculation of two subscales along these dimensions as well as 
an overall score which measures claustrophobia. Each item is rated on a 0 to 4 scale from 
not at all anxious to extremely anxious, with participants asked to rate how anxious they 
would feel in the given places or situations. The range for the total score for the CLQ is 
from 0 to 104 (high scores = more claustrophobic distress). Items included were akin to 
“using an oxygen mask”, “locked in a dark room without windows for 15 minutes”, and 
“in a public washroom and the lock jams”.  
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The CLQ appears to be a reliable and sensitive measure of claustrophobia and its 
component fears and has demonstrated its usefulness in a medical setting (e.g. McIsaac et 
al., 1998). Radomsky et al. (2001) showed good predictive and discriminant validity; 
when exposed to a confined situation, the CLQ was able to predict subjective fear, bodily 
sensations, and anxiety cognitions very well, but not fear reactions to snakes or heights. 
The measure has also demonstrated good internal consistency (Cronbach’s alpha = .95), 
and good test-retest reliability (r = .89, p<. 001), with normative data collected 
demonstrating the CLQ discriminating between community adults and claustrophobic 
individuals (Radomsky et al., 2001). Of pertinence to this study, the CLQ has 
demonstrated its usefulness in medical research by being highly predictive of anxiety and 
panic during MRI scans (McIsaac et al., 1998).  
 
Permission for public use of the CLQ is found in Radomsky et al. (2001), and its use for 
research within medical procedure settings is encouraged. A courtesy letter and the 
findings will be sent to Dr. Radomsky at the time of any publication. 
 
2.1.4. The Anxiety Sensitivity Index 
 
The Anxiety Sensitivity Index (ASI; Reiss et al., 1986. See Appendix 7) is a 16-item, 
self-report questionnaire measuring fear of anxiety-related symptoms as rated by the 
participant. Conceptually, Anxiety Sensitivity has been distinguished from anxiety; 
anxiety is referred to as the frequency of symptom occurrence, whereas Anxiety 
Sensitivity is beliefs about the social and somatic consequences of anxiety symptoms 
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(Reiss et al., 1986). This distinction is discussed in more detail in section 1.3 above. Each 
item is rated for most appropriateness of personal consequences on a five-point scale 
from 0 (very little) to 4 (very much), and is scored by summing all 16 items. It takes 
approximately 3 to 5 minutes and higher scores reflect higher levels of Anxiety 
Sensitivity. 
 
Studies to date have suggested that there may be some differences in Anxiety Sensitivity 
between medical and non-medical settings when ASI scores are categorised (Taylor, 
1999). Therefore, this study will categorise ASI scores into low, medium, and high. In 
order to classify ASI scores in this distinct medical sample of participants, this study will 
follow the procedure of Carr, Lehrer, Rausch, and Hochron (1994) and use the mean and 
standard deviation of the present study’s sample to classify ASI scores into low, medium, 
and high categories (high = one standard deviation above the mean; medium = within one 
standard deviation above and below the mean; and low = one standard deviation below 
the mean). 
 
The ASI has adequate test-retest reliability with correlations in the range of .71 to .75 
(Reiss et al., 1986) and appropriate internal consistency (Cronbach's alpha = .88; Peterson 
& Heilbronner, 1987). Reiss et al. (1986) demonstrated evidence for the criterion validity 
of the ASI and the validity of the distinction between Anxiety Sensitivity and anxiety. 
The ASI appears to be a reliable measurement instrument which is relatively independent 
of anxiety measures (Peterson & Heilbronner, 1987) and normative data collected for 
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nonclinical samples (with more than 4500 participants) reported a mean of 19.1(S.D. = 
9.11) (Peterson & Reiss, 1992, cited in Peterson & Plehn, 1999). 
  
Permission to use the ASI by researchers is free. No money is to be made from the 
present use of the ASI and access to the measure was gained through the Psychology 
Department, University of Canterbury.  
 
2.1.5. The Treatment Credibility/Expectancy Questionnaire 
 
The Treatment Credibility/Expectancy questionnaire (CEQ; Devilly & Borkovec, 2000) 
is a six item scale that has patients rate the credibility of their treatment, and measures 
their expectancies about the improvement of their symptoms from the treatment. While 
the instructions for the CEQ are specific, for the purpose of this study the wording was 
slightly modified to make it relevant to HBOT (refer to Appendix 8 for the modified 
CEQ). The sentence in the non-modified CEQ “We do not want your therapist to ever see 
these ratings, so please keep the sheet covered when you are done” was deleted from the 
instructions because of its irrelevance to HBOT. In addition, the term “trauma symptoms” 
on Set I, questions 2 and 4, and Set II, questions 1 and 2 was modified to “symptoms.”  
 
Participants are required to answer questions either on a scale from 1 (not at all logical) to 
9 (very logical) or from 0% to 100% and the scale is divided into two sets, with items 1-4 
(Set I) asking patients what they think, and items 5-6 (Set II) asking what they feel. 
However, Devilly and Borkovec (2000) cautioned future researchers when utilising the 
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scale because the two factors of Credibility and Expectancy are not derived from the two 
sets; Credibility has been found to be derived from the first three “think” questions (Set I, 
1, 2, & 3) and Expectancy was derived from the fourth think question and the two “feel” 
questions (Set I, 4, & Set II, 1 & 2) (Devilly & Borkovec, 2000). Furthermore, because 
the scale utilises two metrics (1-9, and 0-100%) this study will standardise the scoring in 
the following way. For each question, the mean Likert score (1-9) or mean % score, and 
standard deviation will be calculated and each person’s score will be expressed as a z-
score (individual score – mean score)/standard deviation. The z-scores can now be 
summed, giving factor (Credibility or Expectancy) scores for each individual, with higher 
z scores meaning higher Credibility or Expectancy. These summed scores will be used 
for both calculating group means, and for correlations.  
 
Devilly & Borkovec (2000) evaluated the psychometric properties of the CEQ for use in 
clinical outcome studies, reporting good internal consistency: the Credibility factor had a 
Cronbach’s alpha of between 0.81 and 0.86; the Expectancy factor a standardised 
Cronbach’s alpha of between 0.79 and 0.90; and, the whole scale a standardised 
Cronbach’s alpha of between 0.84 and 0.85. Test-retest reliability also exhibited good 
correlations; 0.82 for Expectancy, and 0.75 for Credibility.  
 
Use of the CEQ was made available when appended in Devilly and Borkovec (2000).  
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2.1.6. Hyperbaric Chamber 
 
The hyperbaric chamber’s overall size is 2640 X 2490 X 4732 MM. The Main Lock 
where patients sit is 2250W X 2100H X 2970L and accommodates four to five people. 
The chamber has two large 330mm clear viewing diameter flat disk viewports in the 
Main Lock. Depending on patient requirements, seats, armchairs, and beds are set up in 
the Main Lock where many of the fittings and pipes are visible. There is a speaker system 
that technical staff use for communication with nursing staff.  
 
2.4. PROCEDURE 
 
The recruitment process (see Figure 2) began once patients were accepted for HBOT. 
Patients were given an explanation of the research and an information sheet (see 
Appendix 3) after their initial assessment. A consent form (Appendix 9) and Booklet 1 
was further explained to those interested. Participants were able to complete Booklet 1 
either with the researcher, or independently, before their first HBOT session. Clinicians 
were also required to complete the clinician questionnaire before the participant’s first 
HBOT session. Participants then completed Booklets 2 and 3 before their 10th and final 
session respectively. While Booklet 1 took approximately 20-30 minutes, Booklets 2 and 
3 were a shortened version, taking approximately 5-10 minutes each. Participants were 
able to withdraw from the study at any time and received standard medical care as per 
normal.  
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Figure 2. Summary of procedure for descriptive study participants 
 
2.5. STATISTICAL ANALYSES 
 
Statistica 8 for Windows was used for descriptive data. Exploratory data analysis, 
comparative data using t-tests for independent means (by groups), correlations, graphical 
analyses, and multiple regressions were performed.  
 
Basic descriptive data were calculated for all variables. Differences between: male and 
female; age according to median split; head hood versus face mask; and previous HBOT 
or not, were tested via t-tests for independent means (by groups). Graphical analyses and 
Repeated Measures ANOVA were performed to assess change over time. Correlational 
analyses were done for all measures and according to gender. Hierarchical regression was 
used to investigate potential predictors of State Anxiety. 
Patient is accepted for 
Hyperbaric Oxygen Therapy 
Do they fit the inclusion criteria? 
Yes No 
Patient to receive standard 
medical care as per normal 
Patient approached at their initial 
HBOT medical assessment 
Interested in participation Not interested in participation 
 
Explanation regarding study 
given 
Patient consents to participation Patient declines participation 
Participant to complete Booklet 
1 before first HBOT session 
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Handling of Missing Data 
  
Missing case data was handled via the pair-wise method for correlational analyses. An 
examination of the distribution of missing data across the cells of the matrix for possible 
systematic "patterns" was done. Data from the one individual who withdrew consent was 
not included. Repeated Measures ANOVA and regressions used the case-wise method for 
handling missing case data.  
 
 
 
PART B – INTERVENTION EVALUATION 
 
2.6. PARTICIPANTS 
 
Participants appropriate for intervention were identified via a screening measure from the 
descriptive study sample.  
 
2.7. MATERIALS 
 
Intervention participants were required to complete Booklet Time one pre- and post-
intervention, with clinicians to complete the Clinician Questionnaire.  
 
 79 
2.8. PROCEDURE 
 
Intervention participants were further identified from the descriptive study sample 
subsequent to consent and completion of Participant Booklet 1 (see Figure 3). 
Participants with a score of 43 or above on the CLQ indicated that they were 
experiencing high claustrophobic distress and were subsequently approached regarding 
the intervention. This cut-off score was derived3 in an effort to encompass the higher end 
of CLQ scores that would indicate high claustrophobic distress, specifically those who 
would potentially benefit from an intervention. These participants were then to be given 
the option to partake in the intervention component (namely, OSET) of the study. For 
those who consented, the two sessions with the therapist (the principal researcher) would 
both take place at Christchurch Hospital’s HMU under the supervision of a supervisor 
who was a registered clinical psychologist. Those who declined the intervention would 
remain in the descriptive study sample and received routine care and support through 
HBOT from the HMU staff.  
 
                                                 
3
 A CLQ cut-off score of 43 was derived from normative data (Radomsky et al., 2000). The mean and 
standard deviation from a claustrophobic student sample was used by subtracting half a standard deviation 
from the mean (51.8-½(16.6) = 43.5). 
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Figure 3. Summary of procedure for intervention participants 
 
The first of the two sessions with the therapist was the Behavioural Analysis Interview 
(BAI; see Appendix 10). This takes approximately an hour, and is to collect information 
and determine suitability regarding the participant. This includes a topographic analysis 
of the patient's problem behaviour (its onset, development, the situations it occurs, and 
the factors that elicit and maintain it), and Behavioural Avoidance Tests (BATs) to assess 
approach behaviour to the phobic stimulus. BATs are the key outcome measure for 
treatment studies for specific phobias (Choy et al, 2007). At the end of the BAI the 
rationale for Öst’s (1989) one-session method is outlined to the patient. This includes 
explanation that the patient will be exposed in a controlled manner, thus enabling him/her 
to realise that the consequences they feared would happen will not occur. The session 
will be planned, gradual and controlled, as opposed to natural situations. The therapist 
will also point out that this session is a start and the patient is expected to continue their 
own treatment by exposing themselves in everyday situations via a voluntary 
Non-intervention participant 
completes and returns Booklet 1 
Is the Claustrophobia Questionnaire score 
above the cut-off score of 43? 
Yes - Participant is approached regarding 
intervention before first HBOT session 
Consents to intervention 
Completes intervention before 
undergoing first HBOT session 
Does not consent to intervention 
Participant to receive standard medical care as 
per normal and remain a non-intervention 
participant 
No – Participant to receive standard medical 
care as per normal and remain a non-
intervention participant 
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maintenance program. Patient instructions emphasise in order to achieve a successful 
result it is important to have teamwork, hard work, equal responsibility, and an open 
attitude. Instructions also emphasise that there will be no unplanned situations, 
everything will be demonstrated first, and only with the patient’s permission will they be 
asked to attempt the tests. An important point stressed is that within the session the 
patient will not exceed any previous feelings of anxiety experienced, even though they 
will be exposed to much more than ever before. They are told that while a high level of 
anxiety will be a side effect of the session, it is not a goal. The two goals of the session 
are that the patient should be able to manage in natural situations after completing the 
treatment, and that the therapist wants the patient to achieve during the therapy session.  
 
The second session, a subsequent exposure therapy session set up as behavioural tests, 
was the intervention OSET (Öst, 1989, 1997). This takes a maximum of three hours and 
the OSET for claustrophobia, as outlined in Öst (1997), was modified for the purposes of 
the current study to make the therapy specific to HBOT patients and the hyperbaric 
chamber. The script was pilot-tested by the researcher and the registered clinical 
psychologist supervisor, and relevant modifications were applied. The full script of the 
modified intervention and intervention steps are further detailed are provided in 
Appendix 11. Participants were able to withdraw from the study at any time and receive 
standard medical care as per normal. 
 
A single-case, multiple baseline design was to be used for intervention participants, in 
which anxiety ratings were recorded regularly at each step of the intervention. Anxiety 
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ratings used were Subjective Units of Distress (SUDs) and were recorded before and 
during each behavioural step within the intervention. The multiple baseline design was 
chosen to demonstrate the effectiveness of OSET. Effectiveness was assessed by 
measuring behaviour change (in this case, SUDs) that accompanied the introduction of 
each behavioural step.  
 
It eventuated that there were no intervention participants for this study. Two participants 
scored above the cut-off mark on the screening measure but did not participate in the 
intervention. Of the two, one declined and one was not able to be offered the extra help 
due to practicality problems. Both were included as part of the descriptive study sample 
and consequently this component of the research will not be included in the Results 
section.  
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CHAPTER THREE 
 
 
3. RESULTS 
 
 
 
3.1. EXPLORATORY ANALYSIS 
 
Analysis began by calculating descriptive statistics via means, standard deviations, range, 
and distributions for each pre-HBOT scale and for State Anxiety at times one, two, and 
three (see Table 7). Using z scores for comparisons where necessary, the current sample 
was then compared to normative data and appropriate research samples. The sample was 
then separated into categories according to gender, previous HBOT experience, type of 
headgear worn, and age. Descriptive data was calculated and group comparison for each 
of the sub-groups was made using t-tests for independent means.  
 
Means, Standard Deviations, Range, and Distribution for Measures 
 
Pre-HBOT scale means, standard deviations, and range for all variables and State 
Anxiety at all times are displayed in Table 7. The distribution for State Anxiety at time 
one was approximately normal, however distributions at times two and three were 
positively skewed. State Anxiety at time three had a strong positive skew, with most 
participants having low scores. Trait Anxiety also showed a slight positive skew. CLQ-T, 
Restriction, and Suffocation distributions were positively skewed, although if one 
extreme score was removed the distributions became approximately normal. Anxiety 
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Sensitivity displayed a positive skew with a slight floor effect, in that four participants 
scored very close to zero. The CEQ-T, Credibility, and Expectancy scales were 
negatively skewed and displayed a ceiling effect where some individuals scored the 
maximum on the scales.  
 
The median age was 65 years but there was one extreme low score, one participant being 
19 years of age. If this participant was removed the data became normally distributed 
around the median. Average number of ‘other people’ in the chamber, total number of 
sessions, and the amount of change in State Anxiety from time one to time three were all 
approximately normal. 
 
Table 7 
Means, Standard Deviations, and Range for Measures 
Measures     Mean  SD  Range*  
State Trait Anxiety Inventory (STAI) 
STAI - S¹ (n=24)    35.21  11.35  21 – 59 
STAI - S² (n=20)    28.5  10.83  20 – 61 
STAI - S³ (n=21)    29.76  12.55  20 – 66 
STAI - T     31.63  9.34  20 – 55 
 
Claustrophobia Questionnaire (CLQ) 
CLQ – Total      19  19.76  0 – 90 
CLQ – Restriction Scale   10.8  10  0 – 42 
CLQ – Suffocation Scale   8.2  10.6  0 – 48 
 
Anxiety Sensitivity Index (ASI)  20.29  14.4  2 – 55 
 
Credibility/Expectancy Questionnaire** (CEQ) 
CEQ - Total     -0.22  4.48  -13.5 – 4.5 
CEQ - Expectancy    0.39  2.61  -5.9 – 2.5 
CEQ - Credibility    -0.61  2.56  -7.7 – 2 
Notes: 
Abbreviations: STAI- S¹²³=State-Trait Anxiety Sensitivity Index-State at times 1, 2, and 3. STAI-T=State-Trait Anxiety Index-Trait.  
*Possible range for measures – STAI S & T: 20-80, CLQ: 0-104, ASI: 0-64 
**CEQ scores have different scales (Likert & percentage) therefore this study standardised scores and displayed them as z scores  
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Reliability of Measures 
 
While reliability coefficients from previous samples or test manuals are of use for 
comparative reasons, it is important to calculate reliability estimates from each study’s 
own sample (Vacha-Haase, Hensen, & Caruso, 2002). The current study assessed 
reliability by Cronbach’s alpha, which is a measure of internal consistency and describes 
the overall consistency of a measure. This estimation of reliability served as a pre-
requisite for claims concerning the validity of the measures, as opposed to the manual 
coefficients. Therefore, Cronbach’s alpha for all measures were calculated and are 
detailed in Table 8. All measures had good reliabilities with Cronbach’s alpha ranging 
from .84 to .97.   
 
Table 8 
Cronbach’s alpha for Measures Used in Present Study 
Measure     Cronbach’s Alpha  
State Trait Anxiety Inventory 
State       .92 
Trait       .92 
 
Claustrophobia Questionnaire 
Total        .97 
Restriction      .95 
Suffocation      .95 
 
Treatment Credibility/Expectancy Questionnaire 
Total       .85  
Credibility      .85  
Expectancy      .84 
 
Anxiety Sensitivity Inventory    .95 
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Current Sample in Comparison to Normative Data and Other Research Samples 
 
Means from all measures taken pre-HBOT were compared to normative data and 
appropriate published samples in medical settings by using z scores to describe the 
difference. These z scores were derived using the normative or published means and 
standard deviations and the current sample’s means4 (see Table 9). The normative data 
used for comparison of the CEQ was derived from a study of Generalised Anxiety 
Disorder (GAD; Devilly & Borkovec, 2000) and examined the association between 
Credibility and Expectancy of symptom improvement for GAD and anxiety outcome 
measures. No published sample was found for comparison to the CEQ due to insufficient 
reporting of descriptive data or detailing of transformations of the data. 
                                                 
4
 To compare the current sample’s means to other samples,  z score differences were calculated by using 
normative/research means and standard deviations ((Current Sample’s M – Normative/Research 
M)/Normative/Research SD)). For example, the current sample’s State Anxiety mean at time one was 
compared to normative data by the following equation ((35.21 – 42.38)/13.79)=-0.52) (see Table 9).  
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Table 9 
Pre-HBOT Comparison of the Current Sample with Previously Reported Samples 
   Comparison Data  Current Sample  Comparison Difference  
Measures  N M SD  M    SD unit 
 
Normative Data 
 
(Spielberger, 1983) 
STAI-S¹   161 42.38 13.79   35.21  -0.52 
STAI-S²   161 42.38 13.79  28.5  -1.01 
STAI-S³   161 42.38 13.79  29.76  -0.92 
STAI-T   161 41.91 12.7  31.63  -0.81   
(Radomsky et al., 2001) 
CLQ-T   78 28.9 19.4  19  -0.51  
CLQ-RS  78 19.9 12.8  10.8  -0.71         
CLQ-SS   78 9.1 7.9   8.2  -0.11    
(Sandin et al., 2001) 
ASI 
   Male   152 18.8 9.3  18.1         -0.08      
   Female  238 22.1 9.2  25.7  0.39      
Total   390 20.5 9.3  20.3  -0.02  
(Devilly & Borkovec, 2000)* 
CEQ-Item 1  69 8.12 1.04  7.88  -0.23 
CEQ-Item 2  69 7.31 1.45  7.75  0.30 
CEQ-Item 3  69 7.40 1.56  7.63  0.15 
CEQ-Item 4  69 67.61 17.24  78.18  0.61 
CEQ-Item 5  69 6.67 1.48  8.08  0.95 
CEQ-Item 6  69 66.79 18.06  79.09  0.68 
 
Research Samples 
 
(Clark et al., 1994) 
STAI-S¹   24 37.4ª 11.1  35.21  -0.2 
STAI-S²   24 31.2ªª 9.3  28.5  -0.29 
STAI-S³   24 31.2 9.3  29.76  -0.15 
STAI-T   24 35.5 9.4  31.63  -0.41    
(McIsaac et al., 1998) 
CLQ-T   75 26.33 18.95  19  -0.4   
CLQ-RS  78 18.17 12.14  10.83  -0.6  
CLQ-SS   76 9.24 8.93  8.17  -0.12    
(McIsaac et al., 1998) 
ASI   80 17.67 9.35  20.29  0.28 
Notes: 
Spielberger (1983): Normative data was calculated from a general medical sample 
Clark et al. (1994): Sample mean collected from patients beforeª and afterªª HBOT 
Radomsky et al. (2001): Normative data was collected from an adult community sample undergoing MRI 
Sandin et al. (2001): Normative data was collected from a sample of Spanish university students 
Abbreviations: STAI- S¹²³=State Trait Anxiety Sensitivity Index-State at times 1, 2, and 3. STAI-T=State Trait Anxiety Index-Trait. 
CLQ-T=Claustrophobia Questionnaire total score. CLQ-RS=Claustrophobia Questionnaire-Restriction Scale. CLQ-
SS=Claustrophobia Questionnaire-Suffocation Scale. ASI=Anxiety Sensitivity Index. CEQ=Treatment Credibility/Expectancy 
Questionnaire.  
*Devilly & Borkovec (2000) report means and SD item by item un-standardised, thus this comparison is done here. Credibility factor 
loads from the first three items, whereas Expectancy factor loads from last three items.  
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State Anxiety at times one, two and three was compared to Spielberger’s (1983) general 
medical sample (GMS). While State Anxiety at time one was lower than the GMS by 
approximately half a standard deviation, it was almost equivalent to a pre-HBOT sample 
(Clark et al., 1994). Additionally, while the current sample’s State Anxiety decreased at 
times two and time three, bringing them to approximately one standard deviation lower 
than the GMS mean, times two and three still remained similar5 to the State Anxiety of a 
post-HBOT sample. A noteworthy comparison was the current study’s Trait Anxiety 
mean, almost one standard deviation lower than Spielberger’s (1983) GMS and almost 
half a standard deviation lower than the HBOT sample (Clark et al., 1994). CLQ-T and 
Restriction scores indicated levels over half a standard deviation less claustrophobic than 
normative (Radomsky et al., 2001) and research sample means (McIsaac et al., 1998), 
whereas Suffocation scores were similar to normative and research sample means. The 
combined score for men and women for Anxiety Sensitivity from the current sample was 
just over one quarter of a standard deviation higher in Anxiety Sensitivity than the 
medical sample (McIsaac et al., 1998), however it was equivalent to normative data 
(Sandin et al., 2001). Anxiety Sensitivity for men was very similar to normative data and 
Anxiety Sensitivity for women was higher than normative data (Table 9). 
 
The current sample was compared to a GAD sample (Devilly & Borkovec, 2000) on the 
CEQ items and exhibited higher Credibility and Expectancy scores on all items except 
item one, which was similar (Table 9).  
 
                                                 
5
 Approximately equal to or less than one quarter standard deviation is considered similar for the purposes 
of this study.   
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Categorical Comparison Data for Sample 
 
The contribution of potential covariables of gender, previous experience of HBOT, type 
of headgear worn, and age – split at the current sample’s median – were assessed by 
independent means sample t-tests (by group). Means and standard deviations are reported 
in Table 10 and significant differences are noted (p < .05).  
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Table 10 
Mean HBOT Scores (Standard Deviations) for STAI-State, STAI-Trait, CLQ, CEQ, and ASI according to gender, previous HBOT, and 
age.  
Measures administered before and during HBOT 
 
 
Gender Previous HBOT Headgear Age† 
 
 
Measures 
 
Men 
n = 17 
 
Women 
n = 7 
 
Yes 
n = 9 
 
No 
n = 15 
 
Mask 
n = 18 
 
Hood 
n = 6 
 
≤ 64 
n = 12 
 
≥ 65 
        n = 12 
State Trait Anxiety Inventory 
(STAI)    
        
   STAI - S¹  34 (12.4) 38.1 (7.6) 31.8 (9.9) 37.3 (12) 34.8 (12) 36.5 (10) 36.2 (11.1) 34.3 (12) 
   STAI - S²***   26.1 (6.1) 34.2 (17.1) 27 (10.2) 29.3 (11.5) 29.3 (11.6) 26.2 (8.8) 31 (13) 25.4 (7) 
   STAI - S³****  25.7 (8.3) 40 (16.1)* 32.4 (16.1) 28.4 (10.9) 25.1 (69) 41.3 (16.5)** 34.5 (15.5) 24.6 (5.2) 
   STAI - T 29.6 (7.8) 36.6 (11.5) 31.7 (7.6) 31.6 (10.5) 30.8 (10) 34.2 (7) 35.7 (10.2) 27.6 (6.5)* 
 
Claustrophobia Questionnaire 
(CLQ)  
        
   CLQ Total Score 13.9 (12.7) 31.3 (28.6)* 16.2 (12.3) 20.7 (23.4) 14.2 (12.6) 33.5 (30.4)* 21.4 (24.3) 16.6 (14.7) 
   CLQ Restriction Scale 8.8 (7.8) 15.7 (13.5) 9.6 (7.9) 11.6 (11.3) 8.4 (7.4) 18.2 (13.8)* 12.1 (11.4) 9.6 (9.1) 
   CLQ Suffocation Scale  5.1 (5.7) 15.6 (15.9)* 6.7 (5.6) 9.1 (12.8) 5.8 (6.2) 15.3 (17.3) 9.3 (13.8) 7 (6.2) 
   
        
Anxiety Sensitivity Index (ASI) 18.1 (12.4) 25.7 (18.3) 15.8 (10) 23 (16.2) 18.7 (14.3) 25.2 (14.9) 22.9 (17.9) 17.7 (9.9) 
   
        
Treatment Credibility/Expectancy 
Questionnaire (CEQ)         
   CEQ - Total   0.1 (3.8) -0.1 (6.1) 0.3 (6) -0.5 (3.5) -0.8 (5) 1.6 (1.8) -1.1 (5.4) 0.6 (3.4) 
   CEQ - Expectancy  0.5 (2.2) 0.1 (3.7) 0.9 (2.7) 0.1 (2.6) -0.3 (2.7) 2.4 (0.3)* 0 (3.1) 0.8 (2) 
   CEQ - Credibility -0.4 (2.3) -1.0 (3.3) -0.7 (3.4) -0.6 (2) -0.6 (2.8) -0.8 (1.8) -1.1 (3) -0.1 (2) 
Notes: 
Abbreviations: S¹²³=State Trait Anxiety Inventory-State at times 1, 2, and 3. T=State Trait Anxiety Inventory-Trait.  
†Age was separated into two groups above and below the present study’s median age (Median = 65 years). 
*Differences significant at 0.05 level  
**Differences significant at 0.01 level 
***N: S² - Men (14) Women (6). Yes HBOT (7) No HBOT (13). Mask (15) Hood (5). ≤64 (11) ≥65 (11). 
****N: S³ - Men (15) Women (6). Yes HBOT (7) No HBOT (14). Mask (15) Hood (6). ≤64 (11) ≥65 (10). 
 91 
 
Gender 
The present study found a number of gender differences. Women scored significantly 
higher than men on CLQ-T (t (22) = -2.09, p < .05) and Suffocation (t (22) = -2.43, p < 
.05). Women also experienced significantly higher State Anxiety at time three (t (19) = -
2.71, p < .05). 
 
Previous HBOT 
No dependent variable differed significantly as a function of previous HBOT experience.  
 
Headgear 
Differences were found between those who wore a face mask and a hood. Those wearing 
a hood exhibited significantly higher State Anxiety at time three, t (19) = -3.25, p < .01, 
than face mask wearers. A chi-square analysis between headgear and gender was 
calculated and was significant (χ² (1) = 5.45, p < .05), indicating a relationship between 
gender and type of headgear worn.   
 
Age 
When the sample’s age was split into two groups – above and below the sample median – 
only one significant difference was found. The younger group scored significantly higher 
on Trait Anxiety t (22) = -2.31, p < .05.  
 
 
 92 
 
3.2. EXAMINATION OF CORRELATIONS 
 
Bivariate correlations (Pearson’s r) were calculated to examine associations between 
variables (see Table 11). Significant correlations only with State Anxiety are described. 
Other significant correlations are subsequently noted. Correlational matrices according to 
gender were calculated and are then discussed. Full correlational matrices including non-
significant results can be seen in Appendix 15  
 
Pairwise deletion was used for missing data (see Appendix 16 for correlation matrix of 
whole sample using casewise deletion method). Means and standard deviations for each 
subset of values used in the calculation of individual correlation coefficients were noted 
to be very similar, thus indicating no systematic bias in the correlation matrix. 
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Table 11 
Correlations between Scales Measuring Individual Variables 
 
  
STAI-T CLQ-T CLQ-RS CLQ-SS CEQ-E CEQ-C CEQ-T ASI STAI-S 1 STAI-S 2 STAI-S 3 
STAI-T - - ns ns ns ns ns ns 0.78** ns 0.61* ns 
CLQ-T  - - 0.96** 0.96** ns ns ns ns ns ns 0.48* 
CLQ-RS   - - 0.84** ns ns ns ns ns ns 0.5* 
CLQ-SS    - - ns ns ns 0.5* ns ns ns 
CEQ-E     - - 0.5* 0.86** ns -0.44* -0.58** ns 
CEQ-C      - - 0.87** ns ns ns ns 
CEQ-T       - - ns ns -0.45* ns 
ASI        - - 0.51* ns ns 
STAI-S 1         - - ns ns 
STAI-S 2          - - ns 
STAI-S 3           - - 
Notes: 
* Correlation is significant at the .05 level 
** Correlation is significant at the .01 level 
Abbreviations: STAI-T=State Trait Anxiety Inventory-Trait; CLQ-T=Claustrophobia Questionnaire; CLQ-RS=CLQ Restriction Scale; CLQ-SS=CLQ 
Suffocation Scale; CEQ-T=Credibility/Expectancy Questionnaire total score; CEQ-E=CEQ Expectancy score; CEQ-C=CEQ Credibility score; ASI=Anxiety 
Sensitivity Index; STAI-S 1=STAI-State score at time 1; STAI-S 2=STAI-State score at time 2; STAI-S 3=STAI-State score at time 3. 
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Correlations 
 
Correlations between State Anxiety at all Times 
There were weak, non-significant correlations between levels of State Anxiety across all 
times. 
 
Correlations between Trait Anxiety and State Anxiety 
No significant correlation was found between Trait Anxiety and participants’ State 
Anxiety at time one or time three. A moderately large, significant correlation between 
Trait Anxiety and State Anxiety was found at time two (r = .61, p < .05). 
 
Correlations between Trait Anxiety and all Other Variables 
Trait Anxiety had a large correlation with Anxiety Sensitivity (r = .78, p < .01). No other 
variable correlated significantly with Trait Anxiety.  
 
State Anxiety with all Other Variables  
There were large, significant correlations of State Anxiety at time three with CLQ-T (r = 
.48, p < .05) and Restriction (r = .5, p < .05). Anxiety Sensitivity significantly correlated 
with State Anxiety at time one (r = .51, p < .05). Significant correlations were not found 
between Anxiety Sensitivity and State Anxiety at times two or three.  
 
Medium to large negative correlations were observed between higher Expectancy and 
lower State Anxiety at time one (r = -.44, p < .05) and at time two (r = -.58, p < .01). 
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There was no significant correlation of Expectancy and State Anxiety at time three or 
between Credibility and State Anxiety at any stage of HBOT. Age was not significantly 
correlated with State Anxiety at any stage of HBOT. There was a moderately large 
correlation between average number of people in the chamber for each participant and 
State Anxiety at time three (r = 0.53 p < .05). When partitioned by gender the correlation 
for women was large (r = .90, p < .05), but not significant for men (r = .28, p > .05) (see 
Appendix 17). This was not found at times one and two.  
 
Other Significant Correlations  
The CLQ subscales, Suffocation and Restriction, were significantly correlated (r = .84, p 
< .01) and, as expected, CLQ-T was highly correlated with both Suffocation (r = .96, p < 
.01) and Restriction scales (r = .96, p < .01). Therefore, further statistical analyses used 
CLQ-T only.   
 
There was a moderate correlation between Expectancy and Credibility (r = .50, p < .05), 
and strong correlations between CEQ-T and its two factors (Expectancy; r = .86, p < .01; 
Credibility; r = .87, p < .01). Because of the suggested theoretical differences (Devilly & 
Borkovec, 2000) and moderate correlation, Credibility and Expectancy were used in 
further analyses as separate factors.  
 
Anxiety Sensitivity was found to be moderately correlated with Suffocation (r = .5, p < 
.05). Age was positively correlated with Credibility (r = 0.44, p < 0.05). Gender (men = 
0, women = 1) was significantly correlated with previous HBOT (yes = 0, no = 1) (r = -
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.45, p < .05. See Appendix 15). Previous HBOT was significantly correlated with total 
number of sessions per participant (r = .46, p < .05. See Appendix 15).  
 
Modified Data 
A further variable of total individual State Anxiety change from time one to time three 
was calculated and investigated for its relationship with pre-HBOT scales. No significant 
correlations were found.6 
 
Gender 
Further investigations on gender differences were undertaken. Correlational matrices 
were calculated according to gender (see Tables 12 and 13).  
                                                 
6
 Other data was also modified. Anxiety Sensitivity scores were divided into low, medium, and high 
categories (see section 2.3.4.) to investigate any further relationships with State Anxiety. Due to 
insufficient sample size in each category further analyses were unable to be performed and Anxiety 
Sensitivity was used in further analyses as the complete sample.  
 97 
Table 12 
Correlations for Women 
 STAI-T STAI-S 1 STAI-S 2 STAI-S 3 CLQ-T CLQ-RS CLQ-SS CEQ-T CEQ-E CEQ-C ASI 
STAI-T -- ns .99** ns ns ns ns ns ns ns .84* 
STAI-S 1  -- ns ns ns ns ns -.85* ns -.83* ns 
STAI-S 2   -- ns ns ns ns ns ns ns .88* 
STAI-S 3    -- ns ns ns ns ns ns ns 
CLQ-T     -- .97** .98** ns ns ns ns 
CLQ-RS      -- .89** ns ns ns ns 
CLQ-SS       -- ns ns ns .77* 
CEQ-T        -- .89** .85* ns 
CEQ-E         -- ns ns 
CEQ-C          -- ns 
ASI           -- 
 
Table 13 
Correlations for Men 
 STAI-T STAI-S 1 STAI-S 2 STAI-S 3 CLQ-T CLQ-RS CLQ-SS CEQ-T CEQ-E CEQ-C ASI 
STAI-T -- ns ns ns ns ns ns ns ns ns .71** 
STAI-S 1  -- ns ns ns ns ns ns ns ns .52* 
STAI-S 2   -- ns ns ns ns ns ns ns ns 
STAI-S 3    -- ns ns ns ns ns ns ns 
CLQ-T     -- .96** .92** ns ns ns ns 
CLQ-RS      -- .78** ns ns ns ns 
CLQ-SS       -- ns ns ns ns 
CEQ-T        -- .85** .87** ns 
CEQ-E         -- ns ns 
CEQ-C          -- ns 
ASI           -- 
Notes for Tables 12 and 13: * Correlation is significant at the .05 level. ** Correlation is significant at the .01 level 
Abbreviations: STAI-T=State Trait Anxiety Inventory-Trait; CLQ-T=Claustrophobia Questionnaire; CLQ-RS=CLQ Restriction Scale; CLQ-SS=CLQ 
Suffocation Scale; CEQ-T=Credibility/Expectancy Questionnaire total score; CEQ-E=CEQ Expectancy score; CEQ-C=CEQ Credibility score; ASI=Anxiety 
Sensitivity Index; STAI-S 1=STAI-State score at time 1; STAI-S 2=STAI-State score at time 2; STAI-S 3=STAI-State score at time 3. 
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Gender Differences 
Bivariate correlations revealed a number of different associations of State Anxiety and 
other pre-HBOT measures as a function of gender. Five associations displayed extremely 
large differences where women had very high correlations and men did not show 
significant correlations – CEQ-T and State Anxiety at time one (women, r = -.85, p < 
.05); Credibility and State Anxiety at time one (women, r = -.85, p < .05); Trait Anxiety 
and State Anxiety at time two (women, r = .99, p < .05); Anxiety Sensitivity and State 
Anxiety at time two (women, r = .88, p < .05); and Anxiety Sensitivity and Suffocation (r 
= .77, p < .05). Only Anxiety Sensitivity and State Anxiety at time one showed a 
significant correlation for men (r = .52, p < .05) but no significant correlation for women. 
While women showed a large relationship between Trait Anxiety and State Anxiety at 
time two, the distribution of State Anxiety scores for women at time two revealed a 
trimodal positively skewed distribution, meaning interpretation of this correlation should 
be done with caution. Lastly, women showed a strong (r = .90, p < .05) significant 
correlation between the average number of other people in the chamber over all sessions 
and State Anxiety at time three.  
 
Gender Similarities 
Correlations also revealed a number of similar associations (see Tables 12 and 13). Both 
men (r = .71, p < .05) and women (r = .84, p < .05) revealed large correlations between 
Anxiety Sensitivity and Trait Anxiety. CEQ-T with Credibility and Expectancy, and 
CLQ-T with Suffocation and Restriction demonstrated significant correlations (see 
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Tables 12 and 13) supporting the whole sample correlation matrix where similar 
correlations were found (see Table 11). 
 
3.3. PREDICTORS OF OUTCOME 
 
Exploratory hierarchical multiple regressions were carried out to determine the extent to 
which variables were able to predict State Anxiety before and during hyperbaric 
treatment. The regression models used were constrained for at least two reasons. First, the 
sample size (n (time 1) = 24, n (time 2) = 20, and n (time 3) = 21) was insufficient for all 
potential predictors to be entered into one regression, therefore, no more than three 
predictors in total were entered into any regression. Secondly, because of high 
correlations between some predictor variables, there was a multicollinearity problem in 
some cases. 
 
Multicollinearity was evident for Anxiety Sensitivity and Trait Anxiety (r = .78). To 
resolve this, the two variables were converted to z scores then combined to make a new 
predictor variable, a composite measure of individual Dispositional Anxiety pre-HBOT, 
referred to as ‘DisAnx’. DisAnx was entered into regressions in the first step, to control 
for the influence of levels of Dispositional Anxiety. While DisAnx was a significant 
predictor at times one and two, it did not account for variance at time three and 
consequently was not included in the regression model for time 3 State Anxiety. 
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A series of exploratory regressions were undertaken with each examining predictors of 
State Anxiety at times one, two, or three (see Appendix 18 for ideal regressions if 
sufficient N). For each regression, casewise deletion method was used in order to allow 
for Beta weight comparisons. Additionally, Tolerance levels and Semi-partial 
correlations were examined to ensure no predictor variables were too highly related 
causing multicollinearity.  
 
The predictor variables entered were the pre-HBOT measures of Expectancy, Credibility, 
CLQ-T, and the composite variable DisAnx (Anxiety Sensitivity + Trait Anxiety). In 
addition, State Anxiety was investigated to observe if levels of State Anxiety at Tx 
predicted State Anxiety at Tx+1 and Tx+2. Demographic information, namely age and 
gender, were examined in the exploratory regressions as control variables to observe any 
potential influences. Predictors were grouped into hierarchical subsets guided by 
theoretical considerations and the pattern of bivariate correlations, and all steps of the 
final models are reported in Table 14.  
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Table 14 
Regression Results: Final Models for State Anxiety at Times One, Two, and Three   
                          
   Dependent Variable: State Anxiety at Time One 
Step Predictor Variables   r Beta t p R² Adj R² R² Change Sig. F Change Semipart Cor. Tolerance 
1 DisAnx   0.444 0.444 2.323 0.030 0.197 0.161         
2 DisAnx  0.444 0.400 2.265 0.034     0.397 0.988 
  Expectancy -0.44 -0.398 -2.253 0.035 0.353 0.292 0.156 5.076 -0.395 0.988 
             
             
   Dependent Variable: State Anxiety at Time Two 
Step Predictor Variables   r Beta t p R² Adj. R² R² Change Sig. F Change Semipart Cor. Tolerance 
1 DisAnx   0.493 0.493 2.407 0.027 0.244 0.201         
2 DisAnx  0.493 0.371 2.022 0.059     0.359 0.936 
  Expectancy -.578 -0.4844 -2.101 0.017 0.463 0.400 0.220 6.959 -0.469 0.936 
             
             
   Dependent Variable: State Anxiety at Time Three 
Step Predictor Variables   r Beta t p R² Adj R² R² Change Sig. F Change Semipart Cor. Tolerance 
1 Gender   0.529 0.529 2.714 0.014 0.279 0.241         
             
OR 1 Claustrophobia 0.479 0.479 2.376 0.028 0.229 0.188         
             
2 Gender  0.529 0.391 1.820 0.086     0.346 0.785 
 Claustrophobia 0.479 0.297 1.385 0.183 0.349 0.276 0.069 ns 0.263 0.785 
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Series 1: State Anxiety at times one and two in predicting time two and three. 
 
Small, non-significant bivariate correlations suggest State Anxiety at times one and two 
had no predictive power for State Anxiety at times two and three respectively. Part of the 
preliminary investigation included regressions to investigate this, and these demonstrated 
that previous levels of State Anxiety did not significantly predict future State Anxiety. 
Therefore, the final models do not contain prior State Anxiety as a predictor.  
 
Series 2: Dispositional Anxiety and Expectancy as Predictors of State Anxiety at Time 
One 
 
After exploratory hierarchical regressions were performed, guided by bivariate 
correlations, two variables – Dispositional Anxiety and Expectancy of symptom 
improvement – made up the final model that significantly predicted State Anxiety at time 
one, F[1, 22] = 5.737, p < .05 (Table 14). Even when controlling for Dispositional Anxiety, 
Expectancy still significantly predicted additional variance at time one, with both 
accounting for approximately 30% of the variance in State Anxiety. This model indicates 
that participants with higher Dispositional Anxiety and lower Expectancy were more 
likely to experience higher State Anxiety before undergoing HBOT. Further regressions 
showed no other variables significantly explained variance at time one. 
 
Series 3: Dispositional Anxiety and Expectancy as Predictors of State Anxiety at Time 
Two 
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Two significant variables made up the final model that predicted State Anxiety at time 
two, F[2, 17] = 7.335, p < .05 (Table 14). As at time one, Dispositional Anxiety and 
Expectancy of symptom improvement significantly predicted State Anxiety at time two, 
accounting for approximately 40% of the variance. Even when controlling for 
Dispositional Anxiety, Expectancy still significantly predicted additional variance at time 
two. This model indicates that participants with higher Dispositional Anxiety and lower 
Expectancy were more likely to still experience higher State Anxiety ten sessions into 
undergoing HBOT. Further regressions showed no other variables significantly explained 
variance at time two. 
 
Series 4: CLQ and Gender as Predictors of State Anxiety at Time Three 
 
The full model predicting State Anxiety at time three included CLQ-T and gender as 
predictors, F[2,18] = 4.82, p < .05 (Table 14). However, neither of the individual predictors 
reached significance in the full model (although gender was approaching significance). 
Gender alone significantly predicted State Anxiety at time three, but when CLQ-T was 
entered, both became non-significant predictors. Because this can indicate 
multicollinearity, Tolerance levels and Semi-partial correlations were examined. 
Tolerance levels were lower than other models, although still reasonable high. Semi-
partial correlations were also lower than other models and suggested some level of 
collinearity.  
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Simple regression coefficients between the three variables were examined – State 
Anxiety at time three, CLQ-T, and gender – and were shown to be moderately correlated 
(see Table 15). Partial correlations were performed to further examine the individual 
relationships between CLQ-T and gender with State Anxiety at time three. When CLQ-T 
was controlled, gender no longer had a significant correlation with State Anxiety at time 
three. When gender was controlled, CLQ-T also was no longer significant. Although 
gender and CLQ-T are only moderately correlated (r = .46), women scored significantly 
higher than men in both CLQ-T (t (22) = -2.09, p < .05) and State Anxiety at time three (t 
(19) = -2.71, p < .05) (as reported in section 3.1) and the regression model reflects this. 
The range of CLQ-T scores for women were approximately twice that of men (0 – 45 for 
men and 8 – 90 for women), and the standard deviation was very high (SD (men) = 12.6; 
SD (women) = 28.6). Additionally, the sample size was small, especially for women at 
time three (women = 6; men = 15). Therefore, it appears that the extreme scores for 
women and variance in CLQ-T, and the small sample size influenced the significant Beta 
values in the model, and gender and CLQ-T are explaining to some extent, some of the 
same variance in State Anxiety at time three. Because gender was explaining more 
variance (see Table 14), CLQ-T was deleted from the final model, leaving a simple 
bivariate regression equation of gender predicting State Anxiety at time three.  
 
Table 15 
Correlational Matrix – State Anxiety at Time Three, CLQ-T, and Gender 
  Gender CLQ-T State 3 
Gender 1.00 0.46 0.53 
CLQ-T 0.46 1.00 0.48 
State 3 0.53 0.48 1.00 
All correlations were significant at p < .05 level 
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3.4. EXPOSURE TO HBOT 
 
The study hypothesised that State Anxiety would change over the course of HBOT as 
individuals become more experienced with hyperbaric treatment. Figures 4 and 5 show 
the change in mean State Anxiety from time one to time two to time three for the whole 
sample, and for women and men respectively.  
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Figure 4: State Anxiety means over time for whole sample (Whiskers denote +/- 0.95 Confidence 
Intervals).  
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State Anxiety levels for the whole sample decreased slightly from time one to time two, 
and changed little from time two to time three, with considerable overlap across the three 
measurements.  
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Figure 5. State Anxiety means over time for men (0) and women (1) (Whiskers denote +/- 0.95 
Confidence Intervals). 
 
State Anxiety levels for women decreased very slightly from time one to time two, but 
increased from time two to time three. The extremely large variance indicates 
considerable overlap across the three measurements. A Repeated Measures 2-way 
ANOVA found no significant change over time. State Anxiety levels for men decreased 
from time one to time two, and again from time two to time three. There was less overlap 
across the three measurements in the variance for men than women and although the 
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Repeated Measures 2-way ANOVA found no significant change over time for men, it 
was approaching significance (F[2, 26] = 3.2541, p = .05480). There was a main effect of 
gender F[1, 17] = 6.83, p < .05, but no interaction between gender and time (F[2, 34] = 1.51, 
p > .05).  
 
Figures 6 and 7 below describe participant change in State Anxiety from time one to time 
two (Figure 6) and from time one to time three (Figure 7). The vertical and horizontal 
lines on the figures represent Spielberger’s (1983) GMS State Anxiety norm score (42). 
Therefore, being above or below this line portrays individuals in the present sample 
relative to those in a GMS (Spielberger, 1983). The diagonal line is the line of no change 
and represents where participants would sit if they did not change from time one to time 
two or time one to time three. Participants falling below the diagonal line represent those 
experiencing a reduction in State Anxiety from time one to time two or time one to time 
three, while those above the line represent those experiencing an increase in State 
Anxiety.  
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Figure 6. State Anxiety at time one plotted against State Anxiety at time two (dark points = men, light 
points = women). 
 
Figure 6 shows a general trend for a reduction in State Anxiety from time one to time 
two. Before participants underwent their first HBOT session approximately one third had 
State Anxiety levels above Spielberger’s (1983) GMS norm, however, approximately two 
thirds of participants decreased in State Anxiety from time one to time two and thus at 
time two almost all participants were less anxious than the GMS norm. One participant 
remained above the GMS norm at both time one and time two, and one participant’s State 
Anxiety increased from below to above the GMS norm.  
0 
10 
20 
30 
40 
50 
60 
70 
80 
0 10 20 30 40 50 60 70 80 
State Anxiety at Time One
St
a
te
 
A
n
x
ie
ty
 
a
t T
im
e 
Tw
o
 
  
 
109 
 
Figure 7. State Anxiety at time one plotted against State Anxiety at time three (dark points = men, light 
points = women).  
 
Figure 7 also shows a general reduction in State Anxiety from time one to time three, 
although there was substantial variance. Again, a decrease in State Anxiety was seen in 
approximately two thirds of participants from time one to time three (see Figure 7), 
however, two participants’ State Anxiety increased from below the GMS norm at time 
one, to above at time three, and one participant remained above at both time one and 
three.  
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CHAPTER FOUR 
4. DISCUSSION 
 
 
The goal of the current study was to investigate anxiety and fear responses to medical 
procedures, specifically HBOT. The current study’s hypotheses were partially supported: 
1) Dispositional Anxiety, Expectancy of symptom improvement, and gender, were found 
to be predictors of State Anxiety before and during HBOT, 2) no significant change in 
State Anxiety over the course of HBOT was found, and 3) Öst’s (1989) OSET 
effectiveness was unable to be evaluated. The following section will initially discuss 
pertinent findings in individual variables and their associations with State Anxiety. This 
will be followed by a discussion of predictors of State Anxiety, exposure to HBOT, and 
the intervention evaluation.  
 
4.1. INDIVIDUAL VARIABLES AND STATE ANXIETY  
 
Individual Variables  
 
The hypothesis that participants with higher Trait Anxiety and Anxiety Sensitivity will 
experience higher State Anxiety was confirmed. However, unlike previous studies 
reporting moderate correlations (Sandin et al., 2001), Trait Anxiety and Anxiety 
Sensitivity were found to be strongly correlated. Research suggests that Trait Anxiety and 
Anxiety Sensitivity are different, yet related constructs (Taylor, 1999), and as no further 
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analyses in the current study beyond bivariate correlations were able to be undertaken to 
further examine their relationship (e.g. factor analysis as in Sandin et al., 2001) this 
significant relationship should be interpreted with caution. Subsequently, for the purpose 
of the current study Trait Anxiety and Anxiety Sensitivity were combined to make a 
composite variable – Dispositional Anxiety, in an attempt to resolve the impact of their 
strong relationship. This variable was consequently able to represent individual levels of 
Dispositional Anxiety, a more stable, non-transitory measure of anxiety than State 
Anxiety.  
 
The current study’s findings are consistent with that predicted by Trait-State Theory 
(Spielberger, 1983), specifically, higher Dispositional Anxiety predicted higher levels of 
State Anxiety. This suggests, that individuals presenting for HBOT with higher levels of 
Dispositional Anxiety (Trait Anxiety + Anxiety Sensitivity) would find the procedure a 
more distressing experience. While Dispositional Anxiety was found to predict State 
Anxiety before and during HBOT, it is important to note that the current sample’s mean 
for Trait Anxiety was low when compared to a normative GMS sample (Spielberger, 
1983), and an HBOT sample recruited in Clark et al. (1994). While this suggests that 
participants in the current sample may have been presenting to the HMU in a position 
more able to cope than previous samples, further research is needed to distinguish 
whether this finding is representative of the wider HBOT population, or a unique 
characteristic of this study. Nevertheless, there are two possibilities contributing to these 
low Trait Anxiety scores. Firstly, while consistent with previous HBOT samples (Ellis & 
Mandal, 1983), initial investigations revealed that the current sample was not balanced by 
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gender (70% males). Research has found lower anxiety levels in men in medical settings 
(e.g. de Jong et al., 1994; Luck et al., 1999; Lukins et al., 1997). Secondly, although the 
current study’s age range (19-81 years) was similar to other studies using medical 
samples (e.g. Clark et al., 1994, 27-81 years; Katz, Wilson, & Frazer, 1994, 18-81 years), 
its mean age (63 years) was higher than other medical studies (Harris et al., 2004; Katz et 
al., 1994). Research suggests a general trend for younger people to be higher in Trait 
Anxiety (Spielberger, 1983). In summary, the reported low number of males and high 
mean age in the current study may be a contributing factor to these lower State and Trait 
Anxiety scores exhibited (see Table 9). 
  
CLQ-T’s lack of relationship with State Anxiety before and during HBOT was an 
unexpected finding. While research in the context of MRI procedures has previously been 
able to predict outcomes related to fear or panic using psychometric indicators of 
claustrophobia (McGlynn et al., 2003; McIsaac et al., 1998), no relationship emerged 
between CLQ-T and State Anxiety at times one and two. Despite finding a positive 
relationship between CLQ-T scores and State Anxiety at time three, further examination 
revealed that rather than this being a direct relationship, it may instead be a function of 
women scoring significantly higher than men in CLQ-T, and gender (being a woman) 
being predictive of State Anxiety at time three. Thus, its utility as a predictor for HBOT 
patients is not supported by the findings of this study. 
 
An explanation for the lack of relationship between CLQ-T and State Anxiety may be 
that the current sample’s CLQ-T scores were below both normative (Radomsky et al., 
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2001) and research (McIsaac et al., 1998) levels and therefore less likely to influence 
State Anxiety. It is unknown whether the low claustrophobic fears were a characteristic 
of the current study, or are representative of HBOT patients in general. However, what is 
clear is that claustrophobia did not emerge as a strong predictor for this sample as 
expected. Of additional interest, the finding that women revealed higher levels of 
claustrophobic fears than men corresponds to the reported ratio in the DMS-IV of more 
females with Claustrophobia than males (APA, 2000).    
 
To my knowledge, no prior research has examined the relationship between Expectancy 
of symptom improvement and belief in Credibility of treatment with State Anxiety. 
Consistent with findings in both previous non-HBOT research (Devilly & Spence, 1999; 
Borkovec & Costello, 1993; Chambless & Tran, 1997; Collins & Hyer, 1986) and HBOT 
research (Stiegler et al., 2006) the present study demonstrated Expectancy of symptom 
improvement linked with an outcome measure – in this study State Anxiety. Lower 
Expectancy of symptom improvement indicated higher State Anxiety levels both before 
and after ten sessions of HBOT. Belief in the Credibility of HBOT however, showed no 
relationship with State Anxiety. While Credibility and Expectancy were moderately 
related – not dissimilar to previous research (Devilly & Borkovec, 2000) – Expectancy of 
symptom improvement for the present sample emerged as explaining more variance in 
State Anxiety than Credibility.  
 
Credibility and Expectancy scores for the current sample tended to be higher than a 
comparative norm sample (Devilly & Borkovec, 2000). These high levels may have been 
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because information gained from HMU physicians directly influenced Credibility and 
Expectancy of HBOT, or it may be easier to accept rationale for HBOT than the 
psychological therapies used in Devilly and Borkovec (2000). However, to conclude why 
participants in this sample scored high in Expectancy and Credibility cannot be 
determined from the current findings. Of interest to consider is the negative relationship 
between Expectancy and State Anxiety – the higher comparable Expectancy rates found 
in the current study may provide some explanation of the lower State anxiety levels also 
reported in this study (Spielberger, 1983. See Table 9). 
 
Confounding Variables 
 
In addition to the above findings, some confounding variables emerged as influential to 
results and subsequently will be discussed.   
 
Gender emerged as an influential covariate. When data were partitioned by gender, 
women exhibited larger values for all correlations (bar one) that were significant for both 
men and women. Additionally, correlations that emerged as significant for women and 
not for men tended to be very large. For instance, men showed no significant correlation 
between Anxiety Sensitivity and State Anxiety at time two, yet women demonstrated a 
strong relationship (r = .88). This suggests that, on the whole, women were displaying 
stronger relationships, from very small differences to extremely large differences, despite 
the much smaller number of women than men in the sample.  
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Research has been inconsistent in finding a relationship between State Anxiety and age in 
medical settings. While the current study found that older participants, when split by the 
sample median, reported significantly higher Trait Anxiety than younger participants, no 
relationship emerged between age and State Anxiety across the course of HBOT. The 
non-significance of age is consistent with Luck et al. (1999) in regard to precolonoscopy 
anxiety. Also of interest was the positive correlation of age and Credibility. It emerged 
that as age increased, so did the belief in the Credibility of HBOT as a successful and 
quality medical procedure. This may have been an attribute of the current study, or it may 
be suggesting that Credibility of HBOT is more easily given in older patients. 
Nevertheless, further research would be needed to understand the mechanisms underlying 
this relationship.  
 
The hypothesis that past exposure to HBOT would be a significant covariate to State 
Anxiety was not confirmed. This finding was consistent with previous research (Harris et 
al., 2001) that reported no differences on any measures between those who had 
undertaken an MRI scan, and those had not.  
 
4.2. PREDICTORS OF STATE ANXIETY 
 
It was encouraging to find that both before HBOT and after ten sessions, Dispositional 
Anxiety and Expectancy of symptom improvement were significant predictors of State 
Anxiety. The predictive power of these variables at time two suggests that these 
individual factors remain important in continuing to predict participant levels of State 
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Anxiety after approximately two weeks of treatment. However, this pattern did not 
continue – thereby suggesting that these variables no longer were of significance on the 
last HBOT session.  
 
Although further research regarding the sustained medical benefits of HBOT are needed 
(Wang, Schwaitzberg, Berliner, Zarin, & Lau, 2003), these ongoing medical benefits are 
presently understood to continue after final treatment. Therefore, it is possible that as 
patients have seen the results of treatment thus far, their Expectancy of improvement may 
have been adjusted by the last HBOT session. However, as Expectancy of symptom 
improvement was not measured at this time, further research would need to assess this 
postulate. Dispositional Anxiety, however, could be argued to still extract some variance 
in explaining State Anxiety at the last session owing to its theoretical link. Due to a small 
sample size, the power of the current study was compromised, and therefore may have 
influenced the lack of relationship between Dispositional Anxiety and State Anxiety at 
time three. What did emerge, however, was that gender (being a woman) predicted State 
Anxiety experienced on the last HBOT session. Women participants, rather than men, 
demonstrated the increased likelihood of experiencing more State Anxiety at time three. 
 
4.3. EXPOSURE TO HYPERBARIC OXYGEN THERAPY 
 
The hypothesis that there would be significant change between State Anxiety at 
participants’ first, tenth, and last HBOT session was not supported. It was surprising to 
note that overall, State Anxiety at earlier times was not predictive of State Anxiety at 
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later times. This suggests that State Anxiety may have been independent across time, and 
therefore was influenced by other factors. However, the decrease from pre-HBOT and the 
tenth HBOT session was approaching significance and an overall significant effect for 
gender emerged. That is, when gender was examined separately, men were approaching 
significance in an overall decrease of State Anxiety change, but women were not. 
Because previous findings have shown a decrease in State Anxiety from pre- to post-
HBOT (Clark et al., 1994), this may suggest that if sample size was larger, and thus 
power increased, a significant difference may have been detected.  
 
The significant effect for gender was apparent through an interesting trend where women, 
but not men, increased in State Anxiety from the tenth HBOT session to the last. Of the 
five women who had data available at both times two and three, four exhibited increased 
State Anxiety levels over this period, despite all having decreased in State Anxiety from 
time one to time two (see Appendix 19). Of these four participants, three wore hoods for 
their oxygen intake during the HBOT sessions. This characteristic explains the finding of 
the significant relationship between gender and headgear and the significantly higher 
scores in State Anxiety at time three for those who wore a hood than those who wore a 
face mask. Because type of headgear worn is a personal preference, and participants were 
able to choose which headgear they would find less anxiety-provoking, it is unlikely that 
the hood is a confounding variable. Additionally, three of these four women who 
exhibited an increase in State Anxiety from times two to three had already undergone 
HBOT before, and all required HBOT because of problem wounds or radiation tissue 
damage.  Therefore, the rationale for the trend of increased State Anxiety for women at 
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their last session is not clear. Many patients continue with further medical care at the 
completion of HBOT sessions (e.g. surgery), and anecdotal evidence suggests this 
increase may reflect worry regarding future health concerns. However, although there 
may be a number of reasons for this trend it may be a chance finding for this particular 
sample, hence generalising is unwise. To theorise about why women both increased in 
State Anxiety, and felt more anxious than men on the last day, would require further 
research – with an emphasis on gathering additional data on the last HBOT session. 
Information regarding fear surrounding one’s health concerns and future prognosis may 
be of interest to assess at this point.  
 
4.4. INTERVENTION COMPONENT 
 
The third and final purpose of this study was to evaluate the effectiveness of Öst’s (1989; 
1997) OSET. Unfortunately, this component of the current study was not able to be 
investigated. Only two participants presented with claustrophobia scores above the cut-
off mark. The first participant, who may have benefited, was not offered intervention due 
to practical issues. The second participant was offered intervention but after viewing the 
chamber, declined. Both participated in the descriptive study. Despite not partaking in the 
intervention, yet scoring very high in claustrophobic tendencies, both went on to tolerate 
HBOT. This may suggest that even patients who express high claustrophobic distress are 
able to cope with HBOT and that psychological intervention may only be necessary in 
extreme cases. From a clinical point of view, the support presently provided by the HMU 
staff at Christchurch Hospital may be satisfactory for most patients.  
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LIMITATIONS 
 
 
A number of limitations are present in the current study. Most notable is the small sample 
size and the resulting impact on the study’s power to detect significant differences. 
Participant numbers were clinically determined; therefore, with the exception of 
extending the study indefinitely, this limitation was unavoidable. Nevertheless, even with 
a small sample size, a number of significant effects were still found.  
 
As the study utilised self-report data, social desirability bias, memory bias, and lack of 
comprehension may have influenced outcome measures and variables in some way. 
While it would be beneficial to the strength of the findings to compare physiological 
methods with self-report measures to further assess State Anxiety, it was not feasible for 
the particular study. Furthermore, generalisability from the current sample was limited 
and should be viewed with caution. The current sample was over-represented in males 
and represented an older population than comparable medical samples. Data from the NZ 
2006 census (Statistics New Zealand, 2007) suggest that the current sample was over-
represented in NZ European and under-represented in other ethnic groups identified in 
NZ. Additionally, the normative data used for comparison to Trait and State Anxiety was 
collected approximately 20 years ago (Spielberger, 1983) and may no longer be 
appropriate. However, strength of this study was its inclusion of both inpatients and 
outpatients, unlike Clark et al.’s (1994) previous HBOT study.  
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While all the current study’s questionnaires revealed good reliabilities for the present 
sample, there were possible limitations for two specific measures when used on medical 
samples. Firstly, the ASI included questions regarding physical sensations. In those who 
are already unwell, question prompts about fear of physical symptoms (e.g. “It scares me 
when I feel ‘shaky’ (trembling)”) may cue specific fear regarding their illness, rather than 
the more general construct of Anxiety Sensitivity. To attempt to control for this in further 
research, investigating information regarding individual perceptions of illness may be 
necessary. Secondly, because the current sample was a medical sample, there is potential 
that State Anxiety measured may be representing non-HBOT related anxiety, for 
example, anxiety surrounding specific fears regarding illness prognosis, HBOT’s 
potential impact on pain levels associated with illness, or other health-related issues.  
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IMPLICATIONS 
 
 
The current study was focused on increasing understanding behind psychological distress 
regarding HBOT, and as a consequence, be able to minimise distress for future HBOT 
patients. The study was able to provide some understanding by identifying important 
predictors of State Anxiety before and during HBOT. However, due to the 
aforementioned limitations extreme caution is needed when making inferences from the 
findings. Nevertheless, some comments can be made.  
 
Low levels of Trait and State Anxiety may suggest that current practices at Christchurch 
Hospital’s HMU are appropriate for the majority of their patients. However, because of 
biases in the representation of the sample, it is difficult to comment without valid 
normative data. The findings may however, tentatively allow for making physicians 
aware that Expectancy of symptom improvement and Dispositional Anxiety continue to 
predict State Anxiety after approximately two weeks of treatment.  
 
To advise on screening measures before undergoing HBOT from the predictors that 
emerged in this study is tempting. Expectancy has the potential to be assessed via four 
oral questions, but Dispositional Anxiety is more burdensome due to being assessed in 
this study via two measures. However, without further replication of the current study’s 
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results, and research that addresses the limitations of this study, it is unwise to suggest 
these clinical changes.  
 
An interesting finding for the current study was the gender differences. At the least, the 
findings suggest that more research is needed to gain a further understanding of the 
relationships between gender and HBOT. At the most, the findings suggest women may 
need an extra element of support on their last HBOT session that men perhaps do not. 
From a clinical standpoint, it may be of benefit to refer patients, particularly women, 
back to visit their primary healthcare provider as a function for support. Again, however, 
the limitations of the current study limit the basis for this inference, and replication is 
needed to investigate whether this is a unique feature of the present sample.  
 
In summary, this research has attempted to use a NZ sample to provide information to 
benefit staff at the HMU. Tentatively, individual predictors of State Anxiety before and 
during HBOT were identified, however lack of methodological strength limits the scope 
for which to utilise them.  
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FUTURE RESEARCH 
 
 
Ideally, for research to influence clinical practice, a number of improvements from the 
current study would need to be made. Research utilising multiple hyperbaric centres 
would enhance participation levels, generalisation, and current NZ normative data for 
HBOT patients. Additionally, the current study used only self-report measures and 
clinician information and these methods of data collection are not ideal. Future research 
could benefit from assessing physiological (e.g. blood pressure and heart rate) and 
behavioural (e.g. BATs) measures of anxiety in conjunction with self-report, including 
participants rate subjective units of distress immediately before, during and after 
specified HBOT sessions. Furthermore, the development of an HBOT measure with 
items particular to issues specified in previous HBOT research may be a valuable tool for 
physicians assessing patients at risk of experiencing distress. 
 
Research (Anderson & Masur, 1983) has recognised the importance of assessing patients 
overall medical status. Further HBOT research assessing comprehensive information of 
medical status and clinical outcome data, and its impact on State Anxiety during HBOT, 
would be very informative. For example, factors such as pain status, concerns regarding 
further medical attention, and perceptions of prognosis could be assessed. Additionally, 
HBOT is a relatively uncommon medical procedure and can be a complete unknown to 
many patients. Despite this, the changing nature of technology in the medical field means 
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patients are becoming more tolerant of technological and remarkable machines necessary 
for treatments. Despite this, it is important to recognise that well-known procedures such 
as MRIs are still warranting research. Lastly, to further understand the mechanisms 
behind the relationship of Expectancy of symptom improvement and State Anxiety would 
be beneficial in the hopes of understanding how this can make patient experiences during 
HBOT less distressing. 
 
In summary, since there are few studies on psychological distress and HBOT, this study 
warrants replication with a larger sample size, including more women and a more 
ethnically diverse sample. Despite the limitations, this study has been able to raise 
awareness surrounding anxiety experienced by patients undergoing HBOT, and builds on 
current knowledge of HBOT patient experiences. Research to further understand the 
mechanisms behind HBOT distress would be valuable for staff and patients alike.  
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APPENDIX 2 
 
CLINICIAN QUESTIONNAIRE 
 
 
Attach patient label: 
 
 
 
 
1. Has this patient had hyperbaric treatment before? (Please circle) 
 
YES    NO 
 
2. What is the main condition that this patient is receiving hyperbaric 
treatment for? 
 
 
………………………………………………………………………. 
 
3. What category best describes this condition? (Please tick) 
 
 Bubble Injury 
 Acute Ischaemic Conditions 
 Infective Conditions 
 Radiation Tissue Damage 
 Problem Wounds 
 Gas Poisoning 
 Ocular Ischemic Pathology 
 Other (specify) 
 Miscellaneous (specify main) 
 
4. What type of head gear will this patient use during their therapy? 
 
MASK   HOOD 
 
 
Date…………………… 
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APPENDIX 3 
 
INFORMATION SHEET 
 
Coping and Hyperbaric treatment 
 
Date…………………………………………. 
 
You are invited to participate in a study on how people manage hyperbaric 
treatment. You have been approached because you are scheduled to have hyperbaric 
treatment in Christchurch Hospital’s Hyperbaric Medicine Unit during 2007 through to 
early 2008. The purpose of this study is to look at what factors may help staff understand 
how people cope with the treatment and how reactions to the treatment may change over 
the treatment period. For a small group of people who become very worried about having 
the treatment, the study will also look at the usefulness of a brief treatment to manage 
these worries.  
 
You will be offered to take part in this study at the time of initial assessment with 
the Hyperbaric Medicine Unit. You will then have time before your first treatment to 
decide whether or not you would like to participate. Please feel free to discuss this 
decision with whanau or friends. Participating in this study is entirely voluntary (your 
choice) and you will receive the standard hyperbaric treatment available. Any 
information obtained in this study that can be identified with you will remain confidential 
and will be disclosed only with your permission. By completing the questionnaires, you 
are consenting to publication of your data as part of the results of the research but no 
information identifying any patient will be published. All data is stored at the University 
of Canterbury and will be destroyed after five years. You may withdraw from the study at 
any time, without giving reason, and this will in no way affect your continuing health 
care.  
 
Participation means that you will be asked to complete questionnaires about 
coping in addition to giving some information about yourself. Extra information about 
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your health condition leading to hyperbaric treatment, and your past use of this treatment, 
will be provided by the Hyperbaric Medicine Unit staff. If you end up being offered extra 
help to cope with hyperbaric treatment, you will be asked to attend two extra sessions at 
the HMU. A voucher to help out with travel will be given to cover the extra time 
involved.  
 
Please indicate on your consent form whether you would like to receive a copy of the 
results, however, please note that there may be a significant delay between data collection 
and publication of results. This study has received ethical approval from the 
____________ Ethics Committee.  
 
If you have any questions regarding this research please do not hesitate to contact 
me. You have the option of whanau/support person/s to accompany you to ask questions 
and/or to understand and complete the study. My email contact is 
reh35@student.canterbury.ac.nz and mobile number is 027-3555-653. Alternatively, any 
queries or concerns can be directed to my supervisor, Associate Professor Neville 
Blampied (Tel. 3642199). 
 
Thank you for your time and participation in this research 
 
Rachel Hodge 
Masters Thesis student 
University of Canterbury 
 
Associate Professor Neville Blampied 
Principal Supervisor 
University of Canterbury 
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APPENDIX 4 
 
Number of other People in Hyperbaric Chamber and Total Number of Sessions 
ID #:      Date : 
 
HBOT 
Session 
# OTHER people in 
HC 
HBOT 
Session 
# OTHER people in 
HC 
1   21   
2   22   
3   23   
4   24   
5   25   
6   26   
7   27   
8   28   
9   29   
10   30   
11   31   
12   32   
13   33   
14   34   
15   35   
16   36   
17   37   
18   38   
19   39   
20   40   
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APPENDIX 5 
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APPENDIX 6 
 
Claustrophobia Questionnaire 
 
 
Radomsky, A. S., Rachman, S., Thordarson, D. S., McIsaac, H. K., & Teachman, B. A. 
(2001). The Claustrophobia Questionnaire. Anxiety Disorders, 15, 287-297. 
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APPENDIX 7 
 
Anxiety Sensitivity Index (Reiss et al., 1986) 
 
Instructions: The statements below describe the thoughts and feelings of some people 
when they feel anxious. Indicate how each item below applies to you by circling the 
appropriate number.  
 
Very Little Little Some Much Very Much 
0 1 2 3 4 
 
1. It is important for me not to appear nervous…    0   1    2    3    4    
2. When I cannot keep my mind on a task, I worry  
       that I might be going crazy…      0   1    2    3    4 
3. It scares me when I feel ‘shaky’ (trembling)…     0   1    2    3    4 
4. It scares me when I feel faint…      0   1    2    3    4 
5. It is important to me to stay in control of my emotions…  0   1    2    3    4 
6. It scares me when my heart beats rapidly…    0   1    2    3    4 
7. It embarrasses me when my stomach growls…    0   1    2    3    4 
8. It scares me when I am nauseous…     0   1    2    3    4 
9. When I notice that my heart is beating rapidly, I worry  
      that I might have a heart attack…      0   1    2    3    4 
10. It scares me when I become short of breath…    0   1    2    3    4 
11. When my stomach is upset, I worry I might be seriously ill…  0   1    2    3    4 
12. It scares me when I am unable to keep my mind on task…  0   1    2    3    4 
13. Other people notice when I feel shaky…     0   1    2    3    4 
14. Unusual body sensations scare me…     0   1    2    3    4 
15. When I am nervous, I worry that I might be mentally ill…  0   1    2    3    4 
16. It scares me when I am nervous…     0   1    2    3    4 
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APPENDIX 8 
 
Treatment Credibility/Expectancy Questionnaire 
 
We would like you to indicate below how much you believe, right now, that the therapy 
you are receiving will help to reduce your anxiety. Belief usually has two aspects to it: 
(1) what one thinks will happen and (2) what one feels will happen. Sometimes these are 
similar; sometimes they are different. Please answer the questions below. In the first set, 
answer in terms of what you think. In the second set answer in terms of what you really 
and truly feel.  
 
Set I 
 
1. At this point, how logical does the therapy offered to you seem? 
1 2 3 4 5 6 7 8 9  
not at all logical  somewhat logical  very logical 
 
2. At this point, how successfully do you think this treatment will be in helping your 
symptoms? 
1 2 3 4 5 6 7 8 9  
not at all useful  somewhat useful  very useful 
 
3. How confident would you be in recommending this treatment to a friend who 
experiences similar problems? 
1 2 3 4 5 6 7 8 9  
not at all confident  somewhat confident  very confident 
 
4. By the end of the therapy period, how much improvement in your symptoms do 
you think will occur? 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
Set II 
For this set, close your eyes for a few moments, and try to identify what you really feel 
about the therapy and its likely success. Then answer the following questions.  
 
1. At this point, how much do you really feel that therapy will help you to reduce 
your symptoms? 
1 2 3 4 5 6 7 8 9  
not at all   somewhat   very much 
 
2. By the end of the therapy period, how much improvement in your symptoms do 
you really feel will occur? 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
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APPENDIX 9 
 
CONSENT FORM 
Coping and Hyperbaric treatment 
 
Researchers: Rachel Hodge    03 364 2987 ext 3400/027 3555 653 
Associate Professor Neville Blampied 033642199/021 022 8287 
Dr Lois Surgenor   03 372 0400 
Dr Mike Davis    03 364 0045 
     
Project explained by Rachel Hodge   Project role: Master of Science 
 
Date………………. Signature……………………………………………………….. 
 
• I understand that I need to be competent in spoken and written English to participate 
in this project.  
• I have read and I understand the information sheet dated _________ for volunteers 
taking part in the study designed to investigate coping with hyperbaric treatment. I 
have had the opportunity to discuss this study. I am satisfied with the answers I have 
been given. 
• I have had the opportunity to use whanau support or a friend to help me ask questions 
and understand the study.  
• I understand that taking part in this study is voluntary (my choice) and that I may 
withdraw from the study at any time without having to give a reason and this will in 
no way affect my continuing health care.  
• I understand that my participation in this study is confidential and that no material 
which could identify me will be used in any reports on this study. 
• I have had time to consider whether to take part. 
• I know whom to contact if I have any side effects or have any questions about the 
study. 
• I wish to receive a summary of the results  YES NO 
 
 
I ___________________ (full name) hereby consent to take part in this study.   
 
Date……………………. 
 
• I consent to the researcher, Rachel Hodge, her supervisors Associate Professor 
Neville Blampied and Dr Lois Surgenor, to have access to my medical records for 
information that is related to the purpose of this study. 
 
Date…………………….  Signature………………………………………... 
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APPENDIX 10 
 
Behavioural Analysis Interview (BAI) 
SCRIPT 
 
Black – background information Bold – my verbal script 
 
The BAI is a screening interview and its purpose is to establish whether or not the patient 
fulfilled the criteria necessary, and to do the BATs. It is a semi-structured interview based 
on Öst’s (1989, 1997) instructions and using questions based from the Interview Guide 
for Evaluating DSM-IV disorders (First, Gibbon, Spitzer, & Williams, 2002). 
 
Establish rapport with patient – engage in small talk.  
 
Overview: 
The purpose of today’s session is to have a chat about yourself and how you’re 
feeling. It is also to give you some information about the extra help we are offering. 
First, I will ask you some questions about yourself, and about your worries and 
thoughts concerning the hyperbaric treatment you are going to receive at the 
hospital. We’ll then chat a bit about the help we are offering. If at any stage in both 
our sessions together you decide you don’t want to carry on, this is absolutely fine 
and this will not affect your medical care in any way, ok? Do you have any 
questions? 
 
I will be writing down a few notes as we go along today, just as a reminder for me. 
So please bear with me as I write.  
 
My Prompt 
· Investigate their catastrophic beliefs – note down their CBs and investigate these as 
much as possible. 
· “What do you think will happen if you encounter your feared situation?” i.e. 
feelings/sensations, images, physical behaviours. Think about their reactions; self-
report, behavioural, and physiological.  
· Get participant to tell you their CBs and to make predictions about what might 
happen in their feared situations. Note these down.  
· Summarise what they tell me so make it clear what their CBs are.  
 
If they are having problems identifying their anxious thoughts, ask them to imagine being 
in an enclosed space with no escape and to then tell you what they would think might 
happen and how they think they may feel.  
 
 
 
First I want to ask you some questions about yourself; just to get an understanding of 
your worries and where you’re at.  
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1. I noticed from your questionnaires that you have a few worries about some 
situations; can you tell me about these?  
a. Are you afraid of closed places and confined situations? (Ask this question 
if they have not already mentioned this)  
2. I’d like to get more specific about your worries you have mentioned, for instance,  
a. Which situations do you feel worried about? E.g. closets, elevators, toilets.  
b. Did you always feel frightened when you were confronted with 
[closed/confined or aforementioned situations]? 
c. Do you remember when first started feeling this way? 
3. What were you afraid would happen or what are you afraid will happen, when 
you are confronted with [closed/confined or aforementioned situations]? 
a. How strong are these feelings when you encounter these situations? 
b. If you can’t get away from these situations, what do you think would 
happen? 
c. What is the worst thing that might happen to you in these situations? 
d. How certain are you that the worst thing will happen to you, give me your 
certainties in differing situations.  
e. Have you ever been in a confined place where you felt frightened?  
4. These worries you have (e.g. faint), have they ever happened before?  
a. Do you know what it is like for this to happen to you? 
5. Did you or do you think that you were more afraid of [closed/confined or 
aforementioned situations] than you should have been or should be? 
6.  Did you or do you go out of your way to avoid [closed/confined or aforementioned 
situations]?  
a. How often will you avoid the situation? i.e. every time, sometimes, etc. 
7. Are there things you didn’t do or you don’t do because of this fear, which you 
would have otherwise done or do? If so, what are these?  
8. How are these (and have these) worries/fears interrupting and/or interfering with 
your daily life? 
a. Have you noticed any good things that come out of you having these 
worries [positive consequences]? 
b. Can you think of anything in particular that might be negative if you 
didn’t worry about [confined places/feared situation]?  
 
Assessing Suitability for Treatment (Öst, 1989) 
 
Inclusion and Exclusion Criteria: 
a. The patient must have scored above the cut-off score 43 on the Claustrophobic 
Questionnaire  
 
[Refer to participant’s questionnaire booklet and re-check what their CLQ score 
was].  
As I’ve said, we’ve asked you to come along today because from your 
questionnaires, I can see that there are some situations that you are worried about. 
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From this, we believe that you might benefit from receiving some help from us 
before you have your hyperbaric treatment.  
 
b. The phobia should be monosymptomatic and only concern one specific situation 
or object  
 
This should have been established via the above questions, specifically under 2a (which 
situations?). Thus, the participant should be specifically worried either about the 
hyperbaric chamber, or closed and confined spaces [situation].  
 
c. The patient must be motivated enough to get rid of his/her phobia and be prepared 
to tolerate a possibly high level of anxiety over a rather long time  
 
Something that is important in making sure you benefit from our extra sessions is 
for you to be ready and willing to help yourself.  
· How prepared are you to try to change how you think about 
hyperbaric treatment and the chamber? 
 
Also, there is a possibility that you may feel quite nervous at times throughout our 
session, which may take a wee while.  
· Are you ok with this possibility? 
 
d. There must be no predictable negative consequences if phobia treatment is 
successful 
 
This question should have been answered during the earlier questioning – in number 8.  
 
Rationale (Öst, 1997)  
The extra help that we want to offer you is like an introduction exercise and I just 
want to give you a quick explanation as to what it’s about. Our purpose is for you to 
be able to undergo hyperbaric treatment and to feel ok about doing that. Together 
we’ll go through a few practical steps that will help you become more comfortable 
with the chamber. The reasons that we are going to use this particular exercise is; 
(1) it is a quick, effective approach that we can do together here at HMU using the 
actual chamber, (2) it’s been shown to be a really good way for helping people who 
are worried about enclosed places and, (3) is a way to introduce the hyperbaric 
chamber to you in a controlled and non-threatening way.  
 
Another part of this exercise that is important in helping you to overcome your 
worries is that it helps you learn new information about what will happen when you 
enter the chamber. Some usual concerns of people who have a fear of enclosed 
places can be worries about being trapped or having a lack of fresh air. This 
exercise will help you to learn new information about these worries and may change 
possible misconceptions you may have about enclosed situations. As I understand, 
you have avoided these types of situations in the past, and by avoiding these 
situations you essentially are not seeing whether or not these worries that you have, 
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are coming true or not. So, to just summarise that, this exercise works in 2 ways: 
first, we are going to gradually introduce to the chamber so you feel more 
comfortable, and second, while doing this, we are going to test out your worries in 
order to get new information to about them.  
 
A really important point I want you to know is that this exercise is very different 
from being out in the real world because it’s planned, gradual, and controlled. 
When you come across these situations in everyday life, they are generally quite 
uncontrolled. For example, think about getting into a hot bath. Compare getting 
thrown in the water all in one go as compared to getting in bit by bit, toe by toe. 
When you have no control over it you may panic, you may be shocked by the hot 
water and have intense pain (like your worries about being in the chamber). But by 
gradually getting in the hot water you can let your body adjust bit by bit to the hot 
water. Same goes for this; we will take you step by step getting “adjusted” to the 
hyperbaric chamber. We gradually will test out your worries together, and you will 
decide how far we go at each step ok?  
 
Lastly, I do want to let you know that this exercise may not make you completely 
“worry-free” in terms of enclosed spaces, but it is a start for you to build upon. It 
should help give you some skills to be able to try to deal with situations you worry 
about in everyday life after you leave here.  
 
 
 
Pre-Treatment Instructions (Öst, 1997) 
 
We’re now coming to the end of our session today, but before we finish I’m going to 
go over some instructions that will be helpful for when we do the exercise. It is 
important for both of us and your success that we try and follow these. 
 
1. Firstly, teamwork is important in carrying out this exercise and we’re going to 
do this together. Both you and I have equal responsibility for achieving a good 
result. Is this ok? 
 
2. Next, I want to emphasise again that I will never do anything unplanned during 
the exercise; this is not a “shock” therapy. Instead, I will describe to you what 
will happen, and then demonstrate it myself, and finally will get your permission 
to do it. Only with your permission will you be asked to try out anything I’ve 
demonstrated. Ok? 
 
3. Because I understand that you may be worried about being nervous, I want you 
to think about the most frightening and worried situation that you have ever 
experienced in relation to enclosed places. Call this your “personal record of 
anxiety” and give it a maximum score of 10 on a 0-10 anxiety scale. I want you to 
know that because this introduction exercise is gradual, you will not break your 
“personal record of anxiety”. Ok?  
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4. Finally, I want you to know that a high level of anxiety is not a goal in itself, but 
can be considered a consequence. However, you will probably experience less 
anxiety than you expect. What is important however is that you give me a 
commitment that we will stay in the situation until you feel comfortable? Is this 
ok? 
 
Do you have any questions?  
 
Behavioural Avoidance Tests (BATs) 
 
Ok, the last thing we’re going to do before we finish is to see how you feel when I ask 
you to approach and enter the chamber, and how you feel when asked to try on the 
head gear. I will let you know what I’d like you to try to do as we go along, but I do 
want you to know that you don’t have to do any more of this than you want to. If 
you don’t even want to go in the chamber yet, that is ok, and if you want to stop at 
any time, that is ok too.  
 
1.  “Approach Test”.  
 
The first of our assessments is going to be approaching and standing in the doorway 
of the chamber. You may find you have no trouble doing this, or you may find it 
quite stressful. Either is ok. I will be asking your anxiety score, which is your 0 to 10 
on your anxiety scale, at various times ok? Are you ready to start? 
 
a. Participant is to stand 3 metres from the door and rate their anxiety using the 
SUDs ratings.  
b. Participant is to stand 1.5 metres from the door and rate their anxiety using the 
SUDs ratings.  
c. Participant is to stand at the outer doorway and rate their anxiety using the 
SUDs ratings.  
d. Participant is to stand at the inner doorway and rate their anxiety using the 
SUDs ratings.  
 
There will be two scores: 
 The time they spend in the foyer will be their first score (i.e. max. is 3mins) 
 They will also be asked to rate their SUDs at every 30 seconds; from 0 seconds to 
180 seconds.  
 
2. “Mask/Hood Test” 
 
Lastly, I am now going to ask you to wear the mask and then the hood for as long as 
you feel comfortable, up to 5 minutes. Again, I will also be asking you to rate your 
anxiety score at different periods through these 5 minutes. Ok?  
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a. The patient will be asked to wear the mask for up to 5 minutes. The 
participant’s first score will be their time. They will also be asked to rate their 
SUDs at every 30 seconds.  
b. The patient will be asked to wear the hood for up to 5 minutes. The 
participant’s first score will be their time. They will also be asked to rate their 
SUDs at every 30 seconds.  
 
That’s really great; we will be doing those again after the exercise session. Are you 
feeling ok and do you have any questions? 
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APPENDIX 11 
 
OUTLINE OF ONE-SESSION EXPOSURE THERAPY Adapted Version 
(Öst, 1989, 1997) 
 
Focus of treatment – to reduce the patient’s anxiety regarding hyperbaric treatment. 
 
SUMMARY 
The first step in the procedure is the Behavioural Analysis Interview (see Appendix 10). 
This interview is to establish whether or not the patient fulfils the criteria necessary to be 
included in the study, as well to conduct the behavioural avoidance tests. 
 
Outline of therapy: 
 Pre-session behavioural analysis to determine suitability for treatment. 
 Exposure situation involves a set of behavioural tests regarding phobic stimulus. 
 Patient makes a commitment to remain in the exposed situations until their anxiety 
subsides. 
 Patient is encouraged to approach stimulus as much as possible and remain until their 
anxiety goes away. 
 The therapy session is not ended until the anxiety level has been reduced by at least 
50%, or has completely gone. 
 Therapist will demonstrate first then gradually involve patient. 
 
Goals of therapy: 
1. For patient to manage in natural situations after treatment. 
2. The therapist wants the patient to achieve (this goal is not communicated to the 
patient because of the potential to not turn up for treatment and to prevent 
rumination). 
 
Rationale of therapy: 
Therapist will outline clearly:  
 Exposure is controlled, planned and gradual and what they fear will happen does not 
occur; and  
 The session is a start and the patient is expected to continue their own treatment by 
exposing themselves in everyday situations. 
 
Instructions of therapy: 
Emphasis is on:  
 Teamwork and hard work between patient and therapist;  
 No unplanned situations;  
 Patient permission is always sought; and  
 Anxiety will not exceed anything previously experienced. 
 
 
  
 
159 
 
Intervention Steps  
 Go through very quickly how the door locks. 
 
Thanks for coming along today, how are you doing? [Small talk]  Before we start 
today/now I want to quickly go over a few things we talked about in our previous 
session we had together recently. Our purpose is to introduce you to hyperbaric 
treatment in a controlled way, so we can try and learn some new information about 
what might happen when you have your hyperbaric treatment. Our final goal is for 
you to be able to undergo hyperbaric treatment and to feel ok about doing that, does 
that make sense?  
 
 
Rationale & Instructions Reiteration: 
 So, can you tell me what you understand today’s session is about?  
Quick, effective way to help   
We can use actual chamber  
 It’s getting you used to the chamber slowly and gradually 
Helps teach you new information 
 Also, can you remember the instructions that are helpful for us that we talked 
about in our previously? For instance, the emphasis on teamwork, no unplanned 
situations, and permission.  
Teamwork and equal responsibility 
 Nothing unplanned, permission always sought  
Reiterate anxiety ratings  
Expect some anxiety – probably less than you anticipate 
 
 
Last minute instructions: 
And lastly, before we start, today we are going to check out your worries we talked 
about at our last session/just before by trying out some situations that might make 
you nervous, and attempting to stay there until you feel more comfortable. You and 
I need to be completely honest with each other, and it would be really helpful for 
you to think “let’s give it a go and see what happens in these situations”. As I have 
said, you will not be asked to do anything without your permission, and each 
practical step will be gradual. Remember how we talked about your anxiety score 
being out of 10; with 10 being the most scared you’ve ever been in enclosed spaces? 
Well, I will be asking you for your current anxiety scores regularly throughout the 
session and for my memory’s sake I need to note these down, so please bear with me 
while I do that. Last but not least, I want you to chat to me about how you’re 
feeling, and what you are thinking as we go through our session. So, do you have 
any questions before we start and are you ready to begin? 
 
If yes – ask for their first anxiety rating.  
If no – what is it you are feeling hesitant about?  
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The following steps will have to be modified for participants who may be in wheelchairs.  
 
1. The patient is to take a peek in the open door of the HC, but not to enter.  
 
• The patient may want to know how the lock works to be sure about how it is 
opened from inside 
 
 The first task is to take a peek in the open door of the HC, but not to enter.  
o Please give me your SUDs rating right now 
 I will now do this myself and you just need to watch (do task). 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now take a peek in the open door of the HC, but not to enter. 
o [When task is finished] Please give me your SUDs rating 
 
2. Then the patient is encouraged to enter the HC with the therapist and close the door. 
 
• If they want to, the patient can exit  
 
 The second task is to enter the HC with me and to close the door.  
o Please give me your SUDs rating right now 
 I will now do this myself and you just need to watch (do task). 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now enter the HC with me and close the door. 
o [When task is finished] Please give me your SUDs rating 
 
3. The next step is to enter the HC with the therapist and close the door and sit down and 
stay there for a while.  
 
• While the patient is inside the therapist prompts him/her to constantly talk 
aloud and verbalise what and how he/she is doing and feeling. In this way 
tendencies to cognitive avoidance are greatly reduced.  
• After a while the patient may want to exit and talk with the therapist about the 
experience. 
 
 The third task is to enter the HC with me and to close the door and sit down, but 
this time to remain here for a while.  
o Please give me your SUDs rating right now 
 I will now do this myself and you just need to watch (do task). 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now enter the HC with me, close the door and sit down and 
remain with me for a while. 
o [When task is finished] Please give me your SUDs rating 
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4. The next step is for the patient to enter the HC again with the therapist, close the 
door, sit down, and stay there longer than before. 
 
• While the patient is inside the therapist prompts him/her to constantly talk 
aloud and verbalise what and how he/she is doing and feeling. In this way 
tendencies to cognitive avoidance are greatly reduced.  
 
 The fourth task is to enter the HC again with me, sit down, and to close the door 
and remain there longer than before.  
o Please give me your SUDs rating right now 
 I will now do this myself and you just need to watch (do task). 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now enter the HC with me, close the door, sit down, and remain 
there longer than last time. 
o [When task is finished] Please give me your SUDs rating 
 
• Ask patient to make conclusions on their catastrophic belief predictions  
 
5. The next step is to enter and sit in the HC with the door closed with the therapist. This 
time the technician will simulate chamber noise.  
 
Patient is to be told they will be feeling a change in pressure when they next enter. They 
will be taught the exercises used during hyperbaric treatment to clear the pressure in 
one’s ears.  
 The next step is to enter and sit in the HC with the door closed with therapist. This 
time the technician will simulate chamber noise.  
o Please give me your SUDs rating right now 
 I can do this first with you watching, or we can do it together? 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now enter and sit in the HC with the door closed with me. This 
time the technician will simulate chamber noise. 
o [When task is finished] Please give me your SUDs rating 
 
6. The next step is to enter and sit in the HC with the door closed. This time the door 
will be locked and the technician will put the pressure to approximately a ½m.   
 
 The next step is to enter and sit in the HC with the door closed with therapist. This 
time the door will be locked and the technician will give the chamber a tiny bit of 
pressure.  
o Please give me your SUDs rating right now 
 I can do this first with you watching, or we can do it together? 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
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 Please will you now enter and sit in the HC with the door closed with therapist. 
This time the door will be locked and the technician will give the chamber a tiny 
bit of pressure.  
 [When task is finished] Please give me your SUDs rating 
 
7. The next step is to enter and sit in the HC with the door closed. This time the door 
will be locked and the technician will put the pressure to approximately 2m. Exercises 
will be necessary.  
  
 The next step is to enter and sit in the HC with the door closed with therapist. This 
time the door will be locked and the technician will give the chamber a bit more 
pressure than last time and we will remain here for a few minutes. 
o Please give me your SUDs rating right now 
 I can do this first with you watching, or we can do it together? 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now enter and sit in the HC with the door closed with therapist. 
This time the door will be locked and the technician will give the chamber a bit 
more pressure than last time and we will remain here for a few minutes. 
 [When task is finished] Please give me your SUDs rating 
 
8. The next step for the patient is to begin to wear the headgear for a short while. 
 
This is to be done over by the bed area, with participants sitting or standing as 
appropriate.  
 
a. The patient is to put on the mask [hood] for a few moments without it being 
properly done up, and then can take it off straight away.  
 
 The patient is to put on the mask [hood] for a few moments without it being 
properly done up, and then can take it off straight away if they like. 
o Please give me your SUDs rating right now 
 I will now do this myself and you just need to watch (do task). 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now put on the mask [hood] for a few moments without it being 
properly done up, and then can take it off straight away if you like. 
 [When task is finished] Please give me your SUDs rating 
 
b. The patient is to put the mask [hood] on and do it up properly. They can take it off 
after a short while if they like. 
 
 The patient is to put on the mask [hood] and do it up properly. They can take it off 
after a short while if they like. 
o Please give me your SUDs rating right now 
 I will now do this myself and you just need to watch (do task). 
  
 
163 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now put on the mask [hood] and do it up properly. You can take it 
off after a short while if you like. 
  [When task is finished] Please give me your SUDs rating 
 
c. The patient is to put the mask [hood] on and do it up properly and leave it on for a 
few minutes.  
• While the patient is wearing the mask the therapist prompts him/her to 
constantly talk aloud and verbalise what and how he/she is doing and feeling. 
This may not be possible with the headgear, thus when the headgear comes off 
the patient is to talk about how they felt and did.  
 
 The patient is to put on the mask [hood] and do it up properly and leave it on for a 
few minutes. 
o Please give me your SUDs rating right now 
 I can do this first if you like, and you just need to watch (do task), or you can do it 
now. 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now put on the mask [hood] and do it up properly and leave it on 
for a few minutes. 
  [When task is finished] Please give me your SUDs rating 
 
How are you feeling? What does it feel like? Is your breathing ok? Is there anything 
worrying you at the moment? 
 
d. Repeat steps a) to c) with the hood.  
 
9. Then the patient will go through a series of steps that combine time in the HC as well 
as wearing the headgear for a set amount of time. They will be using the headgear 
that they will be using for their HBOT sessions.  
 
• The therapist and the participant are to talk about the participant’s catastrophic 
thoughts after each step. 
 
a. The patient is to enter the HC and then put the headgear on briefly, but not to 
attach it to the oxygen system. They do not need to close the door and they may 
exit when they wish.  
 
 The patient is to enter the HC, sit down, and then put the headgear on briefly, but 
not to attach it to the oxygen system. They do not need to close the door and they 
may exit when they wish. 
o Please give me your SUDs rating right now 
 I can do this first if you like, and you just need to watch (do task), or you can do it 
now. 
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 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now enter the HC and sit down and put the headgear on. You do 
not need to close the door and you may exit when you wish. 
  [When task is finished] Please give me your SUDs rating 
 
b. The patient is to now enter the HC and close the door, then put on the headgear 
and attach it to the oxygen system and sit there for a wee bit (without actual 
oxygen). 
 
 The patient is to now enter the HC and close the door, then put the headgear on 
and therapist will attach it to the oxygen system. The patient is to sit there for a 
wee bit (without actual oxygen). 
o Please give me your SUDs rating right now 
 I can do this first if you like, and you just need to watch (do task), or you can do it 
now. 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now enter the HC and close the door, put the headgear on and I’ll 
attach it to the oxygen system and you can sit there for a wee bit. You won’t be 
getting actual oxygen. 
  [When task is finished] Please give me your SUDs rating 
 
c. The patient is to now enter the HC and close the door, then put on the headgear 
and attach it to the oxygen system and sit there for a few minutes. This time the 
technician will release oxygen. 
 
 The patient is to now enter the HC and close the door, then put the headgear on 
and therapist will attach it to the oxygen system. The technician will release 
oxygen and the patient is to sit there for a few minutes. 
o Please give me your SUDs rating right now 
 I can do this first if you like, and you just need to watch (do task), or you can do it 
now. 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now enter the HC and close the door, then put the headgear on 
and I will attach it to the oxygen system. The technician will release oxygen and 
you are to sit there for a few minutes. 
  [When task is finished] Please give me your SUDs rating 
 
10. The final goal is that the patient should be able to stay inside the locked HC wearing 
their headgear, fully attached with oxygen and with the chamber at a small pressure, 
for approximately 10 minutes with a maximum Subjective Units of Disturbance 
rating of 20 (this may be adjusted depending on the level of the patient’s initial 
anxiety).  
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 The last step if for the patient to enter the HC and close the door, then the 
therapist will attach their headgear to the oxygen system. The technician will 
release oxygen and give the chamber a small feeling of pressure. The patient is to 
sit there for approximately 10 minutes with the therapist. 
o Please give me your SUDs rating right now 
 We will do this together now. 
 Do I have your permission to ask for you now to do this task?  
o Please give me your SUDs rating 
 Please will you now enter the HC and close the door, and then I will attach your 
headgear to the oxygen system. The technician will release oxygen and give the 
chamber a small feeling of pressure. We are to sit here for approximately 10 
minutes together. 
  [When task is finished] Please give me your SUDs rating 
 
 
Final step – The participant will be encouraged to continually expose him or herself 
post-treatment.  
 
Lastly, I do want to let you know that today may not make you completely “worry-
free” in terms of enclosed spaces, but it is a start for you to build upon. Although 
obviously you will not be able to practice on hyperbaric chambers in the future, 
when you come across situations that you’re worried about, I’d like you to try to use 
the skills you have learnt today to deal your worries and the situation. Are there any 
situations that you can see yourself avoiding and that you now might try and face? 
I.e. perhaps lifts, crowded places, goggles? Talk about future situations. 
 
The last thing we are going to do is to repeat the assessments we did at our previous 
session, so we can see the difference from before today’s session. Also, just before 
you leave I am going to give you the same set of questionnaires that you filled in 
previously we had. You will need to bring it completed to your first HBOT session.  
 
Do BATs, and then give the participant the questionnaire booklet. 
 
Thanks so much for your hard work today, you’ve done really well. How are you 
feeling?  
 
Together with the participant, talk about their anxieties before the therapy started, and 
compare to how they are feeling now. Go through how their anxieties changed step by 
step, as well as showing them the comparisons on their BATs. Hopefully, these should 
show that their avoidance behaviours have improved. Get the participant as involved as 
possible in making these comparisons.  
 
Thank them again for their hard work and go over with them when they will have 
their first hyperbaric session.  
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age sex p 
HBOT 
trait CLQ CLQ 
RS 
CLQ 
SS 
CEQ 
Exp 
CEQ 
Cre 
CEQ 
Tot 
ASI State 
1 
State 
2 
State 
3 
Tot # 
ses 
avg # 
HC 
SA 
Change 
DisAnx 
age 1.00 0.00 -0.25 -0.06 -0.04 -0.11 0.03 0.20 0.44 0.36 0.08 -0.01 -0.10 -0.10 -0.19 -0.14 0.15 0.03 
  N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p= --- p=.989 p=.242 p=.799 p=.856 p=.621 p=.897 p=.360 p=.033 p=.080 p=.706 p=.967 p=.683 p=.654 p=.397 p=.520 p=.513 p=.892 
sex 0.00 1.00 -0.45 0.35 0.41 0.32 0.46 -0.08 -0.11 -0.11 0.25 0.17 0.35 0.53 -0.12 0.00 -0.36 0.30 
  N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p=.989 p= --- p=.027 p=.096 p=.048 p=.128 p=.024 p=.712 p=.600 p=.606 p=.245 p=.429 p=.129 p=.014 p=.586 p=.982 p=.106 p=.151 
prev -0.25 -0.45 1.00 0.00 0.11 0.10 0.11 -0.16 0.02 -0.08 0.25 0.24 0.10 -0.15 0.46 -0.04 0.40 0.16 
HBOT N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p=.242 p=.027 p= --- p=.987 p=.605 p=.639 p=.601 p=.442 p=.922 p=.696 p=.243 p=.260 p=.662 p=.505 p=.028 p=.858 p=.069 p=.463 
trait -0.06 0.35 0.00 1.00 0.35 0.28 0.38 -0.19 -0.08 -0.16 0.78 0.28 0.61 0.30 -0.03 0.32 -0.12 0.92 
  N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p=.799 p=.096 p=.987 p= --- p=.096 p=.183 p=.065 p=.383 p=.695 p=.463 p=.000 p=.186 p=.004 p=.183 p=.888 p=.138 p=.606 p=.000 
CLQ -0.04 0.41 0.11 0.35 1.00 0.96 0.96 -0.11 -0.23 -0.19 0.40 0.18 0.40 0.48 -0.15 0.28 -0.20 0.40 
  N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p=.856 p=.048 p=.605 p=.096 p= --- p=.000 p=.000 p=.621 p=.282 p=.367 p=.053 p=.408 p=.077 p=.028 p=.486 p=.204 p=.377 p=.052 
CLQ  -0.11 0.32 0.10 0.28 0.96 1.00 0.84 -0.10 -0.30 -0.23 0.27 0.08 0.35 0.50 -0.22 0.28 -0.29 0.29 
RS N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p=.621 p=.128 p=.639 p=.183 p=.000 p= --- p=.000 p=.653 p=.160 p=.289 p=.202 p=.724 p=.130 p=.021 p=.304 p=.193 p=.201 p=.170 
CLQ  0.03 0.46 0.11 0.38 0.96 0.84 1.00 -0.11 -0.15 -0.15 0.49 0.26 0.43 0.43 -0.07 0.25 -0.12 0.47 
SS N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p=.897 p=.024 p=.601 p=.065 p=.000 p=.000 p= --- p=.619 p=.493 p=.494 p=.014 p=.221 p=.061 p=.050 p=.735 p=.253 p=.618 p=.019 
CEQ  0.20 -0.08 -0.16 -0.19 -0.11 -0.10 -0.11 1.00 0.50 0.87 -0.05 -0.44 -0.58 0.03 0.04 0.04 -0.34 -0.11 
Exp N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p=.360 p=.712 p=.442 p=.383 p=.621 p=.653 p=.619 p= --- p=.013 p=.000 p=.810 p=.031 p=.008 p=.902 p=.853 p=.868 p=.134 p=.607 
CEQ  0.44 -0.11 0.02 -0.08 -0.23 -0.30 -0.15 0.50 1.00 0.86 0.05 -0.23 -0.22 0.04 0.00 -0.18 -0.09 -0.01 
Cre N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p=.033 p=.600 p=.922 p=.695 p=.282 p=.160 p=.493 p=.013 p= --- p=.000 p=.829 p=.270 p=.342 p=.855 p=.992 p=.423 p=.709 p=.980 
CEQ  0.36 -0.11 -0.08 -0.16 -0.19 -0.23 -0.15 0.87 0.86 1.00 0.00 -0.39 -0.45 0.04 0.02 -0.08 -0.27 -0.07 
Tot   N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p=.080 p=.606 p=.696 p=.463 p=.367 p=.289 p=.494 p=.000 p=.000 p= --- p=.986 p=.058 p=.046 p=.848 p=.918 p=.720 p=.237 p=.754 
ASI 0.08 0.25 0.25 0.78 0.40 0.27 0.49 -0.05 0.05 0.00 1.00 0.51 0.38 0.08 0.20 0.21 0.27 0.97 
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  N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p=.706 p=.245 p=.243 p=.000 p=.053 p=.202 p=.014 p=.810 p=.829 p=.986 p= --- p=.011 p=.102 p=.747 p=.365 p=.340 p=.238 p=.000 
State  -0.01 0.17 0.24 0.28 0.18 0.08 0.26 -0.44 -0.23 -0.39 0.51 1.00 0.07 0.03 0.24 -0.07 0.66 0.44 
1 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p=.967 p=.429 p=.260 p=.186 p=.408 p=.724 p=.221 p=.031 p=.270 p=.058 p=.011 p= --- p=.771 p=.893 p=.278 p=.735 p=.001 p=.030 
State  -0.10 0.35 0.10 0.61 0.40 0.35 0.43 -0.58 -0.22 -0.45 0.38 0.07 1.00 0.25 0.18 0.12 -0.22 0.49 
2 N=20 N=20 N=20 N=20 N=20 N=20 N=20 N=20 N=20 N=20 N=20 N=20 N=20 N=19 N=20 N=20 N=19 N=20 
  p=.683 p=.129 p=.662 p=.004 p=.077 p=.130 p=.061 p=.008 p=.342 p=.046 p=.102 p=.771 p= --- p=.306 p=.440 p=.619 p=.365 p=.027 
State  -0.10 0.53 -0.15 0.30 0.48 0.50 0.43 0.03 0.04 0.04 0.08 0.03 0.25 1.00 -0.11 0.53 -0.73 0.17 
3 N=21 N=21 N=21 N=21 N=21 N=21 N=21 N=21 N=21 N=21 N=21 N=21 N=19 N=21 N=21 N=21 N=21 N=21 
  p=.654 p=.014 p=.505 p=.183 p=.028 p=.021 p=.050 p=.902 p=.855 p=.848 p=.747 p=.893 p=.306 p= --- p=.641 p=.014 p=.000 p=.459 
Tot  -0.19 -0.12 0.46 -0.03 -0.15 -0.22 -0.07 0.04 0.00 0.02 0.20 0.24 0.18 -0.11 1.00 -0.12 0.23 0.11 
# N=23 N=23 N=23 N=23 N=23 N=23 N=23 N=23 N=23 N=23 N=23 N=23 N=20 N=21 N=23 N=23 N=21 N=23 
Ses p=.397 p=.586 p=.028 p=.888 p=.486 p=.304 p=.735 p=.853 p=.992 p=.918 p=.365 p=.278 p=.440 p=.641 p= --- p=.576 p=.309 p=.605 
avg #  -0.14 0.00 -0.04 0.32 0.28 0.28 0.25 0.04 -0.18 -0.08 0.21 -0.07 0.12 0.53 -0.12 1.00 -0.43 0.27 
in HC N=23 N=23 N=23 N=23 N=23 N=23 N=23 N=23 N=23 N=23 N=23 N=23 N=20 N=21 N=23 N=23 N=21 N=23 
  p=.520 p=.982 p=.858 p=.138 p=.204 p=.193 p=.253 p=.868 p=.423 p=.720 p=.340 p=.735 p=.619 p=.014 p=.576 p= --- p=.050 p=.221 
State  0.15 -0.36 0.40 -0.12 -0.20 -0.29 -0.12 -0.34 -0.09 -0.27 0.27 0.66 -0.22 -0.73 0.23 -0.43 1.00 0.13 
Change N=21 N=21 N=21 N=21 N=21 N=21 N=21 N=21 N=21 N=21 N=21 N=21 N=19 N=21 N=21 N=21 N=21 N=21 
  p=.513 p=.106 p=.069 p=.606 p=.377 p=.201 p=.618 p=.134 p=.709 p=.237 p=.238 p=.001 p=.365 p=.000 p=.309 p=.050 p= --- p=.582 
Dis 0.03 0.30 0.16 0.92 0.40 0.29 0.47 -0.11 -0.01 -0.07 0.97 0.44 0.49 0.17 0.11 0.27 0.13 1.00 
Anx N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=24 N=20 N=21 N=23 N=23 N=21 N=24 
  p=.892 p=.151 p=.463 p=.000 p=.052 p=.170 p=.019 p=.607 p=.980 p=.754 p=.000 p=.030 p=.027 p=.459 p=.605 p=.221 p=.582 p= --- 
Whole sample correlations including both non-significant and significant results and p levels 
Note:  
Headgear was not included because patients were not always aware of the type of headgear that would wear for HBOT when they completed the questionnaires. 
Headgear was investigated through independent t-tests and chi square analysis.  
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age sex prev  trait CLQ CLQ  CLQ  CEQ  CEQ  CEQ  ASI State State State Tot # avg #  State  DisAnx 
  
    HBOT     RS SS Exp Cre Tot   1 2 3 ses in HC Chan   
age 1.00 0.02 -0.27 -0.02 -0.10 -0.19 -0.03 -0.04 0.35 0.21 0.10 0.15 0.01 -0.13 -0.19 -0.11 0.19 0.06 
  p= --- p=.922 p=.266 p=.932 p=.675 p=.448 p=.914 p=.856 p=.138 p=.394 p=.692 p=.550 p=.962 p=.588 p=.433 p=.657 p=.428 p=.821 
sex 0.02 1.00 -0.37 0.23 0.45 0.31 0.54 -0.04 0.16 0.09 0.15 0.11 0.26 0.58 -0.12 0.11 -0.35 0.19 
  p=.922 p= --- p=.124 p=.346 p=.054 p=.192 p=.017 p=.885 p=.504 p=.724 p=.535 p=.663 p=.286 p=.010 p=.613 p=.654 p=.138 p=.436 
prev  -0.27 -0.37 1.00 0.24 0.17 0.17 0.17 -0.23 -0.13 -0.22 0.44 0.42 0.24 -0.17 0.71 -0.15 0.40 0.39 
HBOT p=.266 p=.124 p= --- p=.324 p=.474 p=.477 p=.498 p=.354 p=.604 p=.363 p=.056 p=.073 p=.314 p=.497 p=.001 p=.551 p=.092 p=.102 
trait 
-0.02 0.23 0.24 1.00 0.39 0.34 0.41 -0.15 0.16 0.02 0.80 0.13 0.56 0.26 0.07 0.43 -0.10 0.92 
  p=.932 p=.346 p=.324 p= --- p=.102 p=.160 p=.083 p=.550 p=.522 p=.950 p=.000 p=.591 p=.013 p=.285 p=.782 p=.066 p=.673 p=.000 
CLQ -0.10 0.45 0.17 0.39 1.00 0.96 0.97 0.09 -0.18 -0.07 0.50 0.20 0.39 0.45 0.21 0.30 -0.19 0.48 
  p=.675 p=.054 p=.474 p=.102 p= --- p=.000 p=.000 p=.725 p=.451 p=.776 p=.031 p=.400 p=.101 p=.056 p=.385 p=.216 p=.430 p=.038 
CLQ  -0.19 0.31 0.17 0.34 0.96 1.00 0.88 0.20 -0.22 -0.03 0.38 0.10 0.30 0.48 0.18 0.32 -0.28 0.38 
RS p=.448 p=.192 p=.477 p=.160 p=.000 p= --- p=.000 p=.414 p=.362 p=.914 p=.108 p=.671 p=.212 p=.039 p=.449 p=.176 p=.244 p=.106 
CLQ  -0.03 0.54 0.17 0.41 0.97 0.88 1.00 -0.01 -0.14 -0.10 0.57 0.28 0.44 0.39 0.22 0.26 -0.11 0.53 
SS p=.914 p=.017 p=.498 p=.083 p=.000 p=.000 p= --- p=.953 p=.564 p=.676 p=.012 p=.248 p=.060 p=.096 p=.361 p=.286 p=.667 p=.019 
CEQ  -0.04 -0.04 -0.23 -0.15 0.09 0.20 -0.01 1.00 0.24 0.76 -0.16 -0.40 -0.49 0.14 -0.52 0.20 -0.36 -0.16 
Exp p=.856 p=.885 p=.354 p=.550 p=.725 p=.414 p=.953 p= --- p=.328 p=.000 p=.524 p=.093 p=.035 p=.576 p=.022 p=.419 p=.130 p=.512 
CEQ 0.35 0.16 -0.13 0.16 -0.18 -0.22 -0.14 0.24 1.00 0.81 0.16 -0.04 -0.01 0.09 -0.28 -0.23 -0.09 0.16 
Cre p=.138 p=.504 p=.604 p=.522 p=.451 p=.362 p=.564 p=.328 p= --- p=.000 p=.525 p=.877 p=.970 p=.701 p=.249 p=.341 p=.701 p=.502 
CEQ  0.21 0.09 -0.22 0.02 -0.07 -0.03 -0.10 0.76 0.81 1.00 0.01 -0.27 -0.30 0.15 -0.50 -0.03 -0.28 0.01 
Tot   p=.394 p=.724 p=.363 p=.950 p=.776 p=.914 p=.676 p=.000 p=.000 p= --- p=.972 p=.272 p=.211 p=.551 p=.029 p=.889 p=.244 p=.962 
ASI 0.10 0.15 0.44 0.80 0.50 0.38 0.57 -0.16 0.16 0.01 1.00 0.53 0.36 0.07 0.21 0.29 0.29 0.97 
  p=.692 p=.535 p=.056 p=.000 p=.031 p=.108 p=.012 p=.524 p=.525 p=.972 p= --- p=.021 p=.127 p=.771 p=.389 p=.227 p=.226 p=.000 
State 0.15 0.11 0.42 0.13 0.20 0.10 0.28 -0.40 -0.04 -0.27 0.53 1.00 -0.06 -0.03 0.47 -0.09 0.68 0.40 
1 p=.550 p=.663 p=.073 p=.591 p=.400 p=.671 p=.248 p=.093 p=.877 p=.272 p=.021 p= --- p=.812 p=.888 p=.042 p=.702 p=.001 p=.093 
State 0.01 0.26 0.24 0.56 0.39 0.30 0.44 -0.49 -0.01 -0.30 0.36 -0.06 1.00 0.25 0.29 0.13 -0.22 0.46 
2 p=.962 p=.286 p=.314 p=.013 p=.101 p=.212 p=.060 p=.035 p=.970 p=.211 p=.127 p=.812 p= --- p=.306 p=.227 p=.595 p=.365 p=.049 
State -0.13 0.58 -0.17 0.26 0.45 0.48 0.39 0.14 0.09 0.15 0.07 -0.03 0.25 1.00 0.06 0.55 -0.76 0.15 
  p=.588 p=.010 p=.497 p=.285 p=.056 p=.039 p=.096 p=.576 p=.701 p=.551 p=.771 p=.888 p=.306 p= --- p=.803 p=.015 p=.000 p=.542 
Tot # -0.19 -0.12 0.71 0.07 0.21 0.18 0.22 -0.52 -0.28 -0.50 0.21 0.47 0.29 0.06 1.00 -0.12 0.26 0.16 
ses p=.433 p=.613 p=.001 p=.782 p=.385 p=.449 p=.361 p=.022 p=.249 p=.029 p=.389 p=.042 p=.227 p=.803 p= --- p=.637 p=.277 p=.501 
avg # -0.11 0.11 -0.15 0.43 0.30 0.32 0.26 0.20 -0.23 -0.03 0.29 -0.09 0.13 0.55 -0.12 1.00 -0.46 0.36 
in HC p=.657 p=.654 p=.551 p=.066 p=.216 p=.176 p=.286 p=.419 p=.341 p=.889 p=.227 p=.702 p=.595 p=.015 p=.637 p= --- p=.045 p=.129 
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State  0.19 -0.35 0.40 -0.10 -0.19 -0.28 -0.11 -0.36 -0.09 -0.28 0.29 0.68 -0.22 -0.76 0.26 -0.46 1.00 0.15 
Change p=.428 p=.138 p=.092 p=.673 p=.430 p=.244 p=.667 p=.130 p=.701 p=.244 p=.226 p=.001 p=.365 p=.000 p=.277 p=.045 p= --- p=.539 
DisAnx 0.06 0.19 0.39 0.92 0.48 0.38 0.53 -0.16 0.16 0.01 0.97 0.40 0.46 0.15 0.16 0.36 0.15 1.00 
  p=.821 p=.436 p=.102 p=.000 p=.038 p=.106 p=.019 p=.512 p=.502 p=.962 p=.000 p=.093 p=.049 p=.542 p=.501 p=.129 p=.539 p= --- 
Casewise Deletion full correlation matrix  
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Correlation matrix including both non- and significant correlations for men 
  
age prev  trait CLQ CLQ  CLQ  CEQ  CEQ  CEQ  ASI State  State  State  Tot # avg #  State  DisAnx 
  
  HBOT     RS SS Exp Cre Tot   1 2 3 ses in HC Change   
age 1.00 -0.32 0.00 0.01 -0.08 0.15 0.02 0.38 0.24 0.16 0.12 0.08 -0.22 -0.15 -0.11 0.23 0.11 
  N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=14 N=15 N=16 N=16 N=15 N=17 
  p= --- p=.212 p=.987 p=.958 p=.746 p=.569 p=.950 p=.136 p=.361 p=.532 p=.652 p=.773 p=.441 p=.592 p=.693 p=.419 p=.685 
prev  -0.32 1.00 -0.07 0.09 0.12 0.04 -0.24 -0.13 -0.21 0.18 0.40 -0.17 0.04 0.33 -0.31 0.40 0.09 
HBOT N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=14 N=15 N=16 N=16 N=15 N=17 
  p=.212 p= --- p=.798 p=.740 p=.660 p=.887 p=.357 p=.630 p=.419 p=.501 p=.114 p=.560 p=.883 p=.217 p=.235 p=.137 p=.737 
trait 0.00 -0.07 1.00 0.07 0.02 0.14 0.37 0.18 0.32 0.71 0.17 -0.11 0.37 -0.14 0.60 -0.10 0.89 
  N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=14 N=15 N=16 N=16 N=15 N=17 
  p=.987 p=.798 p= --- p=.776 p=.935 p=.595 p=.142 p=.497 p=.217 p=.001 p=.523 p=.704 p=.177 p=.606 p=.013 p=.720 p=.000 
CLQ 0.01 0.09 0.07 1.00 0.96 0.92 -0.35 -0.11 -0.26 -0.13 0.00 -0.17 0.45 -0.49 0.25 -0.10 -0.06 
  N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=14 N=15 N=16 N=16 N=15 N=17 
  p=.958 p=.740 p=.776 p= --- p=.000 p=.000 p=.169 p=.675 p=.308 p=.609 p=.989 p=.552 p=.089 p=.052 p=.350 p=.731 p=.826 
CLQ  -0.08 0.12 0.02 0.96 1.00 0.78 -0.26 -0.14 -0.23 -0.20 -0.14 -0.05 0.51 -0.42 0.26 -0.27 -0.13 
RS N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=14 N=15 N=16 N=16 N=15 N=17 
  p=.746 p=.660 p=.935 p=.000 p= --- p=.000 p=.310 p=.597 p=.373 p=.431 p=.594 p=.855 p=.053 p=.101 p=.327 p=.329 p=.629 
CLQ  0.15 0.04 0.14 0.92 0.78 1.00 -0.43 -0.06 -0.27 -0.02 0.20 -0.35 0.33 -0.54 0.21 0.13 0.05 
SS N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=14 N=15 N=16 N=16 N=15 N=17 
  p=.569 p=.887 p=.595 p=.000 p=.000 p= --- p=.088 p=.830 p=.288 p=.943 p=.440 p=.219 p=.236 p=.031 p=.439 p=.640 p=.864 
CEQ 0.02 -0.24 0.37 -0.35 -0.26 -0.43 1.00 0.47 0.85 0.32 -0.42 0.08 -0.23 0.21 -0.04 -0.37 0.36 
Exp N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=14 N=15 N=16 N=16 N=15 N=17 
  p=.950 p=.357 p=.142 p=.169 p=.310 p=.088 p= --- p=.056 p=.000 p=.216 p=.095 p=.782 p=.402 p=.424 p=.884 p=.172 p=.151 
CEQ  0.38 -0.13 0.18 -0.11 -0.14 -0.06 0.47 1.00 0.87 0.31 -0.04 -0.07 -0.15 -0.11 -0.42 0.03 0.28 
Cre N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=14 N=15 N=16 N=16 N=15 N=17 
  p=.136 p=.630 p=.497 p=.675 p=.597 p=.830 p=.056 p= --- p=.000 p=.233 p=.870 p=.824 p=.584 p=.692 p=.107 p=.908 p=.285 
CEQ  0.24 -0.21 0.32 -0.26 -0.23 -0.27 0.85 0.87 1.00 0.36 -0.26 -0.01 -0.22 0.06 -0.28 -0.18 0.37 
Tot   N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=14 N=15 N=16 N=16 N=15 N=17 
  p=.361 p=.419 p=.217 p=.308 p=.373 p=.288 p=.000 p=.000 p= --- p=.153 p=.312 p=.982 p=.428 p=.831 p=.300 p=.523 p=.143 
ASI 0.16 0.18 0.71 -0.13 -0.20 -0.02 0.32 0.31 0.36 1.00 0.52 -0.49 -0.17 0.08 0.17 0.51 0.96 
  N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=14 N=15 N=16 N=16 N=15 N=17 
A
P
P
E
N
D
I
X
 
1
7
 
M
e
n
 
  
 
176 
  p=.532 p=.501 p=.001 p=.609 p=.431 p=.943 p=.216 p=.233 p=.153 p= --- p=.031 p=.074 p=.535 p=.757 p=.531 p=.054 p=.000 
State  0.12 0.40 0.17 0.00 -0.14 0.20 -0.42 -0.04 -0.26 0.52 1.00 -0.41 -0.02 0.25 -0.20 0.85 0.41 
1 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=14 N=15 N=16 N=16 N=15 N=17 
  p=.652 p=.114 p=.523 p=.989 p=.594 p=.440 p=.095 p=.870 p=.312 p=.031 p= --- p=.143 p=.946 p=.345 p=.462 p=.000 p=.098 
State  0.08 -0.17 -0.11 -0.17 -0.05 -0.35 0.08 -0.07 -0.01 -0.49 -0.41 1.00 0.34 -0.02 0.09 -0.48 -0.37 
2 N=14 N=14 N=14 N=14 N=14 N=14 N=14 N=14 N=14 N=14 N=14 N=14 N=14 N=14 N=14 N=14 N=14 
  p=.773 p=.560 p=.704 p=.552 p=.855 p=.219 p=.782 p=.824 p=.982 p=.074 p=.143 p= --- p=.229 p=.944 p=.758 p=.081 p=.188 
State  -0.22 0.04 0.37 0.45 0.51 0.33 -0.23 -0.15 -0.22 -0.17 -0.02 0.34 1.00 -0.13 0.28 -0.55 0.04 
3 N=15 N=15 N=15 N=15 N=15 N=15 N=15 N=15 N=15 N=15 N=15 N=14 N=15 N=15 N=15 N=15 N=15 
  p=.441 p=.883 p=.177 p=.089 p=.053 p=.236 p=.402 p=.584 p=.428 p=.535 p=.946 p=.229 p= --- p=.633 p=.306 p=.035 p=.899 
Tot #  -0.15 0.33 -0.14 -0.49 -0.42 -0.54 0.21 -0.11 0.06 0.08 0.25 -0.02 -0.13 1.00 -0.40 0.22 0.00 
ses N=16 N=16 N=16 N=16 N=16 N=16 N=16 N=16 N=16 N=16 N=16 N=14 N=15 N=16 N=16 N=15 N=16 
  p=.592 p=.217 p=.606 p=.052 p=.101 p=.031 p=.424 p=.692 p=.831 p=.757 p=.345 p=.944 p=.633 p= --- p=.123 p=.431 p=.996 
avg #  -0.11 -0.31 0.60 0.25 0.26 0.21 -0.04 -0.42 -0.28 0.17 -0.20 0.09 0.28 -0.40 1.00 -0.29 0.36 
in HC N=16 N=16 N=16 N=16 N=16 N=16 N=16 N=16 N=16 N=16 N=16 N=14 N=15 N=16 N=16 N=15 N=16 
  p=.693 p=.235 p=.013 p=.350 p=.327 p=.439 p=.884 p=.107 p=.300 p=.531 p=.462 p=.758 p=.306 p=.123 p= --- p=.290 p=.171 
State  0.23 0.40 -0.10 -0.10 -0.27 0.13 -0.37 0.03 -0.18 0.51 0.85 -0.48 -0.55 0.22 -0.29 1.00 0.30 
Change N=15 N=15 N=15 N=15 N=15 N=15 N=15 N=15 N=15 N=15 N=15 N=14 N=15 N=15 N=15 N=15 N=15 
  p=.419 p=.137 p=.720 p=.731 p=.329 p=.640 p=.172 p=.908 p=.523 p=.054 p=.000 p=.081 p=.035 p=.431 p=.290 p= --- p=.283 
DisAnx 0.11 0.09 0.89 -0.06 -0.13 0.05 0.36 0.28 0.37 0.96 0.41 -0.37 0.04 0.00 0.36 0.30 1.00 
  N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=17 N=14 N=15 N=16 N=16 N=15 N=17 
  p=.685 p=.737 p=.000 p=.826 p=.629 p=.864 p=.151 p=.285 p=.143 p=.000 p=.098 p=.188 p=.899 p=.996 p=.171 p=.283 p= --- 
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Correlation matrix including both non- and significant correlations for women 
  
age prev trait CLQ CLQ  CLQ CEQ  CEQ CEQ  ASI State  State  State Tot #  avg # State  DisAnx 
  
  HBOT     RS SS Exp Cre Tot   1 2 3 ses in HC Change   
age 1.00 -0.17 -0.19 -0.14 -0.19 -0.09 0.59 0.64 0.71 -0.08 -0.72 -0.40 -0.32 -0.34 -0.24 0.22 -0.13 
  N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p= --- p=.712 p=.686 p=.766 p=.690 p=.844 p=.162 p=.119 p=.076 p=.857 p=.071 p=.437 p=.536 p=.454 p=.609 p=.679 p=.781 
prev  -0.17 1.00 0.59 0.70 0.54 0.79 -0.22 0.12 -0.07 0.81 0.26 0.72 0.19 0.83 0.33 0.05 0.76 
 HBOT N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.712 p= --- p=.163 p=.081 p=.207 p=.033 p=.638 p=.793 p=.886 p=.026 p=.581 p=.109 p=.716 p=.020 p=.474 p=.918 p=.049 
trait -0.19 0.59 1.00 0.38 0.37 0.37 -0.74 -0.34 -0.63 0.84 0.53 0.99 0.03 0.34 0.04 0.11 0.94 
  N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.686 p=.163 p= --- p=.396 p=.413 p=.409 p=.057 p=.460 p=.128 p=.019 p=.226 p=.000 p=.949 p=.463 p=.931 p=.835 p=.002 
CLQ -0.14 0.70 0.38 1.00 0.97 0.98 0.10 -0.29 -0.09 0.73 0.42 0.42 0.25 0.38 0.34 0.00 0.62 
  N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.766 p=.081 p=.396 p= --- p=.000 p=.000 p=.825 p=.530 p=.845 p=.060 p=.351 p=.404 p=.634 p=.395 p=.449 p=.994 p=.135 
CLQ  
-0.19 0.54 0.37 0.97 1.00 0.89 0.09 -0.43 -0.17 0.64 0.44 0.38 0.32 0.18 0.33 -0.12 0.56 
 RS N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.690 p=.207 p=.413 p=.000 p= --- p=.008 p=.845 p=.336 p=.708 p=.120 p=.317 p=.459 p=.539 p=.703 p=.473 p=.827 p=.192 
CLQ  -0.09 0.79 0.37 0.98 0.89 1.00 0.11 -0.15 -0.02 0.77 0.37 0.44 0.18 0.54 0.34 0.09 0.65 
 SS N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.844 p=.033 p=.409 p=.000 p=.008 p= --- p=.816 p=.743 p=.973 p=.041 p=.410 p=.382 p=.733 p=.211 p=.455 p=.862 p=.118 
CEQ  0.59 -0.22 -0.74 0.10 0.09 0.11 1.00 0.52 0.89 -0.40 -0.66 -0.80 0.19 -0.28 0.11 -0.25 -0.56 
 Exp N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.162 p=.638 p=.057 p=.825 p=.845 p=.816 p= --- p=.231 p=.007 p=.369 p=.107 p=.058 p=.715 p=.540 p=.813 p=.626 p=.195 
CEQ  0.64 0.12 -0.34 -0.29 -0.43 -0.15 0.52 1.00 0.85 -0.22 -0.83 -0.31 0.21 0.19 0.10 -0.33 -0.27 
 Cre N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.119 p=.793 p=.460 p=.530 p=.336 p=.743 p=.231 p= --- p=.014 p=.642 p=.021 p=.547 p=.695 p=.685 p=.823 p=.519 p=.553 
CEQ  0.71 -0.07 -0.63 -0.09 -0.17 -0.02 0.89 0.85 1.00 -0.36 -0.85 -0.64 0.32 -0.07 0.12 -0.46 -0.49 
 Tot N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.076 p=.886 p=.128 p=.845 p=.708 p=.973 p=.007 p=.014 p= --- p=.426 p=.016 p=.170 p=.531 p=.881 p=.791 p=.354 p=.270 
ASI -0.08 0.81 0.84 0.73 0.64 0.77 -0.40 -0.22 -0.36 1.00 0.55 0.88 0.09 0.59 0.27 0.17 0.98 
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  N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.857 p=.026 p=.019 p=.060 p=.120 p=.041 p=.369 p=.642 p=.426 p= --- p=.203 p=.021 p=.869 p=.165 p=.565 p=.746 p=.000 
State  -0.72 0.26 0.53 0.42 0.44 0.37 -0.66 -0.83 -0.85 0.55 1.00 0.60 0.09 0.33 0.24 0.21 0.56 
 1 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.071 p=.581 p=.226 p=.351 p=.317 p=.410 p=.107 p=.021 p=.016 p=.203 p= --- p=.211 p=.860 p=.473 p=.607 p=.683 p=.190 
State -0.40 0.72 0.99 0.42 0.38 0.44 -0.80 -0.31 -0.64 0.88 0.60 1.00 0.03 0.66 0.09 0.15 0.96 
 2 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=5 N=6 N=6 N=5 N=6 
  p=.437 p=.109 p=.000 p=.404 p=.459 p=.382 p=.058 p=.547 p=.170 p=.021 p=.211 p= --- p=.963 p=.150 p=.859 p=.804 p=.002 
State -0.32 0.19 0.03 0.25 0.32 0.18 0.19 0.21 0.32 0.09 0.09 0.03 1.00 0.13 0.90 -0.95 0.07 
 3 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=5 N=6 N=6 N=6 N=6 N=6 
  p=.536 p=.716 p=.949 p=.634 p=.539 p=.733 p=.715 p=.695 p=.531 p=.869 p=.860 p=.963 p= --- p=.802 p=.015 p=.003 p=.896 
Tot #  -0.34 0.83 0.34 0.38 0.18 0.54 -0.28 0.19 -0.07 0.59 0.33 0.66 0.13 1.00 0.42 0.10 0.51 
 ses N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.454 p=.020 p=.463 p=.395 p=.703 p=.211 p=.540 p=.685 p=.881 p=.165 p=.473 p=.150 p=.802 p= --- p=.346 p=.845 p=.241 
avg #  -0.24 0.33 0.04 0.34 0.33 0.34 0.11 0.10 0.12 0.27 0.24 0.09 0.90 0.42 1.00 -0.75 0.19 
 in HC N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.609 p=.474 p=.931 p=.449 p=.473 p=.455 p=.813 p=.823 p=.791 p=.565 p=.607 p=.859 p=.015 p=.346 p= --- p=.086 p=.690 
State  0.22 0.05 0.11 0.00 -0.12 0.09 -0.25 -0.33 -0.46 0.17 0.21 0.15 -0.95 0.10 -0.75 1.00 0.15 
Change N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=6 N=5 N=6 N=6 N=6 N=6 N=6 
  p=.679 p=.918 p=.835 p=.994 p=.827 p=.862 p=.626 p=.519 p=.354 p=.746 p=.683 p=.804 p=.003 p=.845 p=.086 p= --- p=.772 
DisAnx -0.13 0.76 0.94 0.62 0.56 0.65 -0.56 -0.27 -0.49 0.98 0.56 0.96 0.07 0.51 0.19 0.15 1.00 
  N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=7 N=6 N=6 N=7 N=7 N=6 N=7 
  p=.781 p=.049 p=.002 p=.135 p=.192 p=.118 p=.195 p=.553 p=.270 p=.000 p=.190 p=.002 p=.896 p=.241 p=.690 p=.772 p= --- 
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APPENDIX 18 
 
Ideal Regression if Sufficient N 
 
Ideally, if the current study had sufficient n the following series of regressions would 
have been performed. These series would have allowed for controlling Trait Anxiety 
because of its theoretical relationship, in addition to State Anxiety for series two and 
three. However, because of insufficient n only a maximum of three predictors could be 
entered into each series.  
 
Series 1: Dependent Variable – State Anxiety at time one 
 
Step 1: Enter Trait Anxiety 
Step 2: Enter Claustrophobia scores and Anxiety Sensitivity 
 
AND 
 
Step 1: Enter Trait Anxiety 
Step 2: Enter Expectancy and Credibility 
 
Series 2: Dependent Variable – State Anxiety at time two 
 
Step 1: Enter Trait Anxiety 
Step 2: Enter State Anxiety at time one 
Step 3: Enter Claustrophobia scores and Anxiety Sensitivity 
 
AND  
 
Step 1: Enter Trait Anxiety 
Step 2: Enter State Anxiety at time one 
Step 3: Enter Expectancy and Credibility  
 
Series 3: Dependent Variable – State Anxiety at time three 
 
Step 1: Enter Trait Anxiety 
Step 2: Enter State Anxiety at time one 
Step 3: Enter State Anxiety at time two 
Step 4: Enter Claustrophobia scores and Anxiety Sensitivity 
 
AND 
 
Step 1: Enter Trait Anxiety 
Step 2: Enter State Anxiety at time one 
Step 3: Enter State Anxiety at time two 
Step 4: Enter Expectancy and Credibility  
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State Anxiety Change for Women from Times One, Two, and Three 
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APPENDIX 20 
 
 
Ethnicity Data as per Statistics New Zealand 2001 Census  
 
 
Ethnicity n (%) 
 
New Zealand European   22 (91.7%)  
Maori      1 (4.2%)  
Samoan     1 (4.2%) 
Cook Island Maori    0  
Tongan     0 
Niucan      0 
Chinese     0 
Indian      0 
Other      0 
 
 
 
 
Condition Prompting HBOT 
 
 
Condition n (%) 
 
Bubble Injury     0 
Acute Ischaemic Conditions   0 
Infective Conditions    0 
Radiation Tissue Damage   10 (41.7%) 
Problem Wounds    11 (45.8%) 
Gas Poisoning     0  
Ocular Ischemic Pathology   0 
Other (specify)    1 (4.2%) 
Miscellaneous (specify main)   2 (8.3%) 
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APPENDIX 21 
 
PERSONAL INFORMATION  
 
 
 
Attach patient label: 
 
 
 
 
First, we are interested in some things about you: 
 
Gender: Male  Female 
 
Which ethnic group or groups do you belong to? 
 
 
